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Abstract
Biocatalysis continues to emerge as a powerful technique for the efficient synthesis 
of optically pure pharmaceuticals that are difficult to access via conventional 
chemistry. The power of a biocatalytic stage can be enhanced if two or more 
reactions can be achieved by a single whole cell biocatalyst containing a pathway 
designed de novo to facilitate a required synthetic sequence. This will allow higher 
space-time yields and reduce the number of intermediate process steps required. The 
enzymes transketolase (TK) and transaminase (TAm) respectively catalyse 
asymmetric carbon-carbon bond formation and amine group addition to suitable 
substrate molecules. The ability of a transaminase to accept the product of the 
transketolase reaction can allow the two catalysts to be employed in series to create 
chiral amino alcohols from achiral substrates. These compounds are synthetically 
very useful in the production of a range of compounds with pharmaceutical 
application.
The p-alanine: pyruvate aminotransferase (p-A: P TAm) from Pseudomonas 
aeruginosa has been cloned, to create plasmid pQR426, for over-expression in E.coli 
strain BL21gold(DE3). The aromatic transaminase (ArTAm) from E.coli was also 
cloned, to create plasmid pQR416. The substrate specificity of the transaminases has 
been explored in order to assess the feasibility of functioning downstream of TK and 
the potential to access a wider range of TK-TAm pathway products. Both directed 
evolution and site directed mutagenesis have also been applied in order to facilitate 
acceptance of transketolase products. Over-expression of the p-A: P TAm alongside 
the native transketolase (from plasmid pQR411), in a single E.coli host, has created a 
novel bacterial biocatalyst capable of the synthesis of chiral amino alcohols via a 
synthetic two-step pathway. The feasibility of using the biocatalyst has been 
demonstrated by the formation of 2-amino-1,3,4-butanetriol (ABT) product, in up to 
21 % yield, by the p-alanine: pyruvate transaminase, via transamination of L- 
erythrulose synthesised by transketolase, from glycolaldehyde (GA) and p- 
hydroxypyruvate (p-HPA) substrates. The degradation of the amino alcohol product 
and the low activity of the transaminase, initial rate 0.1 mM.hr'1, relative to TK, 
initial rate 2.1 mM.min'1, are found to be limiting the process requiring further 
investigation.
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ABT 2-amino-1,3,4-butanetriol
ACN Acetonitrile
AmpR Ampicillin resistance
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IPTG Isopropyl-P-D-thiogalactosidase
KanR Kanamycin resistance
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Km Michaelis constant
MBA Methylbenzylamine
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OD Optical density
P.aeruginosa Pseudomonas aeruginosa
PCR Polymerase chain reaction
PHA Polyhydroxlalkanoates
PLP Pyridoxal phosphate
PMP Pyridoxamine phosphate
P.putida Pseudomonas putida
RBS Ribosome binding site
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis
TAm Transaminase
TFA Trifluoroacetic acid
TK Transketolase
TK-TAm Co-expressed transketolase and transaminase pathway
TLC Thin layer chromatography
TPP Thiamine pyrophosphate
Tris Tris(hydroxymethyl)aminomethane
UV Ultraviolet
Umax Maximal velocity
pmax Maximal specific growth rate
wpepPCR Whole plasmid error prone PCR
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Chapter 1 -  Introduction and Project Aims
1.1 Development of chiral pharmaceuticals
With the cost of drug discovery estimated at 0.8 to 1.3 billion $US per new 
compound (Schmidt, E. and Blaser, H.-U., 2003) the need for a reduction in overall 
costs of development and production are obvious. Additionally the competition from 
the drug candidates of other companies requires the timely development of a drug to 
minimise the time to market. The technology harnessed, to both develop and 
manufacture a drug, therefore needs to be cost effective, rapid and sustainable. The 
emphasis of either time or cost depends on the phase of development of a candidate 
drug (Yazbeck, D.R. et al, 2004). Initially, during the discovery phase of a candidate 
compound, when small amounts of material, i.e. lOmg -  lOOg are required, it is the 
time taken to produce material for further investigation and characterisation of 
pharmacological properties that is vital. Later on, when process development is 
being carried out and production at the kilogram and potentially the ton-scale, is 
required, process cost and sustainability become the defining parameters. A cost 
effective process requires conversion at the highest possible yield with the minimum 
of side products utilising materials that are affordable and available from reliable 
sources. The cost of goods is impacted by the value of process reagents. This 
includes both the starting materials and reagents used in each processing step, thus 
the number of processing steps can significantly increase overall costs. Productivity 
includes the output for time spent in the factory, which defines how many processing 
cycles can be completed in a given time, as well as the overall process product yield. 
Overall product yield is also impacted on by the number of processing steps since 
yield losses will be incurred at each stage. The type of process developed is further 
restricted by the sustainability of supply of materials, the availability of suitable 
facilities for operating the process, and in an age where the environmental issues are 
an important factor, the production and disposal of waste streams must be accounted 
for. Additionally, intellectual property issues may prevent the use of a certain 
technologies in a commercial process.
The increase in demand for the production of optically pure compounds has been 
largely driven by the pharmaceutical industry with 80% of compounds in the 
development pipeline being single-isomer compounds (Breuer, M. et al 2004). It is
16
now required by the regulatory bodies that characterisation of the single optical 
isomers of a chiral drug compound is carried out before licensing a drug for the 
marketplace (FDA, 1992). This has been forced by the recognition that two 
enantiomers of the same compound can have dramatically different pharmacological 
activities. For example, Verapamil is a drug where the (Sj-enantiomer is used to 
alleviate high blood pressure, whilst the (R)-enantiomer is used to inhibit the 
resistance of cancer cells to chemotherapy agents (Wainer, I.W., 1993). Secondly, 
the single isomers may have different selectivity, for example Ibuprofen where the 
(Sj-enantiomer of the drug is more selectively effective than the (7?)-enantiomer 
(Kelley, M.T. et al., 1992). Therefore, a single enantiomer formulation would have 
higher potency and thus require lower dosages, subsequently reducing the potential 
side effects of the drug (Stinson, S.C., 1994). Similarly, in the agro-chemical 
industry, single enantiomer compounds may reduce application volumes thus 
reducing cost and lessening the environmental impact.
The synthesis of optically pure products is often multi-step, employing complex 
chemistry and producing low product yields. This increase in complexity and 
subsequent cost of the production of homochiral compounds, versus racemates, has 
led to the development of several ‘toolboxes’ for asymmetric synthesis (Yazbeck,
D.R. et al, 2004). These approaches include asymmetric chemocatalysis, use of a 
precursor from a chiral pool, crystallisation of diastereomeric salts, biocatalysis, and 
chromatographic separation. These will be assessed during development of a process 
to find the most efficient process. The use of asymmetric chemocatalysis is an 
attractive option, particularly for hydrogenation reactions, although the scope of this 
technique may be limited by the commercial availability of catalyst, patent 
restrictions and the rarity of broad spectrum catalysts. Resolutions of racemic 
mixtures may be carried out by direct crystallisation, diastereomeric crystallisation, 
chromatography or enzyme kinetic resolution. However these all result in at least a 
50% yield loss so that, integration, especially later on in the processing scheme, is 
not ideal. Higher yields may be possible by the introduction of a re-racemisation 
step, of the unwanted isomer, into the process. For example, in the production of D- 
amino acids from racemic hydantoins using D-hydantoinase (Park, J.-H., Kim, G.-J., 
and Kim, H.-S., 2002). Crystallisation faces limitations due to the lack of 
development of efficient high throughput screening methods. However, the
17
generation of homochiral salts does result in ease of downstream processing. 
Chromatography faces high costs due to large waste streams and high cost of resins 
and scalability. Another approach to the synthesis of complex chiral compounds is 
the use of chiral synthons at the beginning of the synthesis. These are relatively 
simple enantiomerically pure starting compounds which provide the desired chirality 
in the reactions that follow. The selection of a chiral precursor from an existing 
chiral pool of compounds may be limited by the type of chemicals available, with the 
majority of commercial chiral molecules (being both cost effective as a precursor 
molecule and available at suitable quantities) being amino acids and simple 
carbohydrates.
Nature itself has demonstrated biological catalysts to have a role in the production of 
chiral molecules. For example, simple carbohydrates can serve as chiral starting 
materials for the synthesis of more complex molecules (Draths, K.M., et al. 1992). 
This is carried out by plants and microbes where the simple carbohydrate D-glucose 
is used as a starting material for the synthesis of amino acids and related metabolites. 
Biocatalysts may perform a synthetic or resolution role depending upon the particular 
reaction in question. The mild conditions under which most biocatalytic processes 
are operated reduce both running costs and the generation of toxic waste stream. 
Processes may also be applied to the synthesis of compounds other than that for 
which it is originally developed. This is due to the ability of many enzymes to accept 
a broad range of substrates. Biocatalysis faces limitations due to laborious screening, 
sensitivity to substrate and product concentrations, the need for specialist factory 
facilities and the problems of recovering products from aqueous process streams 
(Yazbeck, D.R. et al, 2004) . However, the intrinsic regio, chemo and stereo 
selectivity of biocatalysts along with advancements in both protein engineering and 
biochemical process engineering make biocatalysis a toolbox which now demands 
consideration for inclusion in a synthetic process (Rozzell, J.D., 1999).
An example of the assessment of different toolboxes has been described for the 
synthesis of a key chiral building block for the production of Ruprintrivir™, (Figure 
1.1) a remedy for the common cold (Tao, J., McGee, K., 2002; Yazbeck, D.R. et a l ,
2004). An initial process used a chiral non-natural amino acid a as a starting 
material in the discovery and development phase.
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Figure 1.1: Synthetic strategies for the production of Ruprintrivir™ chiral 
building block 2-hydroxy-4-fluorophenyl propionic acid.
(Adapted from (Yazbeck, D.R. et al., 2004)
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However, yields were below 50% and the starting material was very expensive 
therefore a better process was required for production scale. The use of an L-serine 
chiral synthon b was also investigated but the synthesis was long and resulted in 
yields below 42%. An asymmetric chemocatalysis approach for the hydrogenation 
of achiral ketone substrates c was assessed but low enantioselectivity or poor yield 
(for high enantioselective process) was prohibitive. Eventually a process employing 
lactate dehydrogenase to reduce an achiral ketoacid salt d to the 2-hydroxy-4- 
fluorophenyl propionic acid intermediate was developed. This process was useful 
not only in this instance but has broad selectivity giving the potential for the 
conversion of a range of ketoacid substrates to chiral hydroxy acids (Kim, M.-J. and 
Whitesides, G.M., 1998; Schmidt, E. et al., 1992; Simon, E. S., Plante, R. and 
Whitesides, G. M., 1989).
1.2 Industrial Biocatalysis
Biocatalysis has huge potential and despite much recent research, remains a 
relatively unexplored technology, with many organisms yet to be discovered and 
within those organisms many enzymes yet to be investigated (Cowan, D. et al.,
2005). Even with the already known organisms many proteins have unknown or 
only putative functions and even many of the identified enzymes have substrate 
ranges that are uninvestigated. Nevertheless the repertoire of biocatalysis tools is 
increasing steadily and it is becoming a toolbox that is considered as a viable option 
for many industrial chemical syntheses. This is reflected in a poll where it was 
reported 22 out of 38 large scale asymmetric syntheses involve enzyme, or whole 
cell bioconversions (Schmidt, E. and Blaser, H.-U., 2003). Processes including 
biocatalytic steps are extensively reviewed (Breuer, M. et al, 2004; Panke, S., Held, 
M. and Wubbolts, M., 2004; Patel, R.N., 2001; Schmid, A. et al., 2001; Schoemaker,
H.E., Mink, D. and Wubbolts, M.G., 2003; Schultze, B.M.W., Wubbolts, M.G., 
1999; Straathof, A., Panke, S. and Schmid, A., 2002). Some examples of the 
successful application of biocatalysis in industry are the use of acylases in the 
production of p-lactam antibiotics (De Vroom, E., 1999), the production of 
acrylamide from acrylonitrile employing nitrile hyratase (Nagasawa, T and Yamada,
H. 1990) and the industrial scale synthesis of chiral cyanohydrin (S)-meta- 
phenoxybenaldehyde, an intermediate in the synthesis of pyrethroid insecticide using 
recombinant (S)-hydroxynitrilase lyase (Griengl, H. et al, 1998).
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Alongside the increasing number of large-scale processes is the development of 
process technology to overcome some of the limitations of processes involving 
biological systems thus enhancing the viability of a biocatalytic step. This 
technology includes the use of continuous reaction and separation bioreactors 
(DeRoode, B.M. et al, 2001) and 'in situ’, product removal techniques (Hilker, I. et 
al., 2004; Lye, G.J.and Woodley, J.M., 1999), for continuous product removal and 
the use of packed bed reactors (Jeong, S. et al, 2000) which can improve volumetric 
productivity as well as alleviate product inhibition.
1.3 Multi-step Biocatalysis and Pathway Engineering
The literal meaning of ‘biocatalysis’ is the catalysis of a reaction using a biological 
entity. This includes fermentation methods where the metabolism of a living 
organism is used to produce desired compounds from simple starting materials. 
Biocatalysis also encompasses the use of enzymes discrete from the metabolism of 
the host strain and the use of isolated enzymes.
Advances in cloning and over-expression techniques have contributed to the 
construction of industrially useful recombinant biocatalysts. Cloning techniques 
enable the introduction of genes into a host organism where they may be more easily 
utilised than in the native host. Additionally, extension of existing pathways to reach 
a commercially desirable product may be possible by the addition of non-native 
enzymes. Over-expression of cloned genes can enable the production of large 
amounts of protein catalyst. This gives access to a huge number of gene products 
from organisms that are extremely challenging to cultivate on a scale that enables the 
generation of useful amounts of protein. The use of genetic manipulation to create a 
suitable recombinant biological catalyst to carry out desired reactions can be difficult 
and is a time consuming task. However, once completed a catalytic entity to carry 
out the conversion is gained. The recombinant strain itself may be used as the 
catalyst or the over-expressed enzyme more easily isolated for use in a purified 
enzyme process. Whilst this has been extensively investigated in the form of 
pathway engineering (Chotani, G. et al, 2000) the construction of non-natural 
pathways discrete from the host organisms metabolism is less well addressed.
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Pathway engineering is extensively used to exploit the native synthetic functions 
within the organism during fermentation to produce a higher titre of useful end 
product. An increase in product yield may be achieved by modifying metabolism to 
divert carbon towards the desired product. An example of this is the modification of 
the central metabolism in E.coli to divert carbon towards aromatic biosynthesis 
(alongside interruption of primary aromatic synthetic pathway regulation) to produce 
a strain overproducing tryptophan (Ikeda, M. and Katsumata, R., 1999). Similarly, 
the process developed for the manufacture of cystine (Maier, T. and Winterhalter, C, 
2000) utilises a metabolically engineered strain of E.coli which produces elevated 
levels of the amino acid. The excess cysteine, which is not utilised in metabolism, 
leaves the cells and is oxidised to cystine in the fermentation media. The addition of 
further enzymes to utilise naturally occurring compounds from an existing pathway, 
to form useful products, is also extensively exploited. There are many possible 
examples but one is the cloning of a dioxygenase from Pseudomonas into E.coli 
which enabled the production of indigo from indole, an intermediate of tryptophan 
biosynthesis (Ensley, B.D. etal, 1983).
Another example of pathway engineering is the production of polyhydroxlalkanoates 
(PHA), reviewed by Steinbuchel (Steinbuchel, A. and Lutke-Eversloh, T., 2003). 
PHAs are biopolymers synthesised by prokaryotic microorganisms (e.g. Ralstoni 
eutropha, Pseudomonas aeruginosa, and Bacillus megaterium) with industrially 
interesting properties. An example of an application is in the manufacture of 
biodegradable plastics. These polyoxoesters accumulate in the cytoplasm as 
inclusion bodies for the storage of energy and carbon. A range of PHAs can be 
produced by the use of different precursor substrates as the carbon source during 
cultivation of the microorganism. Metabolic engineering of various strains has been 
carried out to enable synthesis of various PHAs from metabolic pathways using 
different carbon sources.
The advancements in protein engineering and mutagenesis techniques have led to the 
possibility of the creation of a ‘designer’ biocatalyst that can carry out multi-step 
biocatalysis. Such an engineered biocatalyst will produce large quantities of the 
multiple enzymes involved in the desired synthesis. In this instance multi-step 
biocatalysis will refer to the use of multiple synthetic enzymatic reactions, not
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naturally carried out in series, independent from the metabolism of the host organism 
for the synthesis of a desired product within a single operation. The harnessing of 
multiple enzyme reactions has produced multiple examples of efficient biocatalytic 
pathways.
One example is the construction of a novel biochemical pathway for the production 
of L-2-aminobutyric acid (Fotheringham, G. et al., 1999; Fotheringham, G.I., 2001). 
The over-expression, of not only the key enzyme, E.coli aromatic transaminase, but 
of two further enzymes, to facilitate the reaction, was shown to significantly improve 
the yield and purity of the product (Figure 1.2). The auxiliary enzymes were E.coli 
K12 threonine deaminase, catalysing the in situ formation of transaminase substrate, 
2-ketobutyrate, from commercially available substrate L-threonine, and Bacillus 
subtilis acetolactate synthase, which eliminates the pyruvate by-product which 
enables conversion of over the 50% equilibrium limitation that the transaminase 
experiences.
The production of amino acids has been the subject of several coupled enzyme 
approaches. Using dehydrogenases (deaminating amino acid oxidoreductases) for 
amino acid production has been hampered by the high costs of the nicotinamide 
cofactors. This has been overcome by the simultaneous over-expression of 
heterologous genes to combine the synthetic enzyme and a cofactor recycling system 
employing formate dehydrogenase into the process (Galkin, A. et al., 1997). 
Subsequently, multi-enzyme schemes for the synthesis of both natural and non­
natural amino acids using dehydrogenases to carry out the reductive amination of 
keto acids to amino acids have been developed (Hanson, R.L. et al., 1999). 
Examples of this approach are two alternative syntheses for the antihypertensive 
Omapatrilat developed by Bristol Myers Squibb (Patel, R.N., 2001). The production 
of L-hydroxynorleucine, a useful chiral synthon used in Omapatrilat synthesis 
(Hanson, R.L. et al, 1999) was carried out using beef liver glutamate dehydrogenase 
(isolated enzyme).
This was coupled with a second dehydrogenase to carry out NADH cofactor 
regeneration. Initially the generation of the ketoacid substrate was via a multi-step 
chemical synthesis. This was overcome by the generation of the ketoacid substrate
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from the D-enantiomer of the more easily preparable racemic 6-hydroxynorleucine 
(by hydrolysis of the corresponding hydantoin) using D-amino acid oxidase (and 
catalase to remove H2 O2 by product). Near complete conversion of the racemate to 
the desirable L-isomer was achieved using this isolated enzyme scheme (Figure 1.3). 
Similarly, an alternative approach to the drug synthesis (Figure 1.4) utilised the 
production of amino acid acetal building block from keto-acid acetal by 
phenylalanine dehydrogenase along with the second dehydrogenase for cofactor 
recycling (Hanson, R.L. et al, 2000). Another multi-enzyme scheme for the 
production of L-amino acids involves the over-expression of enzymes L- 
hydantoinase, L-A-carbamoylase and hydantoin racemase from Arthrobacter 
aurescens in E.coli. The resulting biocatalyst is capable of the fast and complete 
conversion of racemic hydantoins to the corresponding L-amino acids (Wilms, B. et 
al., 2001).
A final example is, again, the synthesis of polyhydroalkanoic acids (polyesters). 
Whilst much work has been done to metabolically engineer strains to produce these 
useful materials via metabolic pathways from simple carbon sources, reviewed in 
Steinbuchel, A. and Lutke-Eversloh, T., 2003, a novel bacterial biocatalyst to process 
unnatural substrates independent of metabolism has also been engineered (Liu, S.-J. 
and Steinbuchel, A., 2000). This involved the construction of a novel pathway over­
expressing two Clostridium acetobutylicum genes, butyrate kinase and 
phosphotransbutyrylase alongside the polyhydroalkanoic acid synthase from 
Thiocapsa pfenniggi (or Allochromatium Vinosum) in E.coli. The non-native 
pathway had low substrate specificity with the ability to accept un-natural substrates 
thus creating a versatile catalyst. The pathway has been demonstrated to synthesise 
various homo and co-polyesters as well as polythioesters (Steinbuchel, A. and Lutke- 
Eversloh, T., 2003). A recombinant E.coli strain with a similar pathway has been 
constructed for the production of (R)-3-hydroxybutyrate (Gao, H.-J., Qiong, W.U. 
and Chen, G.-Q., 2002). This involves the two Clostridium acetobutylicum genes in 
the previous pathway, functioning in the reverse, along with P-ketothiolase and 
acetoacetyl-CoA reductase from Ralstonia eutrophia.
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(Reproduced from Fotheringham, G. et al., 1999)
25
Glucose
dehydrogenase
Gluconic acid ^ ----------  G lucose
T. variablis n a d h  n a d +
D-amino acid
oxidase
o h  _
Glutamate
HO
o
6-hydroxynorleucine + NHs dehydrogenase L-6-hydroxynorleucine
HO
O
L-6-hydroxynorleucine
+
Catalase
H2°2   ► OH2 +  02
+
NH,
Figure 1.3: Enzymatic scheme for the conversion of racemic hydroxynorleucine 
to L-hydroxynorleucine for the synthesis of Omapatrilat.
Formate
dehydrogenase
A m m onium  form ateCO.
N AD+NADH
/  Phenylalanine
NH, , . \3 dehydrogenase
o
OH
Figure 1.4: Enzymatic preparation of acetal intermediate for the synthesis of 
Omapatrilat.
26
1.4 Chiral amines
Whilst amino acids are in huge demand, predominantly by the nutrition industry, an 
increase in demand for optically pure non-proteinogenic amino acids and amines is 
coming from the pharmaceutical sector. The large scale synthesis of chiral amine 
products has been increasingly investigated due to the demand for single enantiomer 
peptidomimetic drugs. The development of rational target structure based drug 
design has led to an increased number of these drugs in development.
Optically pure non-proteinogenic amino acids and amines serve as precursors and 
building blocks for these complex molecules. Some examples of chiral amines in 
commercial molecules include L-tert-leucine (Kempf, D.J. et al., 1991) in an HIV 
protease inhibitor used in AIDS therapy (Figure 1.5 (A)), D-phenylalanine (Bajusz, 
S., et al., 1990) in a structure which targets thrombin to provide treatment for 
thrombosis (Figure 1.5 (B)) and L-6 -hydroxynorleucine (Patel, R.N., 2001) an 
intermediate for antihypertensive Omapatrilat (Figure 1.5 (C)). The non-
proteinogenic amino acids can not be manufactured by the fermentation strategies 
used in the production of L-amino acids. Thus significant effort has been focused on 
identifying strategies for the synthesis of both optically pure un-natural amino acids, 
amines and hydroxy amines (Breuer, M., et al., 2004).
1.4.1 Chemical synthesis routes to chiral amines
Chemical routes to chiral amines are both via resolutions of racemic amines and 
synthetic strategies. Amines can be synthesised in the racemic form then a resolution 
carried out (therefore 50% max yield) to obtain the optically pure amine. A 
resolution technique that could be employed for chiral amines is a diastereomeric 
crystallisation with chiral carboxylic acids (Jacques, J., Collett, A. and Wilen, S., 
1980). This is the formation of a diastereomeric ammonium salt followed by 
fractional crystallisation separating out the enantiomers. The scope of this is limited 
by the chemical characteristics of the amine and availability of a carboxylic acid 
resolving agent of the required chirality. A variation on the classical resolution 
approach is the ‘Dutch resolution’ (Vries, T. et al., 1998). This method combines a 
mixture of optically active acids to precipitate the salt. It is a more versatile 
approach than the use of a single carboxylic acid.
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Figure 1.5: Examples of peptidomimetic drugs
(A) Peptidomimetic HIV protease inhibitor containing L-/m-leucine
(B) Compound containing D-phenylalanine used in thrombosis therapy
(C) Omapatrilat an antihypertensive synthesised from the chiral amine intermediate 
L-6 -hydroxynorleucine
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However recovery of the chiral acids for reuse is difficult as they become a complex 
mixture in the mother liquor of the precipitated salt. The 50% sacrifice in the yield 
by the use of a resolution can be lessened by re-racemisation of the unwanted 
enantiomer and further resolution carried out.
More favourable are synthetic routes enabling yields above the 50% limit of a 
resolution of a racemate. Synthetic methods include the chemical reduction of amino 
acids to form the corresponding amino alcohols as has been developed by chemists at 
Degussa. Starting with a chiral amino acid reduction of the carbonyl of the acid 
group is carried out with reducing agent NaBH4 in the presence of an activator 
(either I2 or H2SO4) (Bommerius, A. et al, 1996; Meyers, A.I. et al, 1994). 
Alongside numerous methodologies for the production of both unnatural and natural 
amino acids this methodology has the scope to access a broad range of amino 
alcohols. The asymmetric production of amines can also be carried out by the 
hydrogenation of C=N bonds (Johansson, A., 1995).
1.4.2 Enzymatic approaches to chiral amines
Enantiopure amino acids can be accessed via several enzymatic syntheses and 
resolutions. Resolution of racemates includes the resolution of racemic hydantoins 
by hydantoinase with carbomylase (May, O., Nguyen, P.T. and Arnold, F.H., 2000; 
Park, J.-H., Kim, G.-J. and Kim, H.-S., 2000; Park, J.H. et al., 2002; Wilms, B. et al., 
2001), resolution of D,L-acyl amino acids using acylases (Machado, G.D.C. et al., 
2005), resolution of racemic amino acid amides with amidases (Eichhorn, E. et al., 
1997; Wang, M.-X. et al., 2005) and the production of chiral amines via lipase 
catalysed resolution of racemic amines (Goswami, A. et al., 2005). The resolution 
approach to a product not only requires a racemic amine substrate but, as stated 
previously, is limited to a 50% maximum yield. Systems to overcome this yield 
limitation have been developed for example in the synthesis of L-hydroxynorleucine 
(Patel, R.N., 2001), previously discussed in Section 1.3, where the unwanted isomer 
is converted into a ketone by an oxidase, followed by stereospecific reductive 
amination to the desired chiral amine. This is not always a feasible approach 
requiring two enzymes with the correct substrate range to synthesise the amine. 
Thus it is the synthetic approach from achiral ketones that attention has been focused 
on.
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Common synthesis reactions include the use of lyases (van der Werf, M.J. et al, 
1995), dehydrogenases and transaminases (Stewart, J.D., 2001). The number of 
papers and US patents filed, by biotechnology companies such as Diversa 
Corporation, (Warren, P.V. and Swanson, R.V., 1999), NSC Technologies 
(Fotheringham, G.I., 2001) and Celgene corporation (Stirling, D.I., 1992; Stirling,
D.I. et al., 1992) involving transaminase reactions perhaps illustrates their potential 
as commercial synthetic tools. Transaminases can be utilised in either a resolution or 
synthetic capacity and require no external cofactor recycling as the pyridoxal 
cofactor is recycled during the reaction cycle. The resolution of a racemic amine is 
achieved by the transfer of the amine group from the unwanted enantiomer to a 
ketone substrate leaving the desired isomer intact. An asymmetric synthesis reaction 
catalysed by a transaminase is carried out by transamination of the corresponding 
ketone precursor. Additionally co-transaminases enable synthesis of various non 
acidic amines (Stirling, D.I., 1992).
1.5 Asymmetric carbon-carbon bond formation
If asymmetric amine synthesis can be carried out using a chiral substrate the 
complexity of the product is increased. The synthesis of a ketone substrate 
containing a chiral centre from achiral starting materials requires asymmetric carbon- 
carbon bond formation. As with the production of optically pure amines asymmetric 
carbon-carbon bond formation presents significant challenges to synthetic chemistry. 
The production of side products and the requirement for protection (and subsequently 
de-protection) of other functional groups on the reactants make chemical routes 
cumbersome (Schoemaker, H.E. Mink, D. and Wubbolts, M.G., 2003)
1.5.1 Enzymatic synthesis of C-C bonds
Several enzymes are capable of the synthesis of ketones containing asymmetric 
carbon-carbon bonds. These include pyruvate decarboxylase (Shin, H.S.and Rogers, 
P.L., 1996), Dox P synthase (Kuzuyama, T. et al., 2000), Fructose-1,6 -diphospahte 
aldolase (Fessner, W.-D. and Helaine, V., 2001) and transketolase (TK) (Turner, 
N.J., 2000). TK (E.C.2.2.1.2) catalyses the formation of asymmetric keto diols via 
the transfer of a two carbon ketol group between several acceptor and donor 
substrates in a reaction dependant upon the presence of thiamine pyrophosphate and 
a divalent metal ion cofactor. The formation of the new carbon-carbon bond is
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highly stereospecific and the reaction can be effectively irreversible if a (3 - 
hydroxypyruvate ketol donor substrate is employed yielding CO2 as a product 
(Hobbs, G.R. et al., 1993). A wide range, of both phosphorylated and un 
phosphorylated compounds, have been found to be accepted as substrates for 
transketolases (Andre, C. et al, 1998; Draths, K.M. et aL, 1992; Effenberger, F. Null, 
V. and Zeigler, T., 1992; Hobbs, G.R. et al., 1993; Humphrey, A.J. et al., 2000; 
Morris, K.G. et al., 1996; Sprenger, G.A. et al., 1995). This has led to the enzyme 
being extensively investigated for its synthetic potential. The development of a stable 
strain over expressing TK (French, C. and Ward, J.M., 1995) and a large scale 
production process (Hobbs, G.R. et al, 1996) has enabled the enzyme to be produced 
in significant quantities for use as a biocatalyst.
1.6 Enzymatic synthesis of amino diols
The production of chiral amino diols via biocatalysis has the potential to yield amino 
alcohols with multiple chiral centres from achiral starting materials. This can be 
achieved if transketolase catalysing chiral ketone formation (Section 1.5.1), from 
either achiral or chiral substrates, is coupled with the biocatalytic addition of an 
amine to the TK product using a transaminase (Section 1.4.2). Using transketolase a 
variety of reaction products can be accessed. In order to couple the two enzymes 
together assessment of possible TK reactions and possible transaminase candidates to 
react with the product of the TK catalysis is required. These are considered in 
Section 1.8 and Section 1.10 respectively.
1.7 Properties of Transketolase
Bacteria are dependent on transketolase for the catabolism of pentose sugars. These 
provide D-ribose 5-phosphate, the precursor for nucleotide and histidine biosynthesis 
and erythrose-4-phosphate required for the biosynthesis of aromatics. E.coli mutants 
deficient in TK are auxotrophic for pyridoxine and a combination of aromatic acids 
and are unable to grow on pentoses, D-arabinose, D-ribose and D-xylose, alone 
(Zhao, G. and Winkler, M.E., 1994). TK has been identified as a candidate enzyme 
for manipulation to enable improved percent conversion of D-glucose into aromatic 
biosynthesis in E.coli. Increasing TK activity has been found to increase the level of 
D-erythrose-4-phosphate (Draths, K.M. et al., 1992) which is a substrate for 3- 
deoxy-D-arabino-heptulosonic acid 7-phosphate (DHAP) synthase, the first enzyme
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unique to the pathway for aromatic amino acid synthesis. The increase was proposed 
as beneficial for the production of fermentation products such as aromatic amino 
acids as well as other commercially useful products. This was demonstrated by the 
synthesis of higher concentrations of the commercially valuable fine chemical 3- 
dehydroxyshikimic acid from glucose with an E.coli strain expressing elevated TK 
and DHAP synthase (Li, K. and Frost, J.W., 1999).
The activity of bacterial transketolase was first discovered in E.coli in 1948 (Racker, 
E., 1948) when cleavage of ribose-5-phosphate by E.coli crude extract was first 
observed. In 1952 transketolase was identified as the enzyme catalysing this process 
(de la Haba, G. and Racker, E., 1952). Transketolase is involved in metabolic 
regulation playing a key role in the non-oxidative pentose phosphate cycle. It 
catalyses the reversible transfer of a two carbon ketol group between several acceptor 
and donor substrates in a reaction dependant upon the presence of thiamine 
pyrophosphate and a divalent metal ion cofactor (Figure 1.6). The catalytic 
mechanism, proposed by Schneider and Lindqvist (Schneider, G. and Lindqvist, Y., 
1993), involves the formation of an addition complex with the carbonyl of the ketose 
substrate and the ionised TPP cofactor. Substrate cleavage occurs yielding activated 
glycolaldehyde and an aldose is liberated. Nucleophilic attack upon the aldehyde 
acceptor substrate then yields the new ketose product. In vivo, TK provides the link 
between the glycolytic and pentose phosphate pathways catalysing the reversible 
transfer of a two carbon ketol group between ribose-5-phosphate and D-erythrose 
and donor phosphorylated sugar substrates xylulose-5-phosphate, fructose 6 - 
phosphate and sedoheptulose-7-phosphate (Datta, A.G. and Racker, E., 1961; Draths, 
K.M. etal., 1992).
The transketolase enzyme exhibits a high degree of stereoselectivity recognising the 
chirality of a hydroxyaldehyde substrate with a preference for the (R) isomer. This 
has been demonstrated with E.coli TK by a comparison of catalysis with D and L- 
glyceraldehyde. In reactions with p-HPA the reaction with D-glyceraldehyde was 
rapid whilst reactivity with L-glyceraldehyde was negligible in the reaction time 
monitored (Morris, K.G. et al., 1996).
32
o
V  O H
H O O C ^ ^  
Hydroxypyruvate
R,
Transketolase o
+
°  TPP, M g2+ OH
Aldehyde Ketoalcohol
+ CO,
Figure 1.6: The transketolase catalysed reaction scheme
Transketolase catalyses the transfer of a 2-carbon ketol group from P-HPA to an 
aldehyde acceptor. This catalysis requires a divalent cation Mg2+ and TPP cofactor. 
The liberation of CO2 from the reaction renders the reaction irreversible.
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The product of a TK synthesised reaction contains an (S) stereo centre yielding 
products with D-threo (35,4/?) stereochemistry. The ability of TK to accept a range 
of aldehyde substrates gives the potential to access a large number of chiral products. 
Aldehyde specificity has been found to vary between transketolases from different 
organisms (Sprenger, G.A. et al., 1995). The TK enzyme from E.coli has been found 
to catalyse a range of reactions with both phosphorylated (Figure 1.7) and non- 
phosphorylated substrates (Tablel.l). Due to this and the availability of a strain 
already established for production of the enzyme it was chosen as the transketolase 
for this work.
1.8 Selection of target reaction
It is sensible to select a target reaction for the linked enzymes for which one reaction 
is already well established. Since TK has been extensively studied ‘in house’ 
(Brocklebank, S. et al., 1996; Hobbs, G.R. et al., 1996, 1996; Mitra, R.K., 1997; 
Mitra, R.K. and Woodley, J.M., 1996; Mitra, R.K., Woodley, J.M. and Lilly, M.D., 
1998; Morris, K.G. et al., 1996) it is logical to pick an already established TK 
reaction and investigate the transaminases to accept the product. The chosen reaction 
should yield products resembling known TAm products as far as possible. The 
selection of the transketolase catalysed reaction for the pathway target reaction 
requires the consideration of several factors. These factors are the availability of 
substrates, the percentage conversion achievable, the rate of reaction and the ability 
to monitor the reaction components including the availability of product standards. 
The published data on substrate specificity is presented as either relative velocity of 
reaction or the percentage conversion achieved depending on the individual study, 
comparing data is, therefore, a little difficult. The reactions that are most 
successfully demonstrated in the literature are illustrated in Table 1.1. Additionally 
the availability of transketolases that can accept heteroaromatic substrates further 
widens the potential choice of reaction (Bacon, S.L., 2001). However these enzymes 
require further characterisation so were not considered as candidates for the 
development of the initial demonstration of the TK-TAm pathway.
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Table 1.1: Transketolase catalysed reactions
The most successful TK aldehyde substrates and products from reaction with p-HPA 
found in the published literature are shown. Activity is measured as percentage 
conversion or Vrei where Vrei = 100 for glycolaldehyde.
Aldehyde substrate Product from reaction with HPA Vrel or % yield Reference
h<Oio
Glycolaldehyde
o
/OH
HO
OH
L-erythrulose
% yield = 74
vre, =
100
(Morris, 
K.G. et al., 
1996)a 
(Hobbs, 
G.R. et al., 
1993)b
OH 
OH O
D-erythrose
OH 0
/O H
HO
OH OH
D-fructose
V reF  89
(Hobbs, 
G.R. et al., 
1993)
OH
"OrS
OH 0
L-threose
OH O 
OH OH
xotOII>
(Hobbs, 
G.R. et al., 
1993)
OH OH 
OH O
D-ribose
OH OH O 
OH OH
Sedoheptulose
V = 2 5v max —
relative to 
Vmax = 60 for 
GA
(Sprenger, 
G.A. et al., 
1995)c
OH
o
glyceraldehyde
OH O 
OH
xylulose
vre, =
37 (using 
racemic 
substrate)
(Hobbs, 
G.R. et al., 
1993)
Continued
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Continued from previous page
Aldehyde substrate Product from reaction with HPA Reference
% yield = 
80%
(Humphrey, 
A.J., et al., 
2000)d
OH OH
OH
OH
5-O-benzyl-D-xylulose
3-O-benzylglyceraldehyde
OH % yield = 
56%
(Humphrey, 
A.J., et al., 
2000)
OH
OH
(Morris, 
K.G. et al., 
1996)
% yield 
= 23%
OH
OH
OH
(Morris, 
K.G. et al., 
1996)
% yield = 
33:18
OH
OH OH
OH
(Hobbs,Vrei = 20 
% yield = 
29%
OH
1996) 
(Morris, 
K.G. et al., 
1996)
Propionaldehyde OH
a = reactions run at 6.9 mM (3-HPA 13.8 mM aldehyde, with TK 600U, autotitrated to pH7.0 at room 
temperature, % yield calculated with respect to |3-HPA concentration. b= reactions run at 7.5 Mm  
HPA 100 mM aldehyde, with TK 50U  at pH 7.6, in glygly buffer at 37°C. Vrei was determined by 
analysis o f  HPA and is presented relative to the rate o f the reaction with glycolaldehyde = 100. c = 
Vmax determined using enzym e linked assays see reference for details, d = conditions as in a except 
racemic aldehyde used with yield calculated with respect to the reactive enentiomer concentration.
36
The TK reaction with glycolaldehyde is both a swift reaction, with the Vre] being 
used as 100 to compare other substrates to, and giving high yields of 74% under the 
conditions tested. Other promising reactions considered are with 3-0- 
benzylglyceraldehyde (80% conversion) and D-erythrose. Both of these reactions 
yield multiple stereocentres. This may present significant challenge to a TAm in the 
multi-enzyme pathway requiring accommodation of multiple branching from the 
main carbon chain (Section 1.7). Additionally the accommodation of the ester and 
benzyl group of 3-O-benzylglyceraldehyde may be troublesome. Whilst the product 
from the erythrose reaction is commercially available that from the 3-O- 
benzylglyceraldehyde reaction would require synthesis to provide TAm substrate to 
investigate the candidate transaminases and for product standards. The reaction with 
glycolaldehyde has previously been studied ‘in house’ (Hobbs, G.R., 1994; Hobbs, 
G.R. et a l , 1993; Mitra, R.K., 1997; Mitra, R.K., Woodley, J.M. and Lilly, M.D.,
1998) therefore the reaction protocols, substrates and product standards and 
analytical assays (Mitra, R.K. and Woodley, J.M., 1996) are readily available. The 
reaction with glycolaldehyde and P-HPA was therefore selected as the first reaction 
in the target two-step synthesis.
The second enzyme in the pathway is a transaminase catalysing the transfer of an 
amine onto a ketone substrate. The model reaction for the TK-TAm pathway (Figure 
1.8) with the first reaction forming L-erythrulose will result in the synthesis of 2- 
amino-l,3,4-butanetriol (ABT). Note that the final stereochemistry of the product 
will depend upon the stereospecificity of the enzyme used to catalyse the 
transamination step. However, to date, no transaminase that catalyses the 
transamination of L-erythrulose has been reported. It is therefore necessary to 
investigate which transaminases are likely candidates for use in the pathway.
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o Transketolase O
OH + HO
HOOC
Hydroxypyruvate
HO
O TPP, Mg2+
OH
+ CO,
Glycolaldehyde OH
L-erythrulose
Amine
Transaminase
Ketone
PLP
HO
NH,
^  OH
OH
2-amino-1,3,4-butanetriol
Figure 1.8: Target reaction scheme
The synthesis of chiral amino alcohol 2-amino 1,3,4-butanetriol from achiral 
substrates glycolaldehyde and hydroxypyruvate using a TK-TAm pathway.
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1.9 Chemical synthesis of pathway product
Although the target reaction is primarily selected to demonstrate the feasibility of the 
engineering of a novel biocatalyst to carry out the TK and TAm reactions in series, 
the pathway product 2-amino-1,3,4-butanetriol (ABT) is coincidently a useful 
product itself. The number of recent papers addressing the chemical synthesis of 
chirally pure ABT illustrates the importance of these compounds as chiral synthons 
(Dequeker, E. et al., 1995; Fadnavis, N.W., Sharfuddin, M. and Kumara Vadivel, S., 
2001; Kwon, S.J. and Ko, S.Y., 2001; Kwon, S.J. and Ko, S.Y., 2002; Merino, P. et 
al., 2002). These compounds have been used as building blocks for statins used in 
the synthesis of protease inhibitors (Kwon, S.J. and Ko, S.Y., 2002), in particular in 
the synthesis of Nelfinavir™ (Figure 1.9), an HIV-protease inhibitor (Kaldor, W.K., 
et al., 1997). ABT is also (in its fully protected form) an intermediate in the 
synthesis of Detoxinine a detoxifying agent used for reducing the toxicity of the 
antibiotic treatment for rice blast disease (Monache, G.D., Misiti, D. and Zappia, G.,
1999). The broad substrate ranges of the TK and TAm enzymes to be investigated, 
and the scope for enlarging the substrate repertoire by mutagenesis, suggest the novel 
biocatalytic TK-TAm pathway will be able to produce other synthetically useful 
amino diol compounds.
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1.10 Transaminases for investigation
Transaminases, or aminotransferases, belong to the E.C.2.6.1 class of transferases 
and are widely distributed throughout nature owing to their important role in 
metabolic pathways. They are involved in vivo not only in the synthesis of non- 
essential amino acids but also in the tricarboxylic acid and urea cycles. They 
catalyse the transfer of an amine group from an amine donor substrate to the 
carbonyl of an acceptor substrate (Figure 1.10). The mechanism of catalysis 
involves the cofactor, pyridoxal phosphate (PLP), bound to the enzyme (E-PLP) 
accepting an amine group from the amine donor substrate and release of the resulting 
ketone. This forms an intermediate enzyme pyridoxamine-complex (E-PMP). The 
amine group then donated to a second substrate, a ketone, to produce the 
corresponding amine and regenerate the E-PLP (Arnone, A. et al, 1985).
The transaminases selected for investigation into the acceptance of the TK products 
will have the potential to accept a range of substrates. For example although 
branching off the main carbon chain is found in the L-erythrulose substrate the 
branched chain transaminase (E.C.2.6.1.42) has not been found to have a wide 
substrate specificity (Inoue, K., et al., 1988), therefore, would be an unwise choice 
for employment in a pathway that will potentially be manipulated to create a broad 
specificity biocatalyst. Additionally, the amount of information already known about 
enzyme structure as well as activity can be important. For example if a TAm 
candidate exhibits low activity towards a desired substrate it may be possible to 
rationally mutate the protein to enable more favourable catalysis of that substrate. 
This sort of rational mutagenesis requires knowledge of the protein structure, 
substrate-enzyme binding contacts and catalytic interactions. However the use of 
enzymes for which little is known, of which there are many, is very important to 
explore the potential of less studied enzymes. For this reason two transaminases 
were picked for investigation as the second enzyme in the TK-TAm pathway.
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OH
Me
OH
Figure 1.9: Structure of the protease inhibitor drug Nelfinavir™
^ H2 O TAm O NH,
t  + if = ? =  n + t
R1 R2 R 3 ^ ^ R 4  PLP R1 R2 R 3^"^R 4
Figure 1.10: Transaminase catalysed reaction
Transaminase catalyses the transfer of an amine functionality between an amine and 
a ketone substrate in a reaction requiring a pyridoxal phosphate cofactor.
41
1.10.1 Aromatic transaminase
First the ArTAm (E.C.2.6.1.5) from E.coli, which in vivo catalyses the last step of 
tyrosine and phenylalanine synthesis was selected for investigation. This enzyme is 
well studied and is closely related to the extremely well studied AspTAm. The
E.coli isoforms of the two enzymes were firstly identified by the activity of 
‘transaminase A’ when Rudman and Meister observed transamination reactions 
involving aspartate, tryptophan, tyrosine and phenylalanine (Rudman, D. and 
Meister, A., 1953). Later the activity described as transaminase A was found to be 
two enzymes, AspTAm and ArTAm (Gefland, D.H. and Rudo, N., 1977a; Gefland,
D.H. and Steinberg, R.A., 1977b). These two enzymes were cloned from E.coli and 
their primary structure compared (Fotheringham, G. et al., 1986). Identity of the 
primary structure between these two transaminases is 43%. Additionally, they share 
similarity between the twenty eight residues that form the active site differing at only 
six residues. The characterisation of the ArTAm and comparison to AspTAm 
(Hayashi, H. et al., 1993) revealed similarities between both the structural and 
catalytic properties of the two enzymes. The ArTAm protein was found to be a 
dimer made up of two 43 KDa subunits associated with one molecule of PLP per 
subunit as had been previously determined for AspTAm (Kondo, K., Wakabayashi, 
S. and Kagamiyama, 1987). The absorption spectra of the two enzymes were 
comparable, with two peaks at 358nm and 430nm, as were the circular dichroism 
(CD) spectra suggesting that the two enzymes are structurally similar. The catalytic 
activity of the two enzymes towards dicarboxylic substrates was found to be 
comparable whilst with aromatic substrates the activity of ArTAm was found to be 
three orders of magnitudes higher. The similarity between the two transaminases is 
such that substituting the six active site residues of the AspTAm, that differ between 
the enzymes, with those found at the corresponding positions in ArTAm increase the 
activity of the AspTAm towards phenylalanine to within seven fold of that of 
ArTAm (Onuffer, J.J. and Kirsch, J.F., 1995). Crystallographic analysis of the 
ArTAm has shown that the structure was similar to that of the AspTAm (Ko, T.-P. et 
al., 1999). The close similarity between the two enzymes allows speculation about 
the properties of ArTAm from studies carried out on AspTAm.
42
ArTAm has relaxed substrate specificity towards the side chain of the amino acid 
substrate with the ability to catalyse reactions with both aromatic and dicarboxylic 
acid substrates. Therefore neither the hydrophobic R group nor the acidic R group is 
essential for catalysis. This flexible specificity may also enable the accommodation 
of the p-hydroxyl group resulting from TK catalysis (Figure 1.6 ). Additionally this 
enzyme has recently been demonstrated to accept heteroaromatic acid substrates 
(Cho, B.-K. et al., 2004). This transaminase may therefore be useful in the longer 
term when TK mutants accepting aromatic or heteroaromatic substrates (Bacon, S.L., 
2001) are substituted into the TK-TAm synthetic pathway.
The acceptance of serine as the amine donor substrate may enable the regeneration of 
TK substrate P-HPA during catalysis. It is not only advantageous to regenerate the 
costly TK substrate but also removal of one of the TAm products may enable the 
50% equilibrium limit of a-TAm catalysed reactions to be overcome allowing higher 
conversions to be achieved. This has been previously demonstrated by the removal 
of oxaloacetate product during the production of L-2-aminobutyrate by a-TAm 
enabling yields of above 90% to be achieved (Fotheringham, G. et a l, 1999). 
However, the acceptance of serine by ArTAm has been shown to be extremely low 
(Hayashi, H. et al., 1993). There is an enzyme class that is specific for serine, 
namely the serineiglyoxylate transaminases (E.C.2.6.1.45). These enzymes are 
found in plants and mammals with reportedly wide substrate specificity (Hagishita, 
T. et al., 1996). The spinach isoform of this enzyme has successfully been 
demonstrated to catalyse a reaction preceeding TK to generate the p-HPA in situ as 
the substrate for TK (Hecquet, L., Bolte, J. and Demuynck, C., 1996). However, the 
complexities of cloning genes from higher organisms into the chosen E.coli host 
ruled this enzyme out of the pathway. These enzymes are also found in certain 
methylotrophs where they play a role in the assimilation of 1 carbon compounds 
(Antony, C., 1982). The enzyme from Hyphomicrobium methylovorum was 
successfully cloned and expressed in E.coli (Hagishita, T. et al., 1996). Investigation 
into catalysis found the enzyme exhibited high substrate specificity (Izumi, Y., 
Yoshida, T. and Yamada, H., 1990) therefore ruling it out as a candidate for the 
pathwgy at this stage.
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1.10.2 (3-alanine: pyruvate transaminase
The family of transaminase enzymes is comprised of both the a-TAms and the co- 
TAms. Subgrouping of the enzymes is by mutual similarities of primary structure, 
this corresponds with structural classification of the substrates utilised by the 
enzymes within subgroups. Groups I, III and IV are comprised of a-transaminases 
whilst the co-TAms make up group II (Mehta, P., Hale, T.I. and Christen, P., 1993). 
Whilst the a-transaminases are well studied, an example of the acceptance of a 
substrate which is a non-keto acid, such as the TK reaction yields, has not been 
reported. With this in mind the less studied class II co-transaminases were considered 
as potential TAm candidates. These enzymes can catalyse reactions with substrates 
where the amine is not adjacent to a carboxylate group. The co-class is comprised of 
several enzymes catalysing reactions with particular substrates. The most frequently 
investigated for their application in biocatalysis are the so called co-amino acid: 
pyruvate transaminases.
Within this group the amine: pyruvate transaminase from Vibrio fluvialis has been 
extensively studied by the Kim group (Park, J.H. et al., 2002; Shin, J.-S., Kim, B.-G., 
2001; Shin, J.-S. et al., 2003). This enzyme has been successfully used to catalyse 
reactions with a range of compounds containing both aromatic and non aromatics 
and acidic and non acidic substrates (Shin, J.-S. and Kim, B.-G., 2002b). The use of 
this enzyme has been demonstrated in a multi enzyme scheme with ArTAm. The 
enzyme is used to simultaneously resolve racemic methyl benzylamine using 
pyruvate resulting from the spontaneous decarboxylation of oxaloacetate produced 
from transamination by ArTAm using an aspartic acid amine donor (Cho, B.-K. et 
al., 2003a; Cho, B.-K. et al., 2003b). Researchers at Celgene have also recognised 
the synthetic potential of the co-amine: pyruvate TAms. An investigation into the 
synthetic potential of co-TAms from Bacillus megaterium, Pseudomonas aeruginosa 
and Pseudomonas putida has been reported (Stirling, D.I., 1992). The use of the co- 
TAms for the production of several chiral amines by either resolution or synthesis is 
demonstrated. The co-TAms are loosely classified by those that accept (3-alanine and 
pyruvate (E.C.2.6.1.18) named the (3-alanine: pyruvate TAms ((3-A: P TAm) and 
those that do not (E.C.2.6.1.19).
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One of the early identifications of the activity of a p-A: P TAm was during the 
investigation of propionic acid metabolism in Clostridium propionicum (Goldfine, H. 
and Stadtman, E.R., 1960). Partially purified enzyme extracts were found to 
consume P-alanine at rates several times greater than that measured for propionate 
formation, which would result from deamination of p-alanine. Therefore a simple 
deamination reaction could not account for the alanine consumption. Furthermore 
the process required catalytic amounts of pyruvate and a-ketoglutarate and led to the 
formation of a-alanine or glutamate respectively. These findings led to the 
conclusion that transamination of the p-alanine was being carried out as an 
intermediate step during propionoate formation.
The isolation of p-A: P TAm was reported by Hayaishi et al in 1960 (Hayaishi, O. et 
al., 1960). The enzyme was purified from Pseudomonas fluorescens, cultivated with 
p-alanine as the major source of carbon and nitrogen. An investigation of the 
reaction with p-alanine and pyruvate showed consumption of these substrates 
matched the production of a-alanine and malonic semi-aldehyde (Figure 3.11). The 
reaction was demonstrated to be both reversible and dependent on the presence of a 
pyridoxal phosphate cofactor. The optimum pH was found to be 9.2 and the Km 
values determined as 62 mM and 14 mM for p-alanine and pyruvate respectively. A 
study of a selection of amine compounds to explore the substrate specificity of the 
enzyme, using pyruvate as the amino acceptor, found that monocarboxylic amino 
acids with the amine at either the p, y and 8  position were good amino donors. 
However a-amino acids proved poor substrates and dicarboxylic acids, aromatic 
acids and hydroxyacids, methionine and dipeptides were reported not to act as 
substrates.
A related enzyme was isolated from Pseudomonas sp. F-126 (Yonaha, K. et al., 
1976). Several studies have been conducted with this enzyme (Yonaha, K., Nishie, 
M. and Aibara, S., 1992; Yonaha, K., Toyama, M. and Kagamiyama, H., 1983; 
Yonaha, K. et al., 1976; Yonaha, K., et al., 1997) including the analysis of a low 
resolution crystal structure (Watanabe, N., et al., 1989) and investigations into the 
catalysis with a range of amines. The enzyme is a tetramer composed of four 
identical 43 KDa subunits (Yonaha, K. et al., 1976; Morita, Y. et al, 1979). Low
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resolution crystal structure analysis (Watanabe, N. et al., 1989) found the monomers, 
composed of a large and small domain, strongly associate as dimers which then 
loosely associate to form tetramers. The globular shape of the co-TAm dimer is 
likened to that of a rugby ball shape whilst that of the a-TAm is an S-shape. 
However the secondary structure topology has been found to have similarities, 
providing a similar environment in the large domain for the PLP cofactor, although 
little homology in the amino acid sequences has been found (Yonaha, K., Nishie, M., 
and Aibara, S., 1992). These structural similarities are indicators that the two types 
of transaminases, a  and go, have evolved from a common ancestor.
The selectivity of the Pseudomonas sp. F-126 co-transaminase toward the amine 
donor substrate has been investigated (Yonaha, K. and Toyama, S., 1978) (Table
1.2). Although no p-branched hydroxylated substrates were tested the substrates 
explored show a favourable range. Enzyme activity was affected by the carbon chain 
length of primary alkyamines. Catalysis was most favourable with the 5 carbon n- 
amylalanine Vrei=80 (Vrei= 1 0 0  for (3-alanine) as opposed to equivalent substrates of 
varied chain length with the relative reactivity of the 4 carbon equivalent being Vrei = 
60. This implies that the 4-carbon erythrulose is an acceptable chain length for this 
enzyme. Branched molecules were accepted with p-aminoisobutyric acid and 
isobutylamine giving Vrei of -50. Hydroxylated molecules, whilst showing lower 
activities than their un-hydroxylated counterparts, for example ethylamine Vrei = 30 
and ethanolamine Vrei = 5, still were substrates for the enzyme suggesting that the 
hydroxy-ketone substrates from TK may be accepted as substrates. Additionally the 
investigation into more bulky substrates such as benzylamine and histamine showed 
these substrates were also accepted. Therefore this enzyme, or one closely related 
may have the scope to catalyse the transamination of a range of TK products. This 
enzyme is not identified in E.coli therefore an alternative source was sought. Since 
Pseudomonas aeruginosa and Pseudomonas putida were both available ‘in house’ 
and have previously been demonstrated to have useful co-TAms (Stirling, D.I., 1992) 
the P-A: P TAm from both organisms were initially investigated as transaminase 
candidates for the linked pathway with TK.
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Table 1.2: Amine substrate reactivity for co-TAm from Pseudomonas putida 
Reproduced from (Yonaha, K. and Toyama, S., 1978). Activity is calculated as the 
amount of alanine produced relative to the reaction with P-alanine.
Relative Relative
SubstrateSubstrate
activity activity
NH
H2N v
n-amylamine100OH
p-alanine
H2N v
Isoamylamine
Ethylamine
H2N OH
Ethanolamine n-heptylamine
NH
H2N v
n-propylamine
NH
Histamine
NH,
o
H2N ^
Isopropylamine
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Benzylamine
H„N
n-octylamine
n-butylamine
NH,
HO
Isobutylamine Tyramine
NH,
sec-butylamine NH,
Tyrptamine
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1.11 Project aims and objectives
The use of enzyme pathways to yield useful products is extensively exploited 
throughout the chemical, pharmaceutical, food and agrochemical industries. 
However the construction of novel biocatalysts with de novo non-native pathways of 
synthetic enzymes, discrete from the host organism’s metabolism, to carryout 
specific chemical transformations, is poorly explored. The ability to co-express 
multiple enzymes in a single host to carry out a sequence of desired chemical 
reactions could enable several synthetic processing steps to be carried out in one 
biocatalytic step. The aim of this project is therefore to demonstrate the construction 
of a transketolase -  transaminase pathway, two enzymes not naturally functioning in 
series, and demonstrate the pathway for a model reaction system (Figure 1.8 ).
In order to achieve this aim the following objectives were set:-
>  To identify and clone candidate transaminases and examine their 
activity with the TK reaction product L-erythrulose. This in itself 
requires the establishment of a cloning strategy to enable the co­
expression of the successful TAm candidate together with TK in an
E.coli host. This is detailed in Chapter 3.
> To establish methodology to assay the activity of the candidate 
transaminases with the TK product L-erythrulose and related 
compounds. This also requires the chemical synthesis of the model 
reaction product 2-amino-1,3,4-butanetriol. This is described in 
Chapter 4.
>  To assess the transaminase candidates for activity with L-erythrulose 
or potential activity with compounds related to TK products, 
discussed in Chapter 4.
> To evaluate the selected transaminase with both natural and non­
natural substrates. This is described in Chapter 5.
>  To demonstrate synthesis of the 2-amino-1,3,4-butanetriol using the 
TK-TAm pathway in a one-pot process, this is detailed in Chapter 6 .
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Chapter 2 - Materials and Methods
2.1 Materials
Molecular biology enzymes were obtained from New England Bio-laboratories 
(NEB, Hitchin, UK). Nutrient broth and nutrient agar were obtained from Oxoid 
(Basingstoke, UK). Commercially competent E.coli cells (XLl-red genotype endAl 
gyrA96 thi-1 hsdR17 supE44 relAl lacmutD5 mutS mutt TnlO (Tetr), XL1 blue 
genotype recAl endAl gyrA96 thi-1 hsdR17 spE44 relAl lac [F’ poAB 
laclqZAM15TnlO (Tetr)] and BL21gold (DE3) genotype E.coli B F  ompT hsdS (re’ 
mB) dcm+ Tetr gaR(DE3) endA) were obtained from Stratagene (Amsterdam, NL). 
Vectors pCR 2.1 TOPO (pUC ori fl ori Kanr Ampr T7 promoter Plac lacZa) and 
pET24(a) (pBR322 ori Kanr T7 promoter lacl) were obtained from Invitrogen 
(Paisley, UK). Primers and oligonucleotides were purchased from Operon (Cologne, 
DE). All other reagents were obtained from Sigma-Aldrich (Gillingham, UK) unless 
otherwise stated. Water was purified to a 15MQ.cm resistance.
2.2 Culturing methodology
Overnight cultures of E.coli strains were grown from inoculation of 5 mL nutrient 
broth with a single colony obtained by streaking out cells from glycerol stocks (25% 
v/v glycerol stored at -80°C) on nutrient agar plates. Growth was for 16 hours at 
37°C, with orbital shaking at 200 rpm using an SI 50 orbital shaker (Stuart Scientific, 
Redhill, UK). Growth selection was achieved by addition of the appropriate 
selection antibiotic (150 jig.mL’ 1 ampicillin or 30pg.mL'1 kanamycin) to the agar or 
broth. The optical density (OD) of liquid cultures was .measured in triplicate by 
absorbance at 600nm using a Unicam (Cambridge, UK) UV2 UV/vis spectrometer. 
This measurement was related to cell concentration, g.L'1, by the conversion factor of 
0.47. This factor was obtained by the calibration of cell density relative to OD 
prepared by measurement of the dry weight of a series of culture aliquots of washed 
resuspended cells of known OD.
When induction of a cloned enzyme was required cells were prepared by a 1/20 
inoculation of nutrient broth, (plus selection antibiotic), from a liquid overnight 
culture of the appropriate E.coli strain. Culture scale was either 100 mL culture in a 
250 mL baffled shake flask or 500 mL in a 2 L flask. Growth was carried out at
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37°C and 200rpm. Induction of enzyme expression was achieved by the addition of 
isopropyl-p-D-thiogalactosidase (IPTG) when an OD6oonm of ~ 0.6 was reached, 
followed by a further 4 hours growth.
Cell lysates were prepared from cultures (O D 6oonm of 3.5) by removal of the 
supernatant following centrifugation and re-suspension of the cell pellet in 1/10 of 
the original volume of 25 mM phosphate buffer, pH 7.0. These were stored at -  
20°C. Upon thawing sonication to lyse cells was carried out using 5 cycles of 10 
second 8 |i pulses with 10 second intervals using a Soniprep 150 sonicator (MSE, 
Sanyo, Jp), prior to use in reactions.
The maximum specific growth rate for liquid cultures, |imax was determined by 
preparation of a semi log plot of growth data (Doran, P.M., 2000). According to the 
equation In x = In xo + pt the linear portion of the graph, where the maximal growth 
rate is constant, has a slope pmax. This is used to calculate doubling time, tD from the 
equation to = ln2/p.
2.3 Standard molecular biology techniques
Recovery of plasmid DNA, from host E.coli cells, was carried out employing a 
QIAprep spin miniprep kit (Qiagen, Crawley, UK) unless otherwise specified. Gel 
extraction or DNA purification was carried out using a QIAquick PCR purification 
kit (Qiagen, Crawley, UK). The concentration of DNA was determined by 
measuring absorbance at 260nm (A2 6 0) where 1 absorbance unit corresponds to 50 
ng.pL'1 of DNA. Restriction digests were carried out for three hours at 37°C in the 
recommended NEB restriction buffer, according to the enzyme used, at an 
appropriate scale (lOpL for analytical digests and 40pL for preparative digest) 
according to the manufacturer’s protocol. All ligations were carried out with T4 
DNA ligase with T4 ligase buffer at 15°C for a minimum of 12 hours.
Agarose DNA gels were run on 1% w/v agarose gel with 0.5X tris-borate-EDTA 
buffer, markers were either lambda DNA cleaved with pst\ or a 1KB ladder (NEB, 
Hitchin, UK) for quantification, staining was with ethidium bromide. Smaller 
fragments of DNA were separated and quantified by 7.5% v/v acrylamide gel
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electrophoresis against a lOObp ladder (NEB, Hitchin, UK). Competent cells were 
made from cultures grown in nutrient broth containing 20 mM MgCh at 37°C, 200 
rpm to an OD of 0.6. Cells were harvested by centrifugation and chilled on ice for 
30 minutes. Resuspension was carried out in 75 mM CaCU and then the cells were 
re-pelleted by centrifugation. This was carried out three times. Following the final 
centrifugation cells were resuspended in 75 mM CaCl2 with 15 % v/v glycerol. Cells 
were aliquoted and either placed on ice for immediate transformation or stored at - 
80°C. Transformations were carried out using heat shock at 42°C for 45 seconds of 
either chemically competent cells made ‘in house’ or commercially available 
competent cells (Stratagene, Amsterdam, NL) of the appropriate strain.
All constructs were commercially sequenced by the service available at The Wolfson 
Institute for Biomedical Research, UCL. SDS-PAGE gel electrophoresis for protein 
analysis was carried out using a Mini-Protean II system (Bio-Rad Laboratories Inc., 
Hemel Hempstead, UK) with 12% w/v acrylamide gels and stained with 0.05 % w/v 
coomassie brilliant blue. Solubility of protein was assessed by clarification of the 
supernatant of lysate and SDS-PAGE analysis of the supernatant and the resuspended 
pellet alongside crude lysate. Quantification of protein was carried out according to 
the Bradford method (Bradford, M., 1976) using a protein assay kit (Bio-Rad 
Laboratories Inc., Hemel Hempstead, UK). The protein concentration was calibrated 
against a bovine serum albumin standard curve. All gels were visualised and 
quantified (where appropriate) on a Gel-Doc-it bioimaging system with labworks 4.5 
software (Bioimaging systems, Cambridge).
2.4 Cloning of synthetic enzymes
2.4.1 Cloning and Expression of TK
2.4.1.1 Construction of plasmid pQR411
Plasmid pMMB67HE was purified by caesium chloride-ethidium bromide gradient 
large scale plasmid preparation (Sambrook, J., Fritsch, E.F. and Maniatis, T., 1989). 
This was followed by an ethanol precipitation step carried out by the addition of 1/10 
of the volume of NaCl and 2 volumes of ethanol followed by incubation at 4°C for 1 
hour. The precipitated DNA was recovered by centrifugation. The E.coli 
transketolase gene (with native promoter) was cleaved out of an existing expression
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construct, pQR706 (obtained from Dr J.Ward, Department of Biochemistry and 
Molecular Biology, UCL), using BamHl and Sacl. Plasmid vector pMMB67HE 
(RSF1010 origin of replication) was digested with the same enzymes. The digested 
components were separated by agarose gel electrophoresis and the excised TK gene 
fragment was gel extracted (Qiagen kit). This was then ligated into the pMMB67HE 
vector and transformed into XL1 blue. Successful insertion of the gene into the 
vector was verified by restriction digest and commercial sequencing. The resulting 
ampicillin resistant plasmid, pQR411, was then purified by miniprep. and used to 
transform JM107 (chemically competent cells) and BL21gold(DE3) E.coli 
expression strains.
2.4.1.2 Verification of the expression of active TK
The over production of TK from the plasmid pQR411 in an E.coli host was assessed 
by SDS-PAGE electrophoresis (Section 2.3) relative to the production of TK from 
the original pQR706 construct at comparable cell densities. The TK produced from 
the new construct pQR411 in the BL21gold(DE3) host was determined to make up 
24% of the total cellular protein. The production of active TK in a JM107 host was 
also assessed relative to the original construct. Activity of the transketolase from 
both strains and the native host strain (un-transformed JM107) was tested in 1 mL 
reactions in deep square well microtitre plates incubated at ambient temperature (~ 
24°C). Lysate was incubated for 30 minutes with cofactors thiamine pyrophosphate 
and MgCL prior to the addition of substrate to initiate the reactions. Each reaction 
contained lOOmM P-hydroxypyruvate (lithium salt) and glycolaldehyde in 50 mM 
tris-HCL, pH 7.0 with 2.4 mM thiamine pyrophosphate and 9 mM MgCL. Lysate 
comprised 50% v/v of the reaction. Samples were quenched by dilution in 0.1% 
TFA for analysis using the RP-HPLC method for transketolase activity (Section
2.5.2).
2.4.1.3 Growth and activity profile of BL21gold(DE3) pQR411
Cultures, 100 mL, of BL21gold(DE3) pQR411 and control strain BL21gold(DE3) 
were grown from a 1/20 inoculum under the conditions previously described (Section
2.2). Aliquots were removed at intervals and the OD and activity measured. 
Activity was measured as initial rate of reaction carried out as describe in Section
2.4.1.2 except for the scale of reaction, 300 pL, and concentration of substrate, 50
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mM. The growth and activity were performed in duplicate on separate occasions 
yielding comparable trends in data.
2.4.2 Cloning and Expression of ArTAm
2.4.2.1 Construction of plasmid pQR416
The Tyr B gene was obtained by PCR from the genomic DNA of E.coli strain 
MG1665 using Taq polymerase. This was inserted into a PCR 2.1 TOPO capture 
vector (Invitrogen) and transformed into E.coli TOPO 10 cells to create pQR400 and 
pQR401. This initial work was carried out by Dr J.Ward, The Department of 
Biochmistry and Molecular Biology, UCL. The presence of the correct gene 
sequence was confirmed by sequencing and the orientation of the gene in the vector 
verified by restriction digestion. Construct pQR400 was found to have the gene in 
the same direction as the T7 promoter of the vector whilst pQR401 has the gene in 
the opposing orientation.
In order to insert the T7 ribosome binding site, complimentary oligonucleotides 
encoding the T7 ribosome binding site with terminal Ndel and Xbal restriction sites 
and an internal Hindlll site were obtained (Operon);
5 ’ CTAGA A A AGCTT ATA ATTTTGTTT A ACTTT A AG A AGG AG AT AT AC A3 ’ 
and 5 ’ T ATGT AT ATCTCCTTCTT A A AGTT AA AC A A A ATT AT A AGCTTTT3 ’. 
These were diluted to 10 pM and annealed by addition of an equal volume of each 
oligonucleotide, heating in boiling water for 5 minutes and cooling to room 
temperature in a water bath. Plasmid pQR400 was digested with Xbal and Ndel and 
purified on a PCR purification column (Qiagen, Crawley, UK) to remove the excised 
fragment. Ligation of the annealed ribosome binding site oligonucleotides into the 
cleaved pQR400 preceded transformation into XL1 blue. Successful insertion of the 
oligonucleotides into the pQR400 vector was verified by restriction digest using 
Hindlll and commercial sequencing. A digest of the construct with Acll and re- 
circularisation enabled the removal of a portion of the ampicillin resistance gene to 
yield kanamycin resistant pQR416.
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2A.2.2 Verification of the expression of active ArTAm
The production and solubility of the ArTAm from plasmid pQR416 in E.coli 
BL21gold(DE3) was assessed by SDS-PAGE electrophoresis (Section 2.3). Activity 
was assayed using an enzyme linked spectrophotometric assay (Section 2.7.1). The 
activity of the ArTAm lysate with various native substrates was assayed by obtaining 
reaction profiles by HPLC using the method for native ArTAm assay (Section 2.5.3). 
Reactions contained 50% reaction volume lysate, 25mM potassium phosphate buffer, 
pH 7.0 with 10 mM ketoacid and various amino acid substrates with 0.2mM 
pyridoxal phosphate cofactor. Reactions were carried out in duplicate at 25°C with 
agitation at 2 0 0  rpm.
2.4.2.3 Growth and activity profile of BL21gold(DE3) pQR416
Cultures, 100 mL, of BL21gold(DE3) pQR416 and control strain BL21gold(DE3) 
were grown from a 1/20 inoculum under the conditions previously described (Section
2.2). Induction was carried out by addition of IPTG to ImM after 4.5 hours of 
growth. Aliquots were removed at intervals, the OD measured and activity tested by 
enzyme-linked assay (Section 2.7.1). This was carried out in duplicate on separate 
occasions yielding comparable data.
2.4.3 Expression of P-A: P TAm
2.4.3.1 Construction of plasmids pQR426 and pQR427
Constructs pQR426 and pQR427 were obtained from Mr M. Bommer (Department 
of Biochemistry and Molecular Biology, UCL). These encode the p-A: P TAm 
genes amplified from the genomes of Pseudomonas aeruginosa (PA0132) and 
Pseudomonas putida (PP0596) respectively, ligated into the Xhol and Ndel sites of 
pET24(a)+. These constructs were transformed into BL21gold(DE3) for expression 
and DNA was prepared for sequencing.
2.4.3.2 Construction of pQR428
Plasmid pQR426 was further modified by insertion of oligonucleotide 
5’CTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCCAT 
CATCATCATCATCA3’ into the Xbal and Ndel sites as described for the addition 
of the oligonucleotide into pQR400 (Section 2.4.2.1). The resulting plasmid,
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pQR428, encodes the p-A: P TAm with an N terminal 6 -histidine tag. This construct 
was then transformed into the E.coli BL21gold(DE3) host strain.
2.4.3.3 Nickel column purification of histidine tagged P-A: P TAm
Purified P-A:P TAm was obtained by purification of the histidine tagged product 
from pQR428 on a nickel column (Hochuli, E., Dobeli, H. and Schacher, A., 1987). 
At a flow rate of 1 mL.min'1, the chelating Sepharose fast flow resin (Amersham 
Biosciences, Little Chalfont, UK) was charged with 1 column volume of 0.2 M 
NiSC>4 followed by washing with 10 column volumes of dFLO and equibrilation with 
2 column volumes of 25mM Tris buffer, pH 8.5. Lysate was prepared from induced 
cultures of BL21gold(DE3) pQR428. This was clarified by centrifugation at 20 OOOg 
for 15 minutes at 4°C and loaded onto the column. A wash of 10 column volumes of 
25 mM Tris buffer, pH 8.5 was carried out to remove non-specifically bound 
material. The bound protein was then eluted with 25mM Tris buffer, pH 8.5, 
containing 250 mM imidazole, pH 8.5. Fractions of 5 mL were collected. These 
were assayed for protein concentration using a standard Bradford assay (Section 2.3). 
Fractions containing eluted protein were combined and dialysed (10,000 molecular 
weight cut off) against 50 mM potassium phosphate buffer, pH 7.2 overnight at 4°C. 
The enzyme was then concentrated in a Vivaspin (Sartorious), molecular weight cut 
off 10,000, at 1800 ref for 15 minutes. An equivalent of 10% v/v of glycerol was 
added and the protein aliquoted for storage at -20°C.
2.4.3.4 Verification of the expression of active P-A: P TAm
The expression of soluble p-A: P TAm by E.coli BL21gold(DE3) was assessed by 
SDS-PAGE analysis (Section 2.3). Activity was verified by reaction, 0.3 mL, with 
substrates P-alanine and pyruvate, 15mM, with 2mM pyridoxal phosphate cofactor in 
25mM potassium phosphate, pH 7.0. The reactions were carried out with 50% v/v 
lysate at 25°C with agitation at 200 rpm. Samples were taken at regular intervals and 
prepared for analysis by the HPLC method for native p-A: P TAm activity (Section
2.5.4) by derivatisation (Section 2.6.2). A 95% confidence interval was calculated 
from experiments performed in triplicate. Following storage of both whole cells and 
lysate overnight at -20°C the above reactions were repeated. A second assay was 
employed to confirm the activity of the p-A: P TAm using a spectrophotometric 
assay measuring activity with p-aminobutyrate and pyruvate (Section 2.7.2).
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2.4.3.5 Growth and activity profile of BL21gold(DE3) pQR426
Cultures, 100 mL, of BL21gold(DE3) pQR416 and control strain BL21gold(DE3) 
were grown from a 1/20 inoculum under the conditions previously described (Section
2.2). Induction was carried out by addition of IPTG to 1 mM after a 1 hour growth 
period. Aliquots were removed at intervals and the OD measured and activity tested 
by reaction with native substrates (Section 2.4.3.4). This experiment was carried out 
in duplicate on separate occasions yielding comparable data.
2.5 HPLC
2.5.1 HPLC system
A Dionex (Camberley, UK) microbore HPLC system controlled by Peaknet 5.1 
software was employed for all RP-HPLC analysis. The system comprised of a GP40 
gradient pump, an LC30 column oven, a PC 10 pneumatic controller post column 
NaOH addition unit and either a AD20 UV detector or ED40 electrochemical 
detector module. An Endurance multiwell plate autosampler (Spark, Emmen, NL) 
was integrated into the Dionex system.
2.5.2 Assay for TK native activity
A 15 minute isocratic assay was adapted from the existing HPLC assay for the TK 
reaction components (Mitra, R.K. and Woodley, J.M., 1996). HPLC analysis of 
glycolaldehyde, p-HPA and L-erythrulose was carried out using an Aminex 87H 
column (Bio-Rad, Hemel Hempstead, UK) at 60°C, mobile phase 0.1% v/v 
trifluoroacetic acid (TFA), flow rate 0.6 mL.min1. Detection was via an 
electrochemical detector (ECD40), set to a standard triple potential, following 
adjustment of pH to above pH 12 by post column addition of NaOH. Samples were 
quenched and diluted with 0.2% v/v TFA. Retention times were HPA 8.40 min, 
erythrulose 11.40 min, glycolaldehyde 12.28 min (Appendix (A)). The linear range 
for all components was determined to 10 mM.
A shorter assay, duration 10 minutes, for (3-HPA and L-erythrulose with a flow rate 
of 0.8 mL.min’ 1 and UV detection at 210 nm was also used. Retention times were 
HPA, 6.38 min, and erythrulose, 8.82 min (Appendix (B)), and a linear range 
determined to 20 mM.
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2.5.3 Assay for native ArTAm activity
To analyse aspartic acid, glutamate and serine a 14 minute gradient HPLC method 
was developed on an ACE 5 C l 8  column with UV detection at 254nm. The solvent 
program employed two phases A = 140mM sodium acetate, pH 5.05 and B = 100% 
ACN. Separation was achieved by a gradient, curve 7, from 100% A to 40% A at 1 
mL.min over 10 minutes. A wash phase and re-equilibrium step is then incorporated 
into the method with a step to 80% B for 2 minutes before the final 2 minutes at 
100% A. Derivatisation of the amines with AQC was required for separation and 
detection using this method (Section 2.6.3). Retention times were aspartate 6.17 min, 
glutamate 6.45 min (Appendix (C)) and serine 6.65 min. Linearity was confirmed to 
1 mM (post derivatisation).
2.5.4 Assay for native P-A: P TAm activity
To analyse a- alanine, p-alanine and ABT a gradient HPLC method was established 
using an ACE 5 C l 8  column (Advance Chromatography Technologies, Aberdeen, 
UK) with UV detection at 254 nm. The solvent program employed mobile phases A 
= 140mM sodium acetate, pH 5.05 and B = 100% ACN. A gradient, curve 8 , was 
run from 85% A to 100% A over 10 minutes, flow rate 0.5 m L.m in1, followed by a 
column wash phase and re-equilibrium step at 1 mL.min'1. Derivatisation of the 
amines with AQC was required for separation and detection using this method 
(Section 2.6.3). Retention times for the standard mixture of ABT diastereomers were 
8.11 min and 8.20 min with the diastereomer generated by the P-A: P TAm eluting 
second (Appendix (D)i) a-alanine elutes at 8.32 min and P-alanine at 8.50 (Appendix 
(D)ii). Components below 1 mM post derivatisation were determined to lie within 
linear range.
2.5.5 Assay for transamination of aromatics
An 8  minute assay for the analysis of aromatic compounds was established using an 
ACE 5 Cl 8  column with mobile phase A=100% ACN and B= 0.1% v/v TFA. The 
method employed a linear gradient of mobile phase A from 20% to 40% over 6  
minutes at a flow rate of 1 mL.min'1, followed by 2 minutes of re-equilibration at 20 
% A. Detection was by UV adsorption at 216nm. Samples were quenched with 
0.2% v/v TFA. Retention times were phenylalanine 2.1 min, MBA 2.40 min, EBA 3 
min and acetophenone 6.1 min with linearity to 5 mM.
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2.6 Synthetic Chemistry
2.6.1 Synthesis of ABT product standard
L-erythrulose (4 g, 33 mmol), 1, was suspended in acetone:dimethoxypropane 9:1 
(30 mL) and p-toluenesulfonic acid (catalyst) was added (Figure 4.1). The mixture 
was stirred at room temperature under N2 for 3 h during which time the reaction 
became homogeneous. The reaction was monitored by TLC (2:1, ethyl 
acetate:hexane). Sodium acetate (0.5 g) was added and the reaction stirred for a 
further hour before the mixture was filtered and concentrated to dryness. The residue 
was purified by flash chromatography on silica gel (ethyl acetate/hexane 1 :2 ) to yield 
the desired 3,4-O-isopropylidene acetal 2 (1.9 g, 38%). To an aliquot of acetal 2 
(487 mg, 3.02 mmol) in methanol (10 mL) was added benzylamine (660 pL, 6.04 
mmol) and then sodium cyanoborohydride (570 mg, 9.06 mmol). The pH was 
adjusted to pH 6.0 (indicated by bromocresol green) using acetic acid and the 
reaction was stirred at room temperature for 6  hours. The reaction was monitored by 
TLC (1:1, ethyl acetate:hexane). The mixture was concentrated under vacuum and 
the residue partitioned between dichloromethane (100 mL) and sodium hydrogen 
carbonate (aq, sat) (100 mL) with vigorous stirring. Solid sodium carbonate was 
added to the suspension in small portions to ensure that the final pH of the aqueous 
layer was ~9. The layers were then separated, the aqueous phase was extracted with 
further dichloromethane (2 x 100 mL) and the organic phases combined and 
concentrated to dryness. The residue was purified by flash chromatography on silica 
gel (ethyl acetate/hexane 1:1 then neat ethyl acetate) to yield the desired amine 3 as a 
1:1 mixture of diastereomers (320 mg, 43%). The diastereomers could have been 
resolved at this stage but this was considered unnecessary.
To a solution of amine 3 (200 mg, 0.80 mmol) in MeOH (5 mL) was added drop 
wise 1 M HC1 (aq) to give a mixture that gave a dark red colour to moist litmus 
paper. The reaction was stirred at room temperature and was monitored by TLC 
(1:1, ethyl acetate:hexane). After 2 h the reaction was complete and the mixture 
concentrated to dryness to yield crude amine 4 as the hydrochloride salt. This residue 
was re-dissolved in MeOH (5 mL) and hydrogenated (balloon pressure) in the 
presence of palladium on carbon ( 1 0 % wt/wt, 1 0 0  mg) at room temperature 
overnight. The catalyst was removed by filtration and the solvent removed under
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vacuum to yield 2-amino-1,3,4-butanetriol 5 as a 1:1 mixture of threo and erythro 
diastereomers (75 mg, 60 %). The NMR spectral data for compounds 2, 3 and 4 was 
in accordance with those reported in the literature (Dequeker, E. et al., 1995). A 
further NMR spectrum was obtained to confirm the structures of the final mixture of 
diastereomers of 2-amino-1,3,4-butanetriol, 5 and was compared with the literature 
valuesfor the single diastereomer (Appendix J ).
2.6.2 Synthesis of derivatising agent
Derivatising agent 6 -aminoquinolyl-AMiydroxysuccinimidyl carbamate (AQC) was 
synthesised ‘in house’ according to the protocol detailed by Cohen, S.A. and 
Michaud, D.P. (Cohen, S.A. and Michaud, D.P., 1993). Di(A-
succinimidyl)carbamate, 1.5g, 6  mmol, was refluxed in 25 mL of dry acetonitrile. 
Dropwise addition of a 6 -aminoquinoline, 0.75g, 5 mmol, solution in dry acetonitrile 
was carried out over 45 minutes. Following a further 30 minutes reflux, 
concentration was carried out to half the original volume. The solution was stored at 
-20°C overnight. The crystals were then filtered off and stored in vacuo. An 8  
mg.mr1 AQC solution was prepared for use by dissolving crystals in dry acetonitrile 
by heating at 50°C for ten minutes.
2.6.3 Derivatisation of amines for HPLC analysis
Samples for amine HPLC analysis were diluted in 0.02M borate buffer, pH 8 .8 , to 
below 1 mM and derivatised by addition of an excess of 6 -aminoquinolyl-A/- 
hydroxysuccinimidyl carbamate.
2.7 Spectrophotometric assays for TAm activity
Enzyme linked spectrophotometric assays were used to test the activity of the various 
transaminases. The rate of TAm substrate turnover was linked to an NADH 
dependent dehydrogenase, which accepts the product of the TAm reaction. The 
millimolar extinction coefficient of NADH, 6.22, at 340 nm, was used to convert 
absorbance readings to concentration. Therefore, the rate of TAm activity could be 
quantified by analysis of the change in NADH concentration.
2.7.1 ArTAm enzyme linked assay
Reactions, 1 mL, containing 19.7 mM of L-aspartate and a-ketoglutarate substrates, 
0.2 mM pyridoxal phosphate cofactor, 0.1 mM (3-nicotinamide adenine dinucleotide
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(NADH), 20 units of malic dehydrogenase (E.C. 1.1.1.38), 38 mM potassium 
phosphate buffer, pH 7.0 were started by the addition of 50 pL of cell lysate. 
Reactions, performed in triplicate, were monitored spectroscopically by measuring 
NADH depletion at A34onm.
2.7.2 co-TAm enzyme linked activity assay
Reactions, 1 mL, containing 50 mM (3-aminobutyrate, 2 mM pyruvate, 0.001 mM 
PLP, 0.1 mM NADH and 0.5 U p-hydroxybutyrate dehydrogenase were started by 
the addition of TAm, (quantity varied). Reactions were monitored spectroscopically 
by measuring NADH depletion at 340nm. All reactions were performed in triplicate.
2.8 Investigation of ArTAm substrate specificity
Reactions contained 50% v/v lysate, 25mM potassium phosphate buffer, pH 7.0 with 
10 mM of the keto acid and amino acid substrates and 0.2 mM pyridoxal phosphate 
cofactor. Reactions were carried out in duplicate at 25°C with agitation at 200 rpm. 
Reactions were analysed by the appropriate HPLC assay according to the substrates 
employed.
2.9 Mutagenesis of ArTAm
2.9.1 Random mutagenesis
2.9.1.1 Random mutagenesis of ArTAm using XLl-red
Plasmid pQR416 was transformed into commercial XLl-red (Stratagene, 
Amsterdam, NL) and grown on nutrient agar plates, containing 20 pg.mL ' 1 
kanamycin, overnight. All colonies (-150) were harvested directly from the surface 
of the plate and used to inoculate 100 mL nutrient broth, 20 pg.mL ' 1 kanamycin in a 
baffled 250 mL shake flask. This was incubated for 12 hours at 37°C. The resulting 
culture was used to inoculate a second 100 mL nutrient broth, containing 20 pg.mL ' 1 
kanamycin, which was incubated for 12 hours. This cycle was repeated a further 7 
times. The ODaoonm was measured at each inoculation and it was estimated that the 
cells had been propagated for a total of approximately 50 generations.
The pQR416 plasmid was then recovered by miniprep and transformed into the 
BL21gold(DE3) expression host. Individual colonies were then picked into standard
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96 well microtitre plates containing 100 pL nutrient broth, kanamycin 15 pg.mL ' 1 
using the colony picking mode of a Qpix robot (Genetix, New Milton, UK). The 
plates were covered with an identical (empty) inverted plate and sealed with plastic 
tape to prevent evaporation. The sealed plates were then incubated at 37°C, on a 
Variomag Teleshake unit (Camlab Ltd., Cambridge, UK) at 1000 rpm, for 16 hours. 
The resulting optical densities of the individual cultures of the plate were measured 
using a FLUOstar Optima plate reader (BMG Labtechnologies GmbH., Offenberg, 
DE) at 600 nm. Following centrifugation the supernatant was aspirated from the 
plate and the cell pellets resuspended in 100 pL 50 mM potassium phosphate buffer, 
pH 7.0. The resuspended cells were then distributed into plates as 20 pL aliquots, for 
use in screening reactions, and frozen at -80°C. The remaining culture was stored at 
-80°C as 25% v/v glycerol stocks. A plate of wild-type ArTAm cells 
BL21gold(DE3) pQR416 was used to prepare wild-type ArTAm aliquots for use as a 
control for the substrate screens.
2.9.1.2 XLl-red library screening
Library plates containing 20 pL of cells in 50mM potassium phosphate buffer, pH 
7.0 were thawed at room temperature. To ensure lysis of cells 20pL bugbuster™ 
(Novagen) was added and incubated for 45 minutes. The substrates for the screen, 
lOmM, in 50mM potassium phosphate buffer, pH 7.0 were then added with 0.2 mM 
pyridoxal phosphate cofactor. The plate was incubated at 25°C for four hours. The 
reactions were quenched by addition of 100 pL 0.1% TFA and subject to HPLC 
analysis for substrate consumption and product formation using the appropriate 
method (Section 2.5).
2.9.2 Whole plasmid error prone PCR
The initial reactions were all carried out, according to protocol from the Matsumura 
laboratory at Emery University, Atlanta, USA (Rowe, L.A. et al., 2003), with 0.2 pM 
primers, M l3 (-20) primer 5’ GTAAAACGACGGCCAGT 3’ and the reverse 
complement, template 34 ng, 0.2 mM dNTPs and 1.5 mM MgCL2 . Polymerases, Pfu 
turbo and Taq polymerase, were added to a concentration of 2.5 U in a 50 pL 
reaction. The Tth/ Vent mix was made up with a ratio of 13 U Tth tol U vent and 
added to a concentration of 2.5 U of Tth in the reaction. The commercial reaction 
buffer for each enzyme was used (except for the reaction with Tth/Vent where the
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buffer composed of 25 mM tricine, 5% v/v glycerol, 5% v/v DMSO, 85 mM 
potassium acetate). The thermocycle used with the pUC18 template was 
denaturation 30s at 95°C, annealing 1 minute at 60°C and extension for 5 minutes at 
72°C, for 24 cycles. Cycling was completed by a final 7-minute extension. Reactions 
with Taq polymerase were carried out with the addition of more polymerase after 12 
cycles. The PCR reactions were then treated with Dpnl to remove methylated 
template DNA and run on an agarose gel. The PCR product was purified from the 
gel, treated with DNA T4 polymerase and ligase and transformed into 
BL21gold(DE3).
2.9.3 Site directed mutagenesis
2.9.3.1 Generation of ArTAm Arg386 mutants
Quickchange PCR was used to introduce mutations at amino acid position 386. 
Primers used were
5 ’ ATCTCATCGCCAGCGGGTNNS ATGTGTGTGTCGCCGGGTT 3 ’.
PCR reactions , in a volume of 50|iL, were 0.2 mM primers, 0.2 mM dNTPs, 37.5 ng 
pQR416 template, lx Pfu reaction buffer and 1.25 units of Pfu turbo. Ten cycles of 
denaturation at 94°C for 30 seconds, annealing at 64°C for 1 minute and extension at 
6 8 °C for 11 minutes was carried out. The resulting 5.1 Kb product was transformed 
into E.coli strain BL21gold(DE3) individual colonies were selected and the DNA 
isolated for sequence analysis.
2.9.3.2 Activity of ArTAm Arg386 mutants
The activity of the variant transaminases was investigated by reaction with various 
substrates and analysis by HPLC as described in Section 2.8.
2.10 Investigation of P-A: P TAm activity
2.10.1 Investigation of P-A: P TAm activity with various substrates
Reactions, 1 mL, were carried out with substrates, 5 mM, in 25mM potassium 
phosphate buffer, pH 7.0 with 0.2 mM pyridoxal phosphate cofactor at ambient 
temperature (~25°C) and agitation at 200 rpm. Catalyst was added to 0.61 mg.mL' 1 
for purified transaminase or lysate to give a concentration of the aminotransferase of 
0.573 mg.mL'1.
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2.10.2 Transamination reactions catalysed by P-A: P TAm
Reactions, were carried out, unless otherwise stated, at a 1 mL scale in sealed glass 
vials with L-erythrulose and L-MBA substrates, 10 mM, (or 10 mM pyruvate and p- 
alanine where stated) in 100 mM potassium phosphate buffer, pH 7.0 with 2mM 
pyridoxal phosphate cofactor at ambient temperature (~25°C) and agitation at 200 
rpm. Catalyst was added as purified transaminase (Section 2.4.3.3) to a 
concentration of 0.61 mg.mL-1. Where stated catalyst was added as lysate from 
BL21gold(DE3) pQR426 comprising 50 % v/v of the reaction to give a concentration 
of the aminotransferase of 0.573 mg.mL'1. Analysis was carried out using the p-A: P 
TAm HPLC assay (Section 2.5.4) unless otherwise specified.
2.10.3 Investigation of substrate concentration on the native P-A: P TAm 
reaction
Reactions were carried out as described in Section 2.10.2 at an enzyme concentration 
of either 0.573 mg.mL' 1 or 1.15 mg.mL' 1 added in lysate from BL21gold(DE3) 
pQR426 for each substrate concentration, 5 mM, 10 mM, 20 mM and 40 mM. 
Reactions with enzyme were repeated at the lower enzyme concentration with lysate 
from different cultures of the strain to ensure the enzyme activity is consistent.
2.10.4 Investigation of substrate concentration on the target P-A: P TAm 
reaction
Reactions were carried out as described in Section 2.10.2 with L-MBA and L- 
erythrulose substrate concentrations of 5mM, lOmM, 20 mM and 40mM. The 
reaction at 10 mM was carried out in duplicate.
2.10.5 Investigation of individual substrate concentration on target P-A: P TAm 
reaction
Reactions were carried out as described in Section 2.10.2 except that the 
concentration of either L-MBA or L-erythrulose was varied, 2.5mM, 5mM, 10 mM 
and 20mM, whilst the other substrate was held constant at 10 mM. Analysis was 
carried out in triplicate using the p-A: P TAm HPLC assay (Section 2.5.4).
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Duplicate reactions were carried out at 10 mM and compared to data from previous 
experiment to ensure reproducibility.
2.10.6 Investigation into product inhibition of target reaction with p-A: P TAm
Reactions were carried out as described in Section 2.10.2 with the addition of 
acetophenone and ABT simultaneously at 2.5 mM, 5 mM or 10 mM. This 
experiment was also repeated with individual addition of each product over the same 
concentration range.
2.10.7 Investigation into reaction equilibrium
Three reactions were run to steady state under the conditions described in Section 
2.10.2. After 72 hours additions to the reactions were made. Enzyme was added to 
the first reaction to give a fresh enzyme concentration of 0.61 mg.mL’ 1 with cofactor 
to a final concentration of 2 mM fresh cofactor. To a second reaction, substrates, 
in 100 mM phosphate buffer, pH 7.0, with cofactor, were added, to raise the substrate 
concentration by 5 mM. Phosphate buffer with cofactor was added to the third 
reaction as a control. Analysis of ABT concentration was carried out using p-A: P 
TAm HPLC assay (Section 2.5.4).
2.11 Dual strain construction and activity
2.11.1 Dual strain construction and activity testing
Cells from BL21gold(DE3) pQR411 were made chemically competent (Section 2.3) 
and transformed with plasmid pQR426. The resulting transformed cells were 
cultured in the presence of both kanamycin and ampicillin to maintain the two 
plasmids. The dual plasmid strain was assayed for activity of both TK (Section
2.4.1.2) and p-A: P TAm (Section 2.4.3.4).
2.11.2 Coupling of TK and TAm reactions
Reactions, 1 mL, were carried out in sealed glass vials with P-HPA, GA and L-MBA 
substrates, 10 mM or 20 mM, in 100 mM potassium phosphate buffer, pH 7.0 with 
cofactors thiamine pyrophosphate, 2.4 mM, MgCL, 9 mM, and pyridoxal phosphate, 
2mM, at ambient temperature (~28°C) with agitation at 200 rpm. The enzyme 
catalysts were added in lysate from the dual plasmid strain BL21gold(DE3) 
pQR411+ pQR426 comprising 50 % v/v of the reaction to give a concentration of
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transketolase of 0.437 mg.mL' 1 and p-A: P TAm of 0.609 mg.mL'1. In the case of 
whole cell reactions freshly cultured induced un-lysed cells were added to obtain the 
same enzyme concentrations as the lysate. Analysis was carried out using HPLC 
assays to analyse each component, P-HPA, GA and erythrulose (Section 2.5.2), 
MBA and acetophenone (Section 2.5.5) and p-A: P TAm HPLC assay (Section
2.5.4).
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Chapter 3 -  Cloning and expression of individual synthetic enzymes
The aim of this project is to demonstrate the potential of creating non-natural (de 
novo) pathways of synthetic enzymes to access desired chiral synthons as outlined in 
Section 1.11. To achieve this the synthesis of chiral amino alcohols is considered 
using an engineered transketolase and transaminase pathway (Section 1.6 ). Selection 
of the target reaction and the rationale for the candidate transaminase enzymes 
choices is detailed in Section 1.8 and Section 1.10 respectively. In this chapter the 
cloning strategy and the production of active transketolase and transaminase catalyst 
in an E.coli host strain is described.
3.1 Introduction
The molecular cloning of a gene enables control of the gene product expression in a 
specific host organism. Over-expression of genes encoding useful biocatalytic 
enzymes can enable production of a desired catalyst in much higher titres leading to 
improved activity per unit biomass. Other advantages of using cloned genes are the 
use of a more suitable host organism than the native host, control of expression using 
an already characterised promoter, the potential to co-express genes from different 
organisms and the ease of further genetic manipulations of a sub-chromosomal 
plasmid, such as mutagenesis, to change the gene product characteristics. Over­
expression of a desired protein is achieved by inserting several copies of the gene 
into a cell and/or using a strong promoter to control the expression of the gene. The 
increase in enzyme produced in a whole cell biocatalyst minimises the impact of any 
competing side reactions catalysed by other enzymes in the host organism. 
Subsequently catalytic yields may be improved due to minimised loss of substrate or 
product and downstream purification may be simplified by lower levels of 
structurally similar by-products.
A host organism should be safe and easily handled, such as a non-pathogenic strain 
of E.coli, but must also share common biochemistry with the native host, such as 
compatible codon usage, to enable production of the functional gene product. 
Cloning is particularly valuable in the transfer of a gene from a pathogenic organism, 
such as the opportunist pathogen Pseudomonas aeruginosa (Sadikot, R.T. et al., 
2005) to a non-pathogenic host strain. This opens the opportunity to use a gene
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product without the need for high containment rated facilities. The use of an already 
characterised host can also greatly simplify the development of fermentation 
strategies. Genes from organisms that are not easily cultured may be cloned into 
hosts for which growth strategies have already been developed. The existing growth 
protocols can then be further refined to enable optimal production of the gene 
product. Use of a rapidly growing host not only increases the cell biomass 
achievable but also reduces the risk of fermentation contamination. A well- 
characterised host such as E.coli is easily manipulated by standard techniques. The 
use of subchromosomal plasmid constructs, which are easily introduced, propagated 
and isolated, enables discrete manipulations of the gene sequence as required. In this 
project the cloning of candidate genes from E.coli and Pseudomonas strains will 
enable the use of an E.coli host. The E.coli strain BL21gold(DE3) will be employed 
as the host strain. This strain has been modified to encode the T7 polymerase under 
the inducible control of the LacUV promoter enabling the use of a T7 promoter to 
control gene expression (Studier, W.F. and Moffatt, B.A., 1986). The strain is 
naturally deficient in the La protease (Chin, D.T. et al., 1988) and has been further 
engineered to remove the OmpT protease (Grodberg, J. and Dunn, J.J., 1988) thus 
degradation of recombinant protein is reduced.
Native promoters may be tightly controlled by cellular processes and expression of 
the gene product only instigated under certain conditions. For example the native 
promoter of E.coli ArTAm has been found to be regulated by the tyrosine repressor 
(Collier, R.H. and Kohlhaw, G., 1972; Silbert, D.F. Jorgensen, S.E. and Lin, E.C., 
1963). The use of an already characterised promoter enables more predictable 
expression. Additionally the ability to switch on gene expression, using a 
characterised inducible promoter, can enable higher expression yields where the 
product is detrimental to cell growth and survival. A reasonable cell density can be 
reached before the added metabolic burden of protein over production and any 
toxicity to the cells is experienced, thus enabling higher protein titres to be reached 
than if a protein is expressed earlier in a culture.
The a priori design and construction of a biosynthetic pathway in E.coli requires the 
co-expression of the pathway enzymes. In the case of amino-alcohol synthesis, the 
over-expression of transketolase to make asymmetric carbon-carbon bonds, and a
67
transaminase to transfer an amine group on to the product of the transketolase 
reaction product, is required. In order to over-express both a transketolase and a 
transaminase within the same host cell, alternative cloning strategies can be used. 
The first is having the two genes encoded on the same plasmid. The second gene can 
be placed directly after the first gene and be read through from the promoter of the 
first gene. This allows little scope for control of expression and the efficiency of the 
‘read-through’ to the second gene may be unpredictable. Alternatively the second 
gene can be inserted into the same plasmid under the control of a second promoter. 
This may enable more flexibility allowing the two genes to be controlled separately 
therefore the expression levels or time of expression of the two genes can be 
different (Jensen, P.R. and Hammer, K., 1998; Ruhdal, P. and Hammer, K., 1998). 
Another approach employs the two genes carried on separate plasmids and most 
usefully under the control of separate promoters in the same host cell. For the stable 
existence of two plasmids within the strain, differences in two of the plasmids 
components are important. Firstly, in order for multiple plasmids to coexist in the 
cell without compromising the copy number of either plasmid, different origins of 
replication must be used. If two different plasmids with the same origin are used the 
numbers of both plasmids may be reduced (but not necessarily by the same amount) 
to meet the origin dictated copy number. Secondly there must be a different 
selectable marker on each plasmid to enable selection for cells harbouring each 
plasmids.
The dual plasmid system has the advantage of allowing the two genes, carried on 
separate compatible plasmids, to be individually manipulated (e.g. mutated) and then 
introduced into a shared host. This is advantageous for the construction of an initial 
system to demonstrate the model reaction allowing the construction of a plasmid 
carrying the transketolase gene, which can be introduced with the plasmid carrying 
the selected transaminase gene without any further cloning. Furthermore 
manipulation of the transaminase gene can be carried out independently to accept the 
product of the established transketolase step as required. Additionally, other enzyme 
candidates can be cloned into compatible vectors to construct alternative pathways. 
For example a non pBR322 vector encoding DoxP synthase (Sprenger, G.A. et al., 
1997) can be used to replace the TK construct to be investigated in a pathway with 
the transaminases cloned. The dual plasmid approach was thus employed in this
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work and all cloning steps carried out with this in mind. This chapter describes the 
construction of expression plasmids for the TK and candidate transaminases and 
verification of active enzyme production. The co-transformation of the vectors 
encoding TK and the candidate transaminase to make the dual plasmid expression 
strain is described later (Section 6.2.) following the investigation of the candidate 
transaminases.
3.2 Subcloning and expression of TK
3.2.1 Subcloning of TK
An E.coli strain JM107, pQR706, over-expressing the endogenous transketolase gene 
(tkt) was obtained from Dr J. Ward, Department of Biochemistry and Molecular 
Biology, UCL. The pQR706 construct is composed of PCR-Script™, a pBR322 
derivative, carrying the transketolase gene under the control of the native E.coli 
promoter. This strain was developed to improve production of transketolase for 
biotransformation applications (French, C., Ward, J.M., 1995). Expression of active 
TK in JM107, pQR706 was found to make up 24% of the total cell protein in a 100 
mL overnight shake flask cultures. A closely related parent plasmid pQR700 
(yielding 17% of total cellular protein at 100 mL scale) was used to study large-scale 
transketolase production. Significant quantities of active transketolase enzyme were 
obtained with the enzyme constituting ~ 43% of the total cell protein in a fed batch 
1000 L fermentation (Hobbs, G.R. at al., 1996).
Many commercial plasmids are descended from pBR322. For the successful 
construction of a dual plasmid biocatalyst, it is required that one gene of interest is 
carried on a plasmid with a non-pBR322 derived origin of replication. Since 
pQR706, a pBR322 derivative, has already been demonstrated as a suitable 
expression vector for production of the TK catalyst it would have been desirable to 
insert the transaminase gene into a non-pBR322 descendant. This would enable the 
use of the existing TK expression construct. It was apparent, however, that using 
expression vector pMMB67HE, an ampicillin resistant (AmpR), non pBR322 
derivative (Furste, J.P., et al., 1986), provided convenient restriction sites {BamHl 
and S a d ) to receive the 2.4 kb transketolase gene, with promoter, cleaved from 
pQR706 with the same restriction enzymes in a direct translocation . Consequently
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this subcloning was carried out and confirmed successful by sequencing (Section 
2.4.1.1). The new construct was named pQR411 (Figure 3.1). This expression 
plasmid is 11.2 Kb in size. The large size is due to the long coding sequence in the 
vector required for broad host compatibility. This includes the IncQ replicon 
RSF1010, which can be mobilised by IncP helper plasmids to transform several 
Gram negative bacteria (Scherzinger, et al., 1984). For use in the chosen E.coli host 
for this work these components are not required. However since the vector was 
stable no attempt to further modify it was deemed necessary at this stage.
3.2.2 Expression of active TK
The activity of transketolase is assessed by the analysis of the model reaction where 
TK catalyses the formation of L-erythrulose and carbon dioxide from P-HPA + 
glycolaldehyde substrates (Figure 3.2). An HPLC method to monitor TK activity, 
via the electrochemical detection of p-HPA and glycolaldehyde substrates and L- 
erythrulose product, was developed by refinement of an existing method (Mitra, R.K. 
and Woodley, J.M., 1996). The method duration was shortened from 45 minutes to 
15 minutes thus improving the throughput of analysis (Section 2.5.2). This was 
achieved by the use of a single Aminex 87H column, where previously two had been 
employed, reducing the retention times of all three components. This was feasible 
due to the substitution of the refractive index detector, employed in the original 
method, for an electrochemical detector. Using this detector resolution of each 
component was achievable following separation on a single column and the TK 
catalysed reaction progress could be monitored. The measured decline in HPA and 
glycolaldehyde during the catalysis corresponds to the formation of L-erythrulose 
(Figure 3.3). The reaction repeatedly yields above 95% conversion of HPA to 
erythrulose (time scale depends upon substrate and enzyme concentration). This is 
as expected by the 1:1 substrate to product stoichiometry of the reaction (Figure 3.2). 
The reaction is able proceed to completion due to the formation of CO2 , which leaves 
the aqueous reaction in gaseous form under the experimental conditions, rendering 
the reaction irreversible.
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Figure 3.1: Construction of TK expression plasmid pQR411
The excision of the TK gene (including native promoter element) from pQR706, 
using restriction enzymes Sacl and BamHl, was followed by ligation into the 
corresponding sites in plasmid vector pMMB67HE. This formed TK expression 
plasmid pQR41 l(AmpR). The subcloning is described in Section 2.4.1.1.
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Figure 3.2: Model transketolase catalysed reaction
Transketolase catalyses the formation of an asymmetric carbon -carbon bond by the 
transfer of a 2-carbon ketol group to an aldehyde acceptor substrate. In the model 
reaction p-HPA is the ketol donor substrate resulting in the elimination of CO2 
rendering the reaction irreversible. The TK catalysed reaction, requiring TPP and 
Mg2+ cofactors, of p-HPA with glycolaldehyde results in the formation of L- 
erythrulose product.
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Figure 3.3: Profile of the TK model reaction
The reaction profile seen for the model TK reaction with 20mM P-HPA and 
glycolaldehyde substrates in 100 mM potassium phosphate buffer, pH 7.0 with 
cofactors thiamine pyrophosphate, 2.4 mM, MgCl2 , 9 mM, and pyridoxal phosphate, 
2mM, at ambient temperature (~28°C) with agitation at 200 rpm (Section 2.11.2). 
Transketolase was added in lysate, giving a transketolase concentration of 440 
pg/mL. Both substrates and products are monitored by HPLC with electrochemical 
detection (Section 2.5.2).
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The production of active transketolase from the newly constructed plasmid pQR411 
was assessed by activity assay with the model reaction relative to transketolase 
produced from the original strain. Cultures of the original TK strain JM107, 
pQR706, newly constructed JM107, pQR411 and the wild-type host strain control 
were grown overnight and diluted to comparable cell densities prior to lysis by 
sonication.
Pre-incubation of the lysates with cofactors TPP, 2.4 mM, and MgCh, 9 mM, was 
carried out to reconstitute the holoenzyme (Sprenger, G.A. et al., 1995). Substrates 
P-HPA and glycolaldehyde, both 100 mM, were added and reactions incubated at 
25°C. Reactions were monitored for p-HPA and glycolaldehyde depletion and L- 
erythrulose production by the refined HPLC assay (Section 2.5.2) over a four hour 
time period. Upon comparison of the erythrulose production of the strains (Figure
3.4) that harboured the new construct, pQR411, was found to produce transketolase 
activity significantly above that of the host strain not over-producing transketolase. 
Some production of L-erythrulose was evident from the wild-type host strain over the 
monitoring period. This is due to the endogenous TK of the bacterial host (Sprenger, 
G.A. et al., 1995). The activity of the transgenic strain harbouring the pQR411 
construct gave product formation at approximately half the rate of the original 
pQR706 construct. The new pQR411 strain reaching 60% conversion in the four 
hour monitoring period whilst the original pQR706 strain reached completion. The 
lower activity of the newly constructed strain can be attributed to the lower copy 
number of pMMB67HE, the parent vector of pQR411, relative to PCRScript™ 
parent vector of pQR706, resulting in less protein production. This difference in 
protein synthesis is observed by SDS-PAGE analysis of the cultures (Figure 3.5). 
Both strains carrying TK encoding plasmids show a strong band at 72 KDa as 
expected for the monomer that makes up the 145 KDa TK homodimer (Sprenger, 
G.A. et al., 1995). This intense band was not evident in the JM107 wild-type lane. 
The band intensity (by eye) is lower for the strain harbouring the pQR411 construct, 
than for that carrying pQR706 at a comparable cell concentration. This lower TK 
concentration from JM107, pQR411 corresponds to the lower measured activity of 
this strain than that measured for JM107, pQR706 (Figure 3.3).
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Figure 3.4: Comparison of the activity of TK produced from different plasmid 
constructs
Lysates of E.coli strains JM107 wild-type, JM107, pQR706 and JM107, pQR41l 
were monitored by HPLC for TK activity forming L-erythrulose from (3-HPA and 
glycolaldehyde. Reactions were carried out with lysates from overnight cultures of 
comparable cell densities for each strain. Reaction contained (3-HPA and 
glycolaldehyde, lOOmM of each, cofactors TPP, 2.4 mM and MgCL. 9mM, in 50mM 
Tris HCL, pH 7.0 (Section 2.4.1.2).
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Figure 3.5: SDS-PAGE analysis of TK produced from E.coli JM107, pQR706 
and JM107, pQR411
Samples of E.coli strains JM107 wild-type, JM107, pQR706 and JM107, pQR411 
were diluted to comparable cell density and run on a 12% v/v acrylamide SDS- 
PAGE gel and stained with commassie blue. The intense band at 72 KDa 
corresponds to the overexpressed TK and was not seen in the wild-type JM107 
control.
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The SDS-PAGE analysis of BL21gold(DE3) pQR411 enabled quantification of the 
TK at 33 % of the cellular protein.
3.2.3 Growth-activity relationship of E.coli BL21gold(DE3) pQR411
The pQR411 construct was transformed into BL21gold(DE3) the chosen host E.coli 
strain for this project (Section 3.1). The growth of the recombinant strain 
constitutively over producing the TK catalyst reproducibly had the same growth 
characteristics as the wild-type host strain (Figure 3.6). The doubling time (to) 
during the exponential growth phase was calculated as 0.70 and 0.71 hours for the 
wild-type and TK overproducing strain respectively (or a jiMax of 0.98 hr' 1 and 0.97 
hr' 1 respectively). Therefore, production of the TK catalyst does not have significant 
adverse effect on the growth of the host cells. Upon investigation of the TK activity 
of the strain throughout the growth period it was found to increase with the cell 
density. Therefore the cells are producing the enzyme throughout the growth period, 
as expected for a protein under a constitutive promoter, without adverse effect on the 
growth of the culture. Comparable trends in growth and activity were observed at 
the 50 mL and 100 mL culture scale.
3.3 Cloning and expression of ArTAm
3.3.1 Cloning of ArTAm
The first transaminase candidate to be investigated for activity with the L-erythrulose 
product of the TK reaction was ArTAm from E.coli (Section 1.10) A strain 
overexpressing aromatic transaminase was not available ‘in house’ when this work 
commenced. Consequently cloning of the E.coli Tyr B gene encoding the aromatic 
transaminase (E.C.2.6.1.57) was undertaken (Figure 3.7). The Tyr B gene was 
amplified by PCR, from the genomic DNA of E.coli strain MG1665, without its 
native promoter. This was to enable expression of the gene to be under the control of 
an already characterised promoter commonly used for over-expression in E.coli. The 
gene product was captured with capture vector PCR TOPO 2.1 (Invitrogen), to form 
pQR400/pQR401. The presence of the Tyr B gene was confirmed by sequencing. 
These initial cloning steps were carried out by Dr J.Ward.
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Figure 3.6: Growth and activity of TK expressing strain BL21gold(DE3) 
PQR411.
Cells were cultured, in lOOmL nutrient broth with ampicillin, in a baffled shake flask 
at 37°C, 200rpm. Growth was monitored by OD60 0 nm measurements and activity 
measured by analysis of the initial rate of the model reaction product, L-erythrulose, 
formation at each time point (Section 2.4.1.3).
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The TOPO vector is designed to capture a PCR product generated with Taq 
polymerase, but can not function as an expression vector due to the absence of a 
ribosome binding sequence. In order to obtain expression of the Tyr B gene product 
insertion into an expression vector is required. Since transketolase was inserted into a 
non pBR322 derivative the transaminase gene could be cloned into an expression 
plasmid with a pBR322 derived origin (Section 3.1). Initially insertion of the Tyr B 
gene into kanamycin resistant pET24a(+), Xhol and Ndel sites, was attempted. 
Following many attempts no success was gained and an alternative approach was 
sought.
The PCR TOPO 2.1 capture vector has a pUC origin (pBR322 derivative) and carries 
a T7 promoter sequence close to the site of PCR product capture. However, it is 
deficient in the ribosome binding site thus the promoter is inactive. Consequently a 
second approach was carried out to convert this plasmid into an expression vector by 
the insertion of a ribosome binding sequence in front of the PCR product gene, 
inserted in the correct orientation with respect to the promoter. Plasmid pQR400 has 
the tyrB gene in the same direction as the plasmid T7 promoter (whilst the PCR 
fragment in pQR401 lies in the opposing direction). Insertion of the ribosome 
binding site sequence enabling the T7 promoter to be used to express the gene 
product was therefore possible by modification of plasmid pQR400. This was 
undertaken by the insertion of a 44 base pair oligonucleotide encoding the ribosome 
binding sequence for a T7 promoter sequence. To enable quick screening of 
transformants a Hindlll restriction site was included into the oligonucleotide 
sequence. The presence of another single Hindlll cleavage site elsewhere in the 
construct enabled detection of oligonucleotide insertion by Hindlll digest of the 
plasmid yielding two fragments of 1296 bp and 3826 bp. Plasmid pQR400 without 
the insert would be linearised. This insertion of the ribosome binding site was 
successful and the resulting expression vector was named pQR415.
The pQR415 plasmid has both the p-lactamase gene conferring AmpR and the 
aminoglycoside phosphotransferase gene conferring resistance to kanamycin (KanR). 
In order to remove one of the antibiotic resistance genes further modification was 
required.
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Figure 3.7: Construction of vector pQR416 for ArTAm expression
Plasmid pQR400 is constructed of the tyrB gene (PCR product) encoding ArTAm 
from E.coli captured by pCRTOPO 2.1 (Section 2.4.2.1). An oligonucleotide 
encoding a ribosome binding sequence was inserted, between the Nde 1 and Xba\ 
restriction sites, to create pQR415. This is a functional expression vector. Further 
modification by digestion with Acl\ and re-circularisation was carried out to remove 
a Section of the (3-lactamase gene conferring AmpR. This formed pQR416 a KanR 
plasmid encoding the ArTAm under the control of an inducible T7 promoter.
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Since this vector was being made to potentially coexist with ampicillin resistant, TK 
encoding, pQR411 removal of the (3-lactamase expression was required. Plasmid 
pQR415 was thus further modified to inactivate the ampicillin resistance gene. This 
was carried out by cleavage with Acll to remove a fragment from the (3-lactamase 
gene. The resulting plasmid, pQR416 confers resistance to kanamycin and not 
ampicillin. The use of a T7 promoter required the use of a DE3 positive host strain 
carrying the T7 polymerase. Subsequently the plasmid was transformed into E.coli 
BL21gold(DE3) for the investigation of ArTAm expression.
3.3.2 Expression of active ArTAm
A convenient spectrophotometric enzyme linked assay for the activity of the ArTAm 
was initially used to assess TAm activity (Section 2.7.1). The aromatic transaminase 
can catalyse the transfer of the amine group from aspartic acid to an acceptor ketone 
substrate a-KG yielding glutamate and an oxaloacetate ketone product. This reaction 
can be coupled to the reduction of the carbonyl of the ketoacid group of the 
oxaloacetate, by lactate dehydrogenase, which requires an NADH cofactor. This 
consumption of oxaloacetate linked to NADH can therefore be measured at 340nm.
Using this assay, somewhat surprisingly, lysate from un-induced cultures of 
BL21gold(DE3) pQR416 was found to have activity thirty fold higher than that 
measured for the wild-type host strain at an equivalent cell density. Some activity 
was detected for the untransformed host due to the presence of the TyrB gene in the 
host genome. It was expected that prior to induction the measurable activity would 
be close to that of the wild-type activity. The T7 promoter requires the T7 
polymerase encoded in the host (DE3) strain whose expression is induced from the 
lacUV5 promoter using IPTG (Studier, W.F. and Moffatt, B.A., 1986). Therefore 
without addition of the IPTG inducer the level of T7 polymerase should be minimal 
and therefore protein expression driven by the T7 promoter would be very low. It is 
probable that the production of ArTAm seen without induction is due to the leaky 
expression of the T7 polymerase. Induction of cultures with IPTG was expected to 
yield higher activity due to a large increase in protein production. However, induced 
cultures yielded half the activity seen without induction.
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Upon investigation of ArTAm protein production by the strain by SDS-PAGE 
analysis it was confirmed that both un-induced and induced BL21gold(DE3) 
pQR416 cells were producing significant amounts of the ArTAm. It was therefore 
apparent that the transaminase is constitutively expressed from the construct due to 
the leaky expression of the T7 polymerase. Furthermore when assessing the soluble 
and insoluble fraction it was found that post induction much of the transaminase was 
in the insoluble fraction, whilst in un-induced cells the majority of the ArTAm 
remained in the soluble fraction. The increase in protein expression by induction is 
therefore leading to increased aggregation of the catalyst, which is detrimental to 
both the ArTAm activity and the growth of the host cells. In subsequent work the 
strain was therefore used to produce ArTAm without IPTG induction.
3.3.3 Growth activity relationship of BL21goId(DE3) pQR416.
Upon investigation of the growth of the ArTAm expressing strain BL21gold(DE3) 
pQR416 it was found that whilst the un-induced BL21gold(DE3) pQR416 strain 
exhibited slower growth than the wild-type BL21gold(DE3) culture it reached a 
comparable cell density over an 8 hour incubation period. When induced with IPTG 
the growth of the BL21gold(DE3) pQR416 was significantly retarded (Figure 
3.8(a)). Growth ceased approximately 1-hour post induction thus reaching only half 
the cell density observed for the other cultures. Since it appears that production of 
ArTAm retards the growth of the cells, even in the un-induced strain, induction, 
further increasing the protein production, may well be expected to further inhibit 
growth. However the increase in protein production retarding the growth would be 
expected to yield higher activity. The trend of activity with respect to cell density 
may be expected to increase sharply as the catalyst concentration increases 
independently of the cell density. However, the culture at one hour after the time of 
induction, when the induced and un-induced cultures were at comparable cell 
densities, yielded -70% of the activity of the un-induced culture (Figure 3.8(b)). 
This corroborates the data from the initial exploratory experiments (Section 3.3.2) to 
demonstrate active ArTAm production from the newly constructed strain.
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Figure 3.8: Investigation of growth of ArTAm producing strain BL21gold(DE3) 
PQR416.
The growth of BL21gold(DE3) pQR416 was monitored for cultures, 100 mL, grown 
from a 1/20 inoculum both induced, with ImM IPTG at 4.5 hours, and un-induced 
alongside the wild-type host strain (Section 2.4.2.3). The growth (A) of the three 
cultures was monitored by measurement of cell density by OD 600nm. Activity (B) 
following induction was monitored by enzyme linked assay (Section 2.7.1).
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3.3.4 Native activity of ArTAm
The native activity of ArTAm catalyses the transfer of the amine group from either 
aspartic acid or phenylalanine (Hayashi, H. et al., 1993). With the activity of the 
cloned enzyme already confirmed with aspartic acid using the enzyme linked assay 
(Section 3.3.2) it was desirable that the activity with phenylalanine, a reportedly 
more favourable substrate (Hayashi, H. et al., 1993), was demonstrated. The 
reactions were assayed by HPLC to monitor both the amine substrate and the 
glutamate produced by transamination of the a-ketoglutarate ketone substrate. The 
method developed for this (Section 2.5.3) was 14 minutes long and required amine 
derivatisation of the samples (Section 2.6.3) prior to injection to enable both 
separation on a C l8 column and detection by UV. The activity of the ArTAm was 
high with the reactions going to equilibrium, with the production of 5 mM glutamate 
from 10 mM substrates, within one minute.
3.4 Cloning and expression of (3-A: P TAm
3.4.1 Cloning of P-A: P TAm
The second transaminase candidate was P-alanine: pyruvate transaminase (Section 
1.10.2) The p-alanine-pyruvate transaminase was cloned from the genomes of 
Pseudomonas. Following amplification of the PA0132 gene it was ligated into the 
Ndel and Xhol sites of expression vector pET24a(+). This places the gene under the 
control of the T7 promoter of the vector. This initial work was carried out by 
M.Bommer. The resulting construct was sequenced and named pQR426 (Figure
3.9). In parallel the p-A: P transaminase from Pseudomonas putida (PP0596) was 
also cloned into pET24a(+) to form expression construct pQR427. These plasmids 
were constructed to be compatible for coexistence with pQR411 carrying the 
transketolase gene (Section 3.1).
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Figure 3.9: Expression vector for p-alanine: pyruvate transaminase
Expression construct pQR426 was constructed by the insertion of the P-alanine: 
pyruvate transaminase gene from Pseudomonas aeruginosa (PCR product from 
genome template) into the Xhol and Ndel sites of pET24a (+) (Section 2.4.3.1).
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3.4.2 Expression of p-A: P TAm
The initial investigation into the expression of the two p-A: P transaminases cloned 
was carried out by SDS-PAGE analysis (Figure 3.10). Here the presence of a strong 
50 KDa band, in induced cultures, comprising -37 % of cellular protein, not present 
in the host strain, indicated the over-expression of the p-A: P transaminase protein 
from both Pseudomonas putida (lane 6) and Pseudomonas aeruginosa (lane 4). This 
band is the correct approximate size compared with the 48.4 KDa weight calculated 
from the amino acid composition. Additionally it corresponds to the -50 KDa band 
seen for the single subunit that makes up dimeric amine: pyruvate transaminase from 
Vibrio fluvialis (Shin, J.-S. et al., 2003). The p-A: P transaminase protein was found 
to be mainly in the soluble fraction by analysis of clarified supernatant (lane 3) 
compared to the pellet fraction (lane 2) for lysate from p-A: P TAm from 
Pseudomonas aeruginosa. This was similarly found for Pseudomonas putida (data 
not shown).
3.4.3 Native activity of p-A: P TAm
The activity of the p-A: P TAms from Pseudomonas aeruginosa and Pseudomonas 
putida was verified by reaction with the native substrates, pyruvate and p-alanine 
(Figure 3.11). Activity was confirmed by monitoring the depletion of p-alanine 
substrate and formation of a-alanine product (Figure 3.12) by HPLC analysis 
(Section 2.5.4). The use of a curved acetonitrile gradient on a Cl 8 column enabled 
the separation of ACQ derivatised (Section 2.6.3) P- and a-alanine. Although 
baseline resolution was not achieved (Appendix D) the ability to see both substrate 
depletion and product formation made this assay accurate enough to quantitatively 
assess enzyme activity. The reaction initially proceeds quickly but levels off after an 
hour and a half at -  30% conversion. Both transaminases were found to have 
comparable activity with this substrate pair. The wild-type host control strain 
showed negligible a-alanine product formation (or loss of p-alanine substrate) over 
the reaction period. Comparable activity was obtained for the p-A: P TAm following 
storage at -20°C overnight as both lysate or whole cells.
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Figure 3.10: Analysis of p-A: P TAm expression
The expression of Pseudomonas aeruginosa P-A: P TAm from the constructed E.coli 
strain BL21gold(DE3) pQR426 was analysed on a 12% v.v acrylamide SDS-PAGE 
gel and stained with commassie blue (Section 2.3). Both the soluble and insoluble 
fractions were examined for the transaminase. Sample lanes: 1= wild-type 
BL21gold(DE3) 2= BL21gold(DE3) pQR426 insoluble fraction, 3= BL21gold(DE3) 
pQR426 soluble fraction, 4= BL21gold(DE3) pQR426 lysate, 5=MW marker, 6= 
BL21 gold(DE3) pQR427 (p-A: P TAm P. putida). Strains over expressing p-A: P 
TAm show a prominent band at 50 KDa not present in wild-type host strain (lane 1).
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p-alanine pyruvate malonic semialdehyde a-alanine
Figure 3.11: Native reaction scheme for P-A: P transaminase
The P-A: P TAm catalyses the transfer of the amine group from p-alanine to the 
ketone substrate pyruvate requiring a pyridoxal phosphate cofactor. This reaction 
yields a-alanine and malonic semialdehyde products.
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Figure 3.12: Activity of P-A: P TAm from P. putida with p-alanine and pyruvate
The lysate of BL21gold(DE3) E.coli strains over producing P-A: P TAm were 
assayed for transamination of pyruvate forming a-alanine using a p-alanine amine 
donor substrate. Reactions contained 15mM p-alanine, 15mM pyruvate, 2mM PLP 
in 25mM potassium phosphate buffer, pH7.0 and were incubated at 25°C (Section
2.4.3.4). Error bars represent a 95% confidence interval.
A second test for activity was carried out using a spectroscopic enzyme-linked assay 
(Burnett, G. et al., 1980). This uses p-aminobutyric acid as the amine donor 
substrate and pyruvate as the ketol-donor substrate. The generation of P- 
hydroxybutyrate allows coupling with NADH-dependant p-hydroxybutyrate 
dehydrogenase (E.C..1.1.30) allowing the reaction to be monitored spectroscopically 
at 340nm (Section 2.7.2). This assay would provide a rapid method to assess the 
acceptance of different ketone substrates by the candidate transaminases. This would 
enable high-throughput analysis and may also be applicable to the screening of 
mutant libraries. The activity with the P-aminobutyrate substrate was confirmed for 
both of the cloned P-A: P TAms. However, the background signal of this assay was 
found to be very high with the wild-type host strain exhibiting half the rate detected 
for the transgenic strains.
3.4.4 Growth activity relationship of BL21gold(DE3) pQR426
Investigation into the growth characteristics of the P. aeruginosa p-A: P TAm 
producing strain BL21gold(DE3) pQR426 were carried out relative to the wild-type 
host strain (Figure 3.13). The induction of p-A: P TAm expression in the 
recombinant strain retarded host cell growth reaching just 55% of the cell density 
achieved by the wild-type host strain. Activity of the P-A: P TAm, not detectable in 
the host strain, followed a similar trend to the growth profile reaching near maximal 
activity 4 hours following induction and rising little after that.
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Figure 3.13: Growth activity relationship of P-A: P TAm expressing strain 
BL21gold(DE3) pQR426
The growth of BL21gold(DE3) pQR426 over expressing p-A: P TAm from 
P.aeruginosa was monitored alongside the host strain. Incubation was at 37°C with 
agitation at 200 rpm. Induction was carried out by addition of ImM IPTG after one 
hour of growth. Growth was monitored by measurement of OD6oonm and activity was 
assayed by reaction with the p-alanine and pyruvate (Section 2.4.3.5).
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3.5 Summary
This chapter describes the construction of plasmid vectors for the expression of the 
candidate enzymes. TK was subcloned from the existing vector pQR706 into an 
alternative expression vector, pMMB67HE, to form pQR411 (Section 3.2.1). Active 
enzyme production (Section 3.2.2) was confirmed using the model reaction with 
substrates p-HPA and glycolaldehyde. The growth of the strain carrying the pQR411 
was found to be comparable to that of the host strain and TK was produced 
constitutively throughout the growth period of the culture (Section 3.2.3).
The ArTAm from E.coli was cloned in to pCRT0P02.1 which was further modified 
to form expression vector pQR416 (Section 3.3.1). Once transformed into the 
BL21gold(DE3) host strain production of active over expressed protein was initially 
demonstrated, without the need for induction, using both an enzyme linked assay 
(Section 3.3.2) and an HPLC assay (Section 3.3.4), enabling different substrates to be 
investigated. The production of the transaminase in un-induced cultures was seen to 
slightly inhibit the rate of cell growth, due to inclusion body formation, but the 
culture reached a comparable cell density as the non-recombinant host strain over an 
eight hour growth period. Induction of transaminase expression led to the culture 
reaching only 55% of the cell density of the un-induced culture. Additionally the 
ArTAm activity of the induced culture was less than 50% of that observed with out 
induction therefore induction was not advantageous to the production of active 
enzyme.
The p-A: P TAm from Pseudomonas aeruginosa, in parallel with P.putida p-A: P 
TAm, was cloned directly into a pET vector forming pQR426 and pQR427. 
Expression was under the control of the T7 promoter therefore requiring induction of 
the T7 polymerase by IPTG. Activity of the expressed p-A: P transaminases was 
confirmed (Section 3.4.3) by monitoring the reaction with native substrates p-alanine 
and pyruvate by HPLC (Section 2.5.4). The growth-activity relationship showed that 
the activity of the transaminase increased sharply following induction and levelled 
off after 3 hours. This was following the same trend as the growth which was 
severely retarded upon induction reaching only 55% of that achieved by the native 
host strain.
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The cloning of the two candidate transaminases and subcloning of transketolase has 
produced the vectors with which a dual TK-TAm expression system can be created 
(Section 6.2). Prior to construction of the dual plasmid strain further investigation of 
the substrates ranges of the transaminases will be carried out as described in the next 
chapter.
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Chapter 4 - Substrate specificity and mutagenesis of candidate 
transaminases
The previous Chapter detailed cloning and expression of various candidate 
transaminases. The ArTAm, from E.coli, and the p-A: P TAm, from both 
Pseudomonas aeruginosa and Pseudomonas putida, were each cloned into a pBR322 
derived expression vector compatible for co-existence with the constructed TK 
plasmid. The enzymes were over-expressed separately in the E.coli strain 
BL21gold(DE3) and demonstrated to be active. In this Chapter the acceptance of the 
transketolase product L-erythrulose by the candidate transaminases, for use in the 
TK-TAm biosynthetic pathway, is described.
4.1 Introduction
Enzymes are selective towards the substrates that they accept for catalysis. This 
selectivity involves chemo, regio, and stereoselectivity. Catalysis of a particular 
compound is dependent on both the chemical properties and the physical structure of 
the compound being compatible with insertion into the active site in such a way that 
catalysis can occur. Chemically unfavourable interactions of the substrate and the 
active site residues may disrupt substrate binding. The binding of a substrate may 
involve very few contacts with the active site residues. Any repulsion between the 
substrate molecule and the amino acids lining the active site may be sufficient to 
disrupt these interactions or cause a change in enzyme conformation making 
catalysis unfavourable. Furthermore, many enzymes exist in a distinct open and 
closed structure with the closure being induced by the substrate binding, an example 
of such an enzyme is aspartate transaminase (Hayaishi, H .,et al., 2003; Jager, J. et 
al., 1994) a close relative of ArTAm. The open conformation allows the substrate 
molecule to pass into the active site before the structural change into the closed 
confirmation required for catalysis. This conformational change may be reliant on 
the contacts between the substrate molecule and certain residues of the enzyme. 
Once in the active site, the alignment of the group at which catalysis is to occur must 
be in sufficient proximity of the catalytic residues of the enzyme to allow the 
necessary chemical interactions to occur. A molecule can have more than one group 
of a certain chemistry but catalysis is regiospecific to that which correctly aligns with
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the catalytic residues. A preference for either the use of a chiral substrate or the 
production of a chiral product is also dictated by the positioning of the molecule 
within the active site. An enantiomer that is not accepted as a substrate may either 
not be able to bind in the active site due to steric hindrance, or may unfavourably 
position the target site of catalysis relative to the active site residues.
Enzymes with a known function are often discovered as part of a metabolic pathway 
and the so-called ‘native activity’ is described by this function. It is often the case 
that the substrate range of a particular catalyst is only explored as far as the interests 
of a particular investigator. The lack of reports on the activity of an enzyme with a 
particular substrate is often not a good indicator that it does not react. The search for 
a suitable transaminase involved the investigation of two transaminases (Section
1.10). Both were evaluated on their ability to accept L-erythrulose and other 
molecules that share structural similarity to transketolase products. This provides not 
only information about the suitability of the catalyst for the desired reaction but also 
possible information about the enzymeisubstrate interactions eluding to other 
potential substrate candidates. Additionally the development of a mutagenesis 
strategy was investigated. This was in order to enhance the activity of the enzyme 
with the desired substrate. This Chapter is therefore divided into four sections. The 
first (Section 4.2) details the synthesis of the pathway product and assay 
development, the second (Section 4.3) probes the substrate range of ArTAm, the 
third (Section 4.4) investigates the mutagenesis, both random and site directed, of 
ArTAm and the fourth (Section 4.5) looks at the substrate range of p-A: P TAm.
4.2 Product synthesis and analytical assays
4.2.1 Synthesis of 2-amino-1,3,4-butanetriol product standard
In order to develop analytical assays to quantitatively monitor the bioconversions, 
standard compounds for both substrates and products are required. The target 
pathway product 2-amino-1,3,4-butanetriol (ABT) was found not to be commercially 
available, thus it was achieved by chemical synthesis (Section 2.6.1).
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Initially a reductive amination of L-erythrulose was carried out using ammonia and a 
sodium cyanoborohydride catalyst in methanol at pH 6.0. The formation of ABT 
was monitored by TLC and a sample isolated from a preparative plate was confirmed 
by mass spectrometry. However, due to the product being soluble in aqueous 
solution, isolation proved difficult. Protection of the hydroxyl groups using tert- 
butyl-dimethyl-silyl chloride (TBDMS) was carried out to enable extraction into an 
organic solvent and separation on a silica column. However the isolation of any 
significant quantity of the product was not achieved.
A second approach was therefore investigated (Figure 4.1) which was adapted from 
published methodology (Dequeker, E. et al., 1995). Following the conversion of L- 
erythrulose, 1 to the 3, 4 -O  -  isopropylidene acetal 2, reductive amination was 
carried out using benzylamine and sodium cyanoborohydride to yield 3 as a mixture 
of diastereomers. De-protection of 3 was carried out with methanolic HC1 to afford 
the aminotriol hydrochloride 4, which was subsequently subjected to hydrogenolysis 
to yield the desired 2-amino-1,3,4-butanetriol product 5 as a 1:1 mixture of threo and 
erythro diastereomers. It should be noted that this synthesis allows for the resolution 
of diastereomers at intermediate 3 should this be considered appropriate. This was 
not carried out at this stage due to the lack of L-erythrulose starting material.
4.2.2 Analysis of 2-amino-l,3>4-butanetriol
The development of methods to enable quantitative analysis of the pathway product 
ABT was required. The previously developed method for (3-A: P TAm activity 
(Section 2.5.4), following derivatisation, resolved the products from the native 
substrates of both the transaminases. This assay was found to also resolve the ABT. 
Baseline resolution of the diastereomers was not achieved but the resolution was 
considered sufficient at this stage.
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Figure 4.1: Synthetic pathway for 2-amino-l,3>4-butanetriol product standard.
a) Me2CO/2,2-DMP (9:1), TsOH (cat.); b) BnNH2, NaCNBH3, MeOH, pH 6; c) 1 M 
HCl/MeOH; d) H2, Pd/C, MeOH. Method described in section 2.6.1.
4.3 Substrate specificity of ArTAm
4.3.1 Activity with L-erythrulose
The activity of the cloned ArTAm from E.coli was previously demonstrated with the 
native substrates L-aspartic acid, or L-phenylalanine, and a-ketoglutarate (Section
3.3.4). The investigation into the acceptance of other substrate compounds was 
carried out under conditions (Section 2.8) where the native conversion, with L- 
phenylalanine and a-ketoglutarate, with lysate went to equilibrium (50% conversion) 
within one hour (Section 3.3.4).
The activity of the aromatic transaminase with target substrate L-erythrulose was 
initially investigated. A reaction containing L-erythrulose, and L-phenylalanine, 10 
mM each, was carried out. The reactions were monitored for ABT formation over a 
24 hour time period, but no activity was observed. A final sample taken at 72 hours 
again showed no detectable product formation. A second experiment, in which 
acceptance of L-erythrulose with aspartic acid was tested, corroborated the initial 
results with no detectable product formation.
4.3.2 Activity with serine
Serine has previously been reported to be a poor substrate for the ArTAm (Hayashi, 
H. et a l, 1993). However, it is a desirable amine source for the transaminase in the 
linked TK-TAm pathway, as transamination using a serine amine donor would yield 
P-hydroxypyruvate as the ketone product. This could feed back into the beginning of 
the pathway as a transketolase substrate. This would not only regenerate the TK 
substrate but would also enable the ArTAm reaction to be pulled past the 50% 
equilibrium by removal of one transamination product. The activity of ArTAm with 
serine as the amino donor was tested initially with phenylpyruvate. The reaction was 
monitored by analysis of the phenylalanine product. No appearance of the product 
was detected. This was in keeping with the results of another reaction of ArTAm 
with serine and a-ketoglutarate where the formation of the glutamate transamination 
product of a-ketoglutarate was not detected. However, in this reaction it was 
possible to monitor both the formation of glutamate and the consumption of serine 
substrate. It was noted that, whilst no glutamate product was detected, the serine
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substrate was being consumed. The appearance of a peak co-eluting with ammonia 
suggested that the serine substrate was being deaminated but was not further 
investigated.
4.3.3 Activity with aromatic amine donors
The key differences between compounds known to be accepted as aromatic 
transaminase substrates (Hayashi, H. et al., 1993) and TK generated substrates, such 
as L-erythrulose, are the presence of a hydroxyl group (from the p-HPA) instead of 
an acid group adjacent to the keto group (i.e. a non keto acid) and the hydroxyl 
branching off the main carbon chain at the-position adjacent to the carbonyl to be 
transaminated (Figure 4.2) generated by the TK catalysed carbon-carbon bond 
formation.
A number of aromatic amine substrates (commercially available) with the structural 
and chemical characteristics of the TK products (Figure 4.3), were tested as 
substrates with the ArTAm. Aromatic substrates were chosen since the reported 
activity of the enzyme with L-phenylalanine is many fold greater than with aspartic 
acid (Hayashi, H. et al., 1993). Therefore the use of an aromatic substrate may 
improve the chances of compounds, lacking the keto acid group or with the addition 
of a P-hydroxyl, binding and reacting with the enzyme. The presence of the aromatic 
ring also makes direct analysis possible, allowing shorter assay development and 
both substrate loss and product formation to be monitored in a single assay, without 
the need for derivatisation.
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Figure 4.2: Illustration of key differences between L-erythrulose and known 
ArTAm substrates
The boxes illustrate the differences between known ArTAm substrates and the target 
substrate. The striped box highlights the hydroxyl branching off the main chain 
adjacent to the carbonyl group. The clear box highlights the presence of a hydroxyl 
instead of an acid group which would form the keto acid functionality.
Phenylaminopropandiol, 1
NH
OH
Phenylaminopropanol, 2
Phenylserine, 3
NH
COOH
Figure 4.3: Alternative aromatic substrates for investigation with TAm
Boxes as described in legend to Figure 4.2
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Phenylaminopropandiol,l, is the aromatic equivalent of L-erythrulose. However it 
may be a more favourable substrate for ArTAm than L-erythrulose due to the 
presence of the benzyl ring. Phenyl ami nopropanol, 2, is a step towards the known 
phenylalanine substrate with no branching hydroxyl, however the favoured keto acid 
moiety is still lacking. Conversely, phenyl serine, 3, is a ketoacid but differs from 
phenylalanine by the presence of the hydroxyl at the carbon adjacent to the carbonyl. 
Although in the case of the target pathway the ketone would be the substrate, only 
the amine forms of the compounds were commercially available. Since the 
equilibrium constant of the enzyme is typically found to be 1, the reversible nature of 
this transaminase suggests that activity with an amine could be used as an indicator 
towards the acceptance of the corresponding ketone as a substrate for this enzyme.
4.3.3.1 Investigation into acceptance of phenylserine as a substrate
The reaction of ArTAm with D-/L-threo-phenylserine and phenylpyruvate yielded 
formation of phenylalanine product (Figure 4.4). The recombinant strain showed 
formation of 2 mM phenylalanine product within one hour. This then levelled off 
and no increase in product was seen in a four and a half hour period. The wild-type 
host strain also showed phenylalanine production but at a much lower rate, this is 
probably due to catalysis of the reaction with phenylserine by the chromosomal 
ArTAm in the E.coli host.
The yield of the product did not reach the 50% equilibrium normally observed for 
catalysis by ArTAm. This can be attributed to the D-/L nature of the substrate 
amine; half of the amine is not a substrate to the transaminase, which exclusively 
accepts L amino acids. The theoretical maximum yield for this substrate is therefore 
25%. The observed yield of 18% is a little lower than the expected maximum yield. 
An investigation into whether it was inhibition that halted the reaction short of the 
theoretical maximum conversion for this particular form of the substrate was carried 
out. Identical reactions were set up (in triplicate) with 10 mM and 5 mM substrate.
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Figure 4.4: The activity of ArTAm with D-IL-threo P-phenyl serine
The activity of the ArTAm with D-/L-threo-p-phenyl serine was tested with phenyl 
pyruvate, both at lOmM each in 25 mM potassium phosphate buffer, pH 7.0 with 10 
mM of the keto acid and amino acid substrates, 0.2 mM pyridoxal phosphate cofactor 
at 25°C with agitation at 200 rpm. (Section 2.8). The reaction was monitored by 
HPLC for both phenylserine depletion and phenyl alanine formation (Section 2.5.5). 
WT = E.coli host strain without a plasmid.
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The reactions were monitored until steady state was reached after 4 hours. The 
steady state point for the reaction with 5 mM substrate was approximately half that 
of the 10 mM reaction (Figure 4.5a). Normalising the results showed (Figure4.5.b) 
that increasing the original substrate charge from 5 mM to 10 mM reduces the 
maximum percent conversion reached by 4 %. This could imply that one of the 
components of the transamination is inhibitory.
It has previously been noted that the erythro form of a L- phenylserine binds and 
gives a distinctly different absorption spectra to that for the threo form of L- 
phenylserine or other ArTAm substrates (Hayashi, H. et al, 1996). During the same 
study, when reactions were carried out in a stopflow reactor, it was observed that 
little of the PMP-ArTAm was produced with the erythro-phenylserine. This was 
postulated to be due to the high affinity of the oxo-acid product for the enzyme. An 
intense quinoid absorption around 500 nm was seen for the erythro form not seen in 
the absorbance spectrum for the threo isomer. This stabilisation of the quinoid 
intermediate by the interaction of the branching-hydroxyl, in the erythro 
configuration, may be extremely detrimental to catalysis. An investigation into the 
removal of the hydroxy functionality at tyrosine 70 (Hayashi, H. et al., 1996) found 
that this destabilised the quinoid intermediate formation with erythro phenylserine, 
yielding a decrease in the quinoid absorption band at 500 nm. Accordingly the 
measured free energy levels of the quinoid intermediates showed a large decrease 
upon the Y70F mutation for the phenylserine substrate whilst for a phenylalanine 
substrate this mutation showed little change. The interaction of the branching 
hydroxyl with tyrosine residue 70 accounts partly for the stabilisation of the quinoid 
intermediate and the remaining stabilisation energy is due to interactions with other 
active site residues. Therefore, it is possible that the non-reacting diastereomer of the 
D-fL threo phenylserine, the D-amine which will have the hydroxyl in the equivalent 
position to the L- erythro-phenylserine, is entering the active site and binding, 
therefore acting as an inhibitor.
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Figure 4.5: Investigation of the effect of substrate concentration for ArTAm 
using p-phenylserine as an amino donor.
(a) The formation of phenylalanine was measured (Section 2.5.5) for the 
transamination between phenylserine and phenyl pyruvate catalysed by ArTAm. 
Two substrate concentrations, 5 mM and 10 mM with reaction conditions 25 mM 
potassium phosphate buffer, pH 7.0 with 10 mM of the keto acid and amino acid 
substrates, 0.2 mM pyridoxal phosphate cofactor at 25°C with agitation at 200 rpm. 
The data in (b) is normalised to the total substrate plus product to enable comparison 
of the equilibrium position of the reactions at the two different substrate 
concentrations. Error bars represent 95 % confidence interval calculated from 
triplicate reactions.
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Further work is required to investigate the catalysis of aromatic hydroxy-ketone 
substrates with ArTAm to investigate the stereochemistry of the amine resulting from 
a transamination. The enantiomer produced will depend upon the orientation of the 
binding of the substrate in the active site. The orientation of binding of the amino-p- 
hydroxyketone substrate may cause the (S) hydroxyl to experience the unfavourable 
interactions with the active site as the erythro phenylserine experiences. Using 
mutagenesis to reduce the interactions of the hydroxyl branch with the active site 
may be possible. The ability to change the activity of a transaminase towards 
branched substrates has previously been carried out on AspAT to enable a five-fold 
increase in the acceptance of branched amino acid valine (Yano, T., Oue, S., and 
Kagamiyama, H., 1998). However it is conceivable that if the substrate is not a keto- 
acid the binding of the substituted alcohol will not hold the substrate in such a rigid 
position as an acid at the equivalent position therefore allowing substrate rotation and 
the possibility of the hydroxyl branching being accommodated.
4.3.3.2 Activity of ArTAm with aminoalcohols
In order to test the acceptance of an aromatic substrate without the acid group 
phenylaminopropandiol, 2, the diol form of phenylserine (Figure 4.3, was 
investigated. This substrate was tested in the 1(5), 2(5)-2-amino-l -phenyl-1,3- 
propandiol form (equivalent to the reactive L-threo phenylserine). This contains the 
(S) stereochemistry of the p-hydroxyl like a TK product. Also tested was \(R),2(R)~ 
2-amino-l-phenyl-1,3-propandiol. Additionally the transamination of the (R) and (S) 
stereoisomers of 2-amino-3-phenylpropanol was investigated. Since the use of 
amino alcohol substrates was investigating the use of a totally new class of 
compounds for ArTAm it is hard to predict the stereochemistry that would result 
from the transamination of the ketone precursor. Therefore both the (R) and (S) 
stereoisomers were tested.
Neither of the phenylaminopropanol isomers with a-ketoglutarate, both at 10 mM, 
yielded any detectable glutamate product formation with ArTAm over a 24-hour 
reaction period. Similarly the reactions with the phenylpropandiol diastereomers as 
the amine donor yielded no glutamate product.
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The branching hydroxyl in L-erythrulose (Figure 4.2) is formed during the TK 
catalysed formation of the asymmetric carbon-carbon bond and is a characteristic of 
all TK products. The terminal hydroxyl is a product of the reaction of TK employing 
p-HPA and is not an intrinsic property of a TK product. The accommodation of the 
hydroxyl branch of phenylserine implies that this enzyme may be able to 
accommodate a molecule with a TK synthesised asymmetric carbon-carbon bond but 
the challenge is the acceptance of a non-keto acid substrate with no examples of 
acceptance of such a substrate for this enzyme. The acceptance of ketomalonic acid, 
in place of P-HPA, by TK was considered as a potential solution. This would result 
in a ketoacid product. This substrate was tested with TK, but again no activity was 
detected. Subsequently finding a TAm to accept a non-ketoacid was focused upon.
4.4 Investigation into the mutagenesis of ArTAm
4.4.1 Consideration of mutagenesis protocols
It was desirable to have a random mutagenesis strategy established both for 
development of the initial pathway (Figure 1.8) and the more long-term goal of 
evolving the constructed pathway to accept alternative substrates. A mutagenesis 
strategy includes the protocols for generating mutants of an enzyme as well as the 
ability to screen the mutant library for the desired activity. Since wild-type E.coli 
ArTAm did not have the desired activity towards any of the substrates resembling a 
TK product (Section 4.3) it could be a candidate for random mutagenesis techniques. 
Therefore, protocols to investigate both the random and site directed mutagenesis of 
ArTAm substrate specificity were investigated.
4.4.2 Mutant library generation by XLl-red mutator strain
XLl-Red allows the generation of large numbers of random mutants (Greener, A., 
Callahan, M. and Jerspeth, B., 1997). XLl-Red is an E.coli strain engineered to be 
deficient in three of the primary DNA repair pathways. Such a strain, often referred 
to as a ‘mutator strain’, can be used to propagate DNA and insert random mutations 
at a rate much higher than would naturally occur in a wild-type E.coli strain. This 
technique may be more convenient than other techniques such as error prone PCR as 
it bypasses the need for many tedious DNA manipulations. In addition, the problem 
of optimising the mutation bias is not present (Cline, J. and Hogrefe, H.H., 2000). In
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order to achieve the increased mutation rate exhibited by XLl-red, the mutS, mutD 
and mutT mutations were introduced into a single bacteria (Greener, A., Callahan, M 
and Jerspeth, B., 1997). These mutations result in disruption of error-prone mismatch 
repair, loss of DNA polymerase III 3’-5’exonuclease activity and loss of hydrolysis 
of 8-oxodGTP lesions respectively. The engineered XLl-Red strain has a reported 
mutation rate approximately 5000 times higher than the parent strain assuming the 
wild-type mutation rate is 10"10 per nucleotide per generation. This strain has been 
successfully used in several instances. Using XLl-red generated mutants the 
enhancement of the activity of alkaline phosphatase towards chromogeneic substrate 
BCIP was achieved (Greener, A., Callahan, M. and Jerspeth, B., 1997), a variant of 
an esterase from Pseudomonas fluorescens able to carry out the resolution of a 
sterically hindered 3-hydroxy ester was obtained (Bomscheuer, U.T., Altenbuchner, 
J. and Meyer, H.H., 1998) and the activity of cycloartenol synthase was altered to 
function as a lanosterol cyclase (Wu, T.-K.a.G., J.H., 2002).
The pQR416 plasmid (Figure 3.7), encoding ArTAm, was propagated through 50 
generations in the XLl-red mutator strain (Section 2.9.1.1). This required several re­
inoculations as the strain achieved an average of 5 generations in a 12-hour growth 
period. The DNA was then isolated and transformed back into the BL21gold (DE3) 
expression host. Sequencing of DNA was then carried out for 10 colonies and the 
screening for activity of a small library (386 mutants) carried out. (Section 4.4.2.2).
4.4.2.1 Quantification of rate of mutagenesis
From sequencing a total of 10 x 1.2 kb genes, only three were found to have point 
mutations and one further sequence had an insertion. These results are summarised 
in Table 4.1. In an attempt to increase the observed mutation rate the mutant plasmid 
preparation used to make this library was reintroduced into XLl-red. A further fifty 
generations were carried out. However, upon sequencing a similar selection of 
random colonies a high frequency of stop codons was detected. This DNA was 
subsequently not used to make a library for screening. The introduction of two 
different stop codons into the sequences, both appearing in more than one sequence, 
implies there may be selection pressure on the cells expressing the protein.
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Table 4.1: XLl-red derived mutations
Sequence mutations in ArTAm gene plasmid from pQR416 after passage through 50 
generations in XLl-red mutator strain (Section 2.9.1.1).
DNA Mutation Effect on amino acid sequence
491 T—> G Leu —> Trp
542 G -> A Cys tyr
212 G —» A Gly —> Glu
Ins G 581 Frame shift
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It has already been shown that over-expression of ArTAm retards growth of the host 
strain (Section 3.3.3.), however XLl-red is not supposed to function as an expression 
strain for a gene under the T7 promoter. To check that expression was not occurring 
SDS-PAGE analysis was carried out. No over-expression of the ArTAm in XLl-red, 
pQR416 was detectable (data not illustrated). Thus the introduction of the stop 
codon is apparently incidental rather than selected for. It is possible that the stop 
codon was introduced early in the mutation cycle and is therefore propagated to 
subsequent daughter generations. This highlights a problem when using the mutator 
strain strategy. A further attempt at generating ArTAm mutant populations using 
XL1 -red was unsuccessful with the growth of the cells and plasmid retention proving 
a problem. A different commercial batch of the cells then yielded no mutations in 6 
Kb sequenced following propagation through 100 generations. The XLl-red 
mutation strategy was subsequently abandoned for this work.
4.4.2.2 Screening of mutant library with alternative substrates
The screening of the 386 mutants from the 50 generation library (Section 2.9.1.2) 
was initially for increased activity towards serine with a-KG. The analysis was 
initially carried out by monitoring the serine depletion (Section 2.5.3). This proved 
unreliable and the analytical methodology was reassessed. Subsequently the library 
was re-screened with phenylpyruvate as the amine acceptor enabling the formation of 
phenylalanine to be monitored. The 50-generation library was screened (against a 
wild-type ArTAm control) for increased activity with serine, phenyl ami nopropanol 
and phenylaminopropandiol. Acceptance of L-erythrulose was also screened 
although this was less reliable as it required the monitoring of phenylalanine amino 
donor substrate depletion. No activity was found to fall outside the variance seen for 
the wild-type for any substrate. This lack of ‘hits’ can be attributed to the low rate of 
mutation and the small library size investigated. The generation of larger mutant 
libraries with higher mutation rates is required. Additionally a more rapid way of 
assaying the samples for potential hits is desirable. This may be achieved by the use 
of auxotrophic strains, colormetric assays or the development of higher throughput 
automated analytical techniques (HPLC or LC-MS).
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4.4.2.3 Native activity screen of library
One 96-well plate from the library was screened for the native activity with aspartic 
acid and phenylpyruvate allowing the formation of the phenylalanine product to be 
monitored (Section 2.5.5). This study enabled the estimation of the number of 
inactivated mutants created by the mutator strain. There were six mutants on the 
plate that yielded no phenylalanine formation. This may be due to the introduction 
of stop codons, or deletions or insertions resulting in a frame shift.
4.4.3 Whole Plasmid error prone PCR
Error prone PCR is an established method for random mutagenesis with many 
examples of successful evolution of desired characteristics including the evolution of 
cytochrome p450 to improve the activity towards non-natural substrates (Gleider, A., 
Farinas, E.T., Arnold, F.H., 2002), the evolution of a restriction enzyme to increase 
substrate specificity (Samuelson, J.C. and Xu, S.Y., 2002) and the modulation of the 
substrate specificity of an acylase (Otten, L.G. et al., 2002) The use of manganese 
to reduce the fidelity of the polymerase used for amplification is used to achieve the 
desired rate of mutagenesis. However, it can be a laborious technique requiring 
optimisation of manganese concentration to obtain the desired mutation rate and 
ligation of the mutant PCR products into a vector prior to screening. Additionally 
mutation rates can be unpredictable and a bias in the observed nucleotide changes 
occurs with Taq polymerase being 4 times more likely to mutate A and T bases than 
C or G.(Matsumara, I. and Ellington, A.D., 2001).
The methodology to carryout successful PCR amplification of large segments of 
DNA from the (3-globin gene cluster from the human genome has been successfully 
demonstrated (Cheng, S. et al., 1994). The thermostable DNA polymerase rTth from 
Thennus thermophilus was shown to reliably amplify 21Kb PCR products. rTaq 
from Thennus aquaticus, was also demonstrated to successfully carryout such long 
amplifications. Using these enzymes it is therefore feasible that error prone PCR can 
be carried out on a whole plasmid circumventing the, often troublesome, ligation of 
the PCR product into a vector by simply re-circularising the linear PCR products 
(and digesting the circular template DNA) to form the complete plasmid for 
transformation into the E.coli host. This technique has been found to yield a high 
frequency of transition mutations (Matsumara, I. Unpublished result). This is a slight
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variation of the methodology published for the production of a (3-glucoronidase 
mutant library by cassette mutagenesis (Rowe, L.A. et al., 2003).
4.4.3.1 Establishment of wpepPCR methodology
To investigate a protocol for a whole-plasmid error prone PCR (wpepPCR) method 
the pUC18 plasmid vector was used for a control experiment. This plasmid provided 
a convenient way to monitor the rate of mutagenesis as mutations inactivating the (3- 
galactosidase gene in the plasmid could be detected by blue and white screening. It 
should be remembered that this is a large underestimate of the actual rate of mutation 
since only changes in the amino acid sequence inactivating the enzyme are detected 
whilst during the generation of a library it is the changes altering, but not inactivating 
the enzyme, that are important. However it was considered a suitable system for 
preliminary investigation into the mutagenesis strategy.
Selection of a suitable enzyme for amplification required not only a polymerase that 
could complete the PCR of the whole plasmid but also the ability to manipulate the 
mutation rate by addition of manganese. Investigation into the suitability of 3 
different DNA polymerases, Pfu turbo, Tth/vent (vent was not able to yield a product 
of the right size alone) and Taq, was carried out by amplification of the plasmid in 
the presence of varying concentration of manganese. The enzymes were chosen for 
their proven ability to amplify long Sections of DNA (Cheng, S. et al., 1994) and 
their different proof reading activity. Pfu turbo is a high fidelity polymerase 
(Lundberg, K.S. et al., 1991) producing an amplified plasmid, which can be directly 
transformed in to an E.coli host. The Tth/vent combination should have minor 
proofreading capability, from the vent, whilst taq has no 3’-5’ exonuclease activity 
so is not capable of proof reading at all. The use of a T4 DNA polymerase step to fill 
in any gaps in the plasmid product and a ligation step should enable transformation 
of the PCR products from all of the enzymes.
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Table 4.2: Results of whole plasmid error prone PCR of pUC18
The fidelity of different DNA polymerises was tested by PCR amplification of the 
pUC18 plasmid (Section 2.9.2), at different manganese concentrations, 
transformation of the resulting products and analysis of the rate of inactivation of the 
p-galactosidase gene by blue-white screening.
Enzyme [Mn'+]mM
Blue
colonies
White
colonies
%
Inactivated
0 165 1 0.6
Vent/Tth 0.01 603 17 2.8
0.1 785 26 3.3
0 889 7 0.8
Pfu turbo 0.01 763 4 0.50.04 421 7 1.7
0.1 699 12 1.7
0 164 13 7.9
Taq 0.01 105 10 9.50.04 184 21 11.4
0.1 28 6 21.4
I l l
The wpep PCR protocol was found to be successful for the pUC18 control plasmid 
(Table 4.2). Each polymerase enzyme yielded detectable PCR product of the correct 
size although smearing was apparent for all but Pfu (Gels not shown). 
Transformation was successfully carried out for all the reactions and the resulting 
colonies analysed by blue and white screening by plating on X-gal. Pfu turbo 
yielded the highest number of colonies with the lowest mutation rate. This was as 
expected since this enzyme has been specifically engineered to carry out high fidelity 
amplifications and manganese has little effect on the efficiency of the proof reading 
activity. The Tth/vent polymerase combination also showed the ability to yield a high 
number of colonies, again this enzyme blend has previously been found to be very 
reliable for long amplifications (Cheng, S. et al., 1994). The rate of mutation was 
seen to increase with manganese concentration with a 3.3% inactivation rate at the 
highest concentration of Mn2+ tested. Taq polymerase yielded the least colonies 
under the PCR conditions but also the highest rate of mutation, even without Mn2+ 
again as expected since this enzyme lacks proof reading activity.
Since identical conditions were used for each polymerase, whilst information about 
the rate of mutagenesis is gained, the number of colonies is not an accurate measure 
of the ability of the enzyme to carryout the wpepPCR. For example it may be 
possible to improve the number of colonies yielded from the Taq reactions by 
refining the PCR conditions to yield a more defined product band. However, even 
under sub-optimal conditions it may be possible to obtain enough colonies by plating 
more culture to enable a mutant library to be generated.
4.4.3.2 Error prone PCR of ArTAm
When the wpepPCR methodology was transferred to mutate the ArTAm encoding 
plasmid, pQR426, it was less successful. Refinement of the PCR conditions for both 
Taq and Tth/vent produced bands with a little smearing similar to the result with 
pUC18. However, the transformation yielded no colonies. This may have been due 
to the plasmid not being intact, therefore, not able to transform or the quality of the 
plasmid being low due to the presence of other products from the messy PCR 
reactions. Both of these issues were addressed. Firstly, the product band was 
excised from the gel and transformed, again this yielded little success with few 
colonies. Several modifications to the protocol were carried out. These included
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further refinement of the PCR reactions to obtain a more defined product band and 
the treatment of the purified product with a kinase to phosphorylate the 5’terminal, 
DNA T4 polymerase to polish the plasmid DNA by filling in any gaps and T4 ligase 
to ensure re-circularisation, finally the use of primers with an internal restriction site 
were used to enable cleavage and re-ligation at this site. Again this was 
unsuccessful. The reasons for the failure of this technique to work for the ArTAm 
plasmid were not identified and investigation was ceased due to other more 
promising leads.
4.4.4 Site directed mutagenesis of Arg386 of ArTAm
4.4.4.1 Interactions of substrates and Arg386
The binding of a dicarboxylic substrate into the active site of E.coli AspTAm 
involves the interaction of the substrate carboxylate groups with Arg386 and Arg292 
(of the other subunit of the dimer). This has been elucidated from crystallographic 
studies (Jager, J. et al, 1994; Kirsch, J. et al., 1984). Each carboxylic group of the 
substrate forms a coplanar bifurcated bond with the guanidium side chains of the 
corresponding arginine residue. This interaction has also been observed with the 
aspartate transaminase from other species for example pig AspTAm, complexed with 
2-methyl aspartate (Amone, A. et al, 1985). These active site residues are similarly 
conserved in the E.coli ArTAm. Though it is noted that the interaction with Arg292 
of ArTAm is non-essential for catalysis due to the ability of this enzyme to catalyse 
the reaction with aromatic substrates. It is widely accepted that the enzymes 
substrate and active site interactions and catalytic mechanisms are very similar 
(Section 1.10.1) including the interaction of the substrates carboxy group with 
Arg386.
A study of the substrate recognition of ArTAm from Paracoccus denitrificans 
(PdArTAm) gives an insight into the role of Arg386 of E.coli ArTAm in substrate 
binding (Okamoto, A. et al., 1998). The PdArTAm shares only 30% amino acid 
sequence homology with the E.coli enzyme. However, all but three active site 
residues are identified as being conserved or homologous (four residues) between the 
two organisms. These conserved residues include all those with direct contact with 
the PLP cofactor or inhibitor studied. Therefore it is probable that the two ArTAms
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share a common substrate recognition mechanism. Crystallisation of the Paracoccus 
denitrificans enzyme with substrate analogs, maleate and phenylpropionate, enabled 
the interactions of the compounds with the active site to be studied. The interaction 
with Arg386 was observed for both substrate analogs binding to subunit B of ArTAm 
which was in the closed conformation. Conversely it was observed that the binding 
of maleate to subunit A (3-phenyl propionate does not bind to subunit A) did not 
involve the formation of a salt bridge with Arg386 or Arg292. This subunit bound 
maleate weakly but remained in the open conformation.
The desire to use the transketolase non-keto acid products (Figure 4.2), with a 
hydroxyl group in place of the acid, as substrates for the transaminase led to 
investigation into the effect of mutagenesis of the arginine at position 386 on 
catalysis. With the keto acid substrate interaction of the a-carboxylic acid and Arg 
386 occurs during catalysis by ArTAm. It has been shown that this interaction, in 
both ArTAm (Islam, M.M. et al., 2000) and AspTAm (Mizuguchi, H. et al., 2001), 
(Hayaishi, H., et al., 2003a and b), provides the strain in the enzyme for domain 
closure and catalysis to occur. It is possible that the absence of the carboxylic acid 
group contacting with the arginine this residue can be substituted by an amino acid 
that can interact with the hydroxyl which replaces the carboxy acid in the TK 
product.
4.4.4.2 Generation of mutants
Mutants were generated by Quickchange PCR using a wobble primer with the 
sequence encoding amino acid position 386 defined as NNS (Section 2.9.3.1). This 
coding sequence allows the introduction of any of the 4 bases in the first two 
positions but only either cytosine or guanine in the third position. The introduction 
of any amino acid is possible, however, the use of S in the third position, enabling 
insertion either C or G, of reduces the number of degenerate codon sequences 
therefore reducing the number of mutants with different codons but the same amino 
acid at position 386. Access to all 20 amino acids can be achieved in this way. 
Initially 18 mutants were sequenced to investigate the efficiency of the mutagenesis. 
Out of 18 randomly picked colonies sequenced amino acid changes were achieved in 
14 sequences accessing 10 different amino acids (Table 4.3). Additionally 3 were 
wild-type with Arg at position 386 and one was truncated by a stop codon at 386.
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Table 4.3 Plasmids encoding ArTAm 386 variants generated by site directed 
mutagenesis.
The Arg 386 site directed mutants were made via Quickchange PCR using wobble 
primers (Section 2.9.3.1).
Plasmid
Codon encoding position 
386
Amino acid 386
pQ R419 GTG Valine
pQR420 CCC Proline
pQR421 TAG Tyrosine
pQR422 GGG Glycine
pQR427 CTC Leucine
pQR428 TTC Phenylalanine
pQR429 ACC Threonine
pQR430 CAG Glutamine
pQR431 AAG Lysine
pQR432 TCC Serine
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4.4.43  Expression and activity of ArTAm Arg386 mutants
The alteration of a single amino acid residue in a protein can lead to a change in the 
protein structure and can lead to insolubility. Therefore it was first confirmed that 
the transaminase protein was found in the soluble fraction of the host cell for each 
mutant by SDS-PAGE. For each mutant, protein was confirmed in the soluble 
fraction (but was not quantified).
The activity of the ArTAm site directed mutants was then tested with various 
substrates (Section 2.9.3.2). Each mutant strain was tested alongside the wild-type 
BL21gold(DE3) host strain and BL21gold(DE3) pQR416 overproducing native 
ArTAm. The substrate combinations tested were: (1) aspartic acid and phenyl 
pyruvate; monitored for phenyl alanine production, (2) phenylalanine and a- 
ketoglutarate; monitored for phenylalanine formation, (3) phenylaminopropanol and 
phenylpyruvate; monitored for both phenylaminopropanol substrate disappearance 
and phenylalanine formation, (4) phenylalanine and L-erythrulose; monitored for 
phenylalanine disappearance and ABT formation and (5) phenylaminopropanol and 
L-erythrulose; monitored for both phenylaminopropanol disappearance and ABT 
formation. The reactions were sampled over a 6-hour period. It was considered that 
any activity detected under these conditions and within this time frame may be useful 
for further investigation.
The activity of the strain carrying pQR431, encoding the mutant with lysine 
substituting arginine at the 386 position, exhibited activity in reactions (1) and (2), 
each containing known ArTAm substrates comparable to that seen with the ArTAm 
wild-type strain. The other mutants exhibited the baseline activity for these native 
reactions of that measured for the wild-type host strain contributed by the 
endogenous transaminases. For the other substrate combinations no activity was 
detectable for any of the strains tested. In a previously reported study the direct 
substitution of Arg386 with a similarly positively charged lysine in AspTAm from 
E.coli was investigated (Inoue, Y. et a l,  1989). Activity was evident as seen here. 
The mutation was reported to yield a decrease in substrate interaction and catalysis 
with aspartic acid, glutamate, oxoglutarate and oxaloacetate. The decrease in activity 
was demonstrated by a decrease in Vmax and an increase in the Km value upon Arg
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386 substitution. The increase of Km ranged from 3 to 30 fold depending on the 
substrate measured. This was considered due to the inability of the lysine to form the 
strong bifurcated bond with the substrate a-carboxylate and subsequent alignment of 
the substrate in the active site required for catalysis to occur. The measurements 
made in this work were not accurate enough to detect the difference in rate of 
catalysis between the mutant Arg386Lys and the wild-type enzyme. Interestingly, 
whilst the Arg386Tyr mutant showed no measurable product formation a study by 
Danishefsky et al (Danishefsky, A.T. et al., 1991) investigating Arg386Phe and 
Arg386Lys in AspTAm from E.coli reported activity. It is possible that the amount 
of soluble enzyme in our constructed Arg386Tyr strain was low and subsequently 
catalysis was not detectable under the conditions tested.
In the Danishefsky study, the rationale behind the mutation Arg386Tyr was to 
remove the positive charge but to maintain a group capable of interacting with the 
substrate a-carboxylate. The phenylalanine substitution has steric similarity with the 
tyrosine substitution but without the ability to form a hydrogen bond with the 
substrate. A reduction in activity relative to the wild-type AspTAm was observed for 
both mutants. Activity (presented as second order rate constant Kcat/Kni measured 
under single turnover conditions rather than steady state) was measured relative to 
previously determined values for the wild-type enzyme (Cronin, C.N. and Kirsch, 
J.F., 1988). The mutation Arg386Tyr gave a reduction of over 5 orders of 
magnitude. However, the activity was 3 fold greater than measured for Arg386Phe. 
This difference in activity was postulated to be due to the ability of tyrosine 
hydrogen bond with the substrate or small changes in local packing of the two 
different residues.
Any residue that could form an electrostatic contact with the substrate would need to 
be not only chemically compatible but also be orientated in such a way that 
interaction of the side chain with the substrate can occur and induce movement 
required for domain closure. This was investigated in the Danishefsky (Danishefsky, 
A.T. et al., 1991) study where crystallisation of the Arg386Phe was carried out (but 
crystallisation of Arg386Tyr was not achieved). The structure of Arg386Phe implied 
that the orientation of the aromatic group points away from the substrate carboxylate.
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Therefore if the orientation of the tyrosine at this position took a similar position it 
would also point away from the carboxylate thus being unfavourable for the 
hydroxyl to hydrogen bond with the substrate. It is further suggested that the 
orientation of the residue at 386 may affect the positioning of neighbouring residues 
and their interaction with the substrate. Also noted was the length of extension, from 
the a-carbon, of the side chain involved in hydrogen bonding would differ between 
arginine and tyrosine. The nitrogen atoms of the guanidium group of the arginine 
residues extend 6.4 and 6.8 angstroms whilst the tyrosine’s oxygen reaches only 6.4 
angstroms. This may further weaken the hydrogen bonding of the tyrosine with the 
substrate and may account for the large reduction in activity observed relative to 
wild-type. Additionally during this study they also investigated two non-native 
substrates with the mutant enzymes. These were P-glutamate whose carboxylate 
could extend further towards position 386 to enable better interaction, and 
isoglutamine, which has a neutral amide group in place of the carboxylate which may 
make a more favourable interaction with the hydroxyl of Tyr386. However, it was 
observed that the second order rate constant for both substrates was at least 10 fold 
lower than that obtained for glutamate. It was thus postulated that interactions other 
than that with Arg386 stabilise the negative charge of the carboxylate. Therefore the 
catalysis of substrates lacking the acid group may require not only substitution of the 
Arg386 interacting residue but also a change in neighbouring residues in the 3D 
structure to enable the exact positioning apparently required for interaction and 
domain movement. Therefore substituting a single active site residue may not be 
adequate to enable catalysis.
This investigation was not exhaustive of all possible amino acid substitutions at 
position 386. It is possible that one of the amino acids not yet tested could yield the 
desired activity. Additionally, the solubility of some of the mutants was lower than 
others therefore the amount of active protein available for catalysis would have been 
lower. This may have led to activity not being detectable under the conditions tested 
despite lysates from cultures with comparable cell densities being used. However 
this investigation was put aside without further characterisation of the mutants 
generated. This was due to encouraging results from the P-A: P TAm.
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4.5 Substrate specificity of P-A: P TAm
4.5.1 P-A: P TAm activity with L-erythrulose
The activity of the cloned P-A: P TAms was initially determined with the native 
transamination (Section 3.4.3). An initial experiment into the acceptance of L- 
erythrulose was carried out with both the p-A: P TAm from Pseudomonas putida and 
Pseudomonas aeruginosa. In reactions, carried out with 5 mM substrates (Section
2.10.1), both of these enzymes were found to be inactive with L-erythrulose with a p- 
alanine amine donor. L-methylbenzylamine (L-MBA), a known substrate for the co- 
TAm from Vibrio fluvialis (Shin, J.-S. and Kim, B.-G., 2001), was considered as an 
amine donor substrate for the p-A: P TAms with the native ketone substrate 
pyruvate. L-MBA is easier to assay than p-alanine as it does not require 
derivatisation for separation on a C l8 column or detection by UV. The reactions 
with L-MBA as the amine donor can be monitored for both amine donor depletion 
and formation of the resulting acetophenone product in one assay (Section 2.5.5).
The activity in lysates from both the P-A: P TAm strains was tested with L-MBA and 
pyruvate as the amine acceptor substrate (Figure 4.6). The conversion of L-MBA 
and pyruvate, with both of the p-A: P TAm, was found to be very slow with the 
reaction occurring over a matter of hours. The native reaction of p-alanine and 
pyruvate was previously found to rapidly reach steady state at -30% conversion after 
a thirty minute reaction period (Section 3.4.3). The reaction of L-MBA and 
pyruvate, catalysed by p-A: P TAm from Pseudomonas aeruginosa, reached 30% 
conversion of L-MBA to acetophenone after 40 hours. The reaction of the enzyme 
cloned from Pseudomonas putida was slightly less favourable showing lower rates of 
reaction and achieving just 15% percent conversion over the same time period. 
Reactions to test the acceptance of L-MBA and L-erythrulose by the P-A: P TAms 
were carried out simultaneously (Figure 4.7). This reaction proceeded to 20% 
conversion of L-MBA to acetophenone in 40 hours, a third lower than the conversion 
observed with pyruvate as the amine acceptor.
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Figure 4.6: The activity of P-A: P TAm with L-MBA as the amine donor
Reactions containing L-MBA and either pyruvate or L-erythrulose substrates, each at 
5 mM, were set up with lysate from the BL21gold(DE3) E.coli strains 
overexpressing the p-A: P Transaminase from either Pseudomonas aeruginosa 
(P.aer) or Pseudomonas putida (P.put.) alongside a wild-type control. Conditions 
were 25 mM potassium phosphate buffer, pH 7.0 with 0.2 mM pyridoxal phosphate 
cofactor at ambient temperature (~25°C) and agitation at 200 rpm (Section 2.10.1). 
Reactions were sampled and assayed for L-MBA consumption and acetophenone 
formation.
I-"MBA L-erythrulose Acetophenone ABT
Figure 4.7: The reaction scheme for the transamination of L-erythrulose by p- 
A: P TAm from Pseudomonas aeruginosa
Transamination of L-erythrulose by P-A: P TAm using L-MBA as an amine donor.
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A reaction with the p-A: P TAm from Pseudomonas putida, with L-erythrulose, once 
again gave less favourable conversion than the corresponding reaction with the 
Pseudomonas aeruginosa enzyme. Subsequently the p-A: P TAm from 
Pseudomonas aeruginosa was chosen as the candidate enzyme for further substrate 
specificity investigation. The wild-type host strain was tested alongside and yielded 
little acetophenone product formation with either ketone substrate.
It is interesting that L-erythrulose is accepted as a substrate with L-MBA but not with 
the p-alanine amine donor favoured in the reaction with pyruvate. The mechanism 
elucidated for the transaminases involves the binding of the amine substrate, 
dissociation and then binding of the second substrate, no physical interaction of the 
two substrates occurs during catalysis. However it is essential that the ketone 
resulting from the amine substrate should not bind more favourably in the active site 
than the second substrate, This is because the ketone product from the first half of 
the reaction will compete with the ketone substrate entering the active site for 
transamination.
4.5.2 Further investigation of the substrate range of p-A: P TAm from 
Pseudomonas aeruginosa
The acceptance of other related substrates was investigated to try and explore the 
substrate repertoire of the Pseudomonas aeruginosa P-A: P TAm enzyme (Table
4.4). Interestingly it was found that whilst the reaction of p-alanine and L- 
erythrulose produced no detectable product, the reaction with a-alanine and L- 
erythrulose yielded a small amount of ABT (Data not shown). The rate was, 
however, a fraction of that observed with L-MBA and L-erythrulose. All other 
substrate combinations tested yielded no product, under the conditions investigated. 
Notable is the inactivity of the enzyme with acetophenone and P-alanine. In 
retrospect a further interesting reaction would have been acetophenone with ABT. It 
should also be noted that at this stage catalysis was assessed using the p-A: P TAm 
in crude lysate preparations. Therefore the rate of any product accumulation must 
been above the rate of any degradation of the compound by the lysate that may occur 
in order to be detected.
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Table 4.4: Substrate combinations tested with p-A: P TAm
The compound pairs illustrated were tested as substrates, 5 mM, for reactions with p- 
A: P TAm from Pseudomonas aeruginosa (Section 2.10.1). Reactions in 25mM 
potassium phosphate buffer, pH 7.0 with 0.2 mM pyridoxal phosphate cofactor at 
ambient temperature (~25°C) and agitation at 200 rpm, were monitored periodically 
using the HPLC method appropriate to the substrates used, over a 40-hour period.
Amine donor substrate Ketone substrate
Analysis
method
Activity
detectable
o
p-alanine
O
Jv /O H
HO
OH
L-erythrulose
A BT formation N o
nh2
' V *o
a -a la n in e
O
.OH
HO Y  
OH
L-erythrulose
A BT formation Yes
nh 5
L-Methylbenzylamine
OJL .OH
HO
OH
L-erythrulose
A BT formation Yes
nh2
ho\ ^ Y ° h
O
L-serine
OJL /O H
HO
OH
L-erythrulose
A BT formation N o
NH?
L-Methylbenzylamine
O\ o
OH
Pyruvate
L-M BA depletion 
Acetophenone 
formation
Yes
cA
Acetophenone
h2n ^ / ^ oh
o
beta-alanine
L-M BA formation 
Acetophenone 
depletion
No
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Amine donor substrate Ketone substrate Analysis Activity
detected
ABT formation N oNH.
OH
HOOH
OH
L-erythrulose
L-Phenylalanine
Ethylbenzylamine
depletion
NoNH.
OH
Pyruvate
L-Ethylbenzylamine
Ethylbenzylamine
formation
N o
OH
Pyruvate
propiophenone
YesOHH,N. a-alanine formation
(3-alanineand
depletionOH
Pyruvate
beta-alanine
N oa-alanine formationNH,
OH
OH
Pyruvate
D,L-tf)reo-3-phenylserine
N oa-alanine formationNH.
OH
OH
Pyruvate
(S)-2-amino-3-phenylpropanol 
R isomer also tested
Noa-alanine formationNH.
OH
OH
Pyruvate
OH
(1S)-(2S)-2-amino- 
1-phenyl -1-3-propandiol 
(1R)-(2R) isomer also tested
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4.6 Summary
This Chapter describes an investigation into the acceptance of L-erythrulose for 
transamination by the cloned candidate transaminases (Chapter 3). Initially the 
better characterised ArTAm (Section 1.10.1) was investigated. The acceptance of L- 
erythrulose as a substrate was not evident (Section 4.3.1). This was attributed to the 
two key differences between L-erythrulose and the native substrates of the enzyme 
(Section 4.3.3). These are the replacement of the acid functionality with a hydroxyl 
group and the branching of a hydroxyl from the main carbon chain adjacent to the 
carbonyl to be transaminated. Investigation into the acceptance of aromatic amines 
with one or both of these differences was carried out (Section 4.3.3), again no 
acceptance was detected.
The investigation of random mutagenesis strategy for the ArTAm was desirable. 
This was potentially useful for both the enhancement of any modest ArTAm activity 
towards a TK product discovered at this stage and also to provide the methodology to 
generate mutant libraries to screen against other substrates in the future to change the 
specificity of the target pathway. The use of mutator strain XLl-Red proved 
unpredictable and the achieved rate of mutagenesis of the ArTAm was not 
considered sufficiently high (Section 4.4.2). This strategy was subsequently 
abandoned. A second strategy examined was whole plasmid error prone PCR 
(Section 4.4.3). This showed promising results for the control experiments with 
pUC18 but the generation of mutants with the ArTAm encoding plasmid was less 
successful. In the meantime, site directed mutagenesis of the arginine residue 
interacting with the acid moiety of the ketoacid substrate was examined (Section
4.4.4). The mutagenesis of this residue has been previously examined but the 
assessment of the activity of the mutants with a non-keto acid substrate has not been 
reported. Of the twelve mutants assessed one with the substitution of arginine 386 to 
lysine, retained the ability to catalyse transamination with the native substrates. 
Activity was not detectable with L-erythrulose or the other non-keto acid aromatic 
amine substrates with any of the mutants created. Whilst this study was not 
exhaustive of all the possible substitutions at arginine 386 it was ceased due to more 
promising results for the (3-A: P TAms.
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The activity of the P-A: P transaminases of P.aeruginosa and P.putida with native 
substrate P-alanine and desired substrate L-erythrulose was not detected (Section 
4.5.1). Since little is known about the substrate repertoire or structure of these 
enzymes the acceptance of a range of substrates was examined (Section 4.5.2). The 
reaction with L-erythrulose with L-MBA as the amine substrate resulted in product 
formation (Section 4.5.1). The enzyme from P.aeruginosa yielded the highest 
activity under the conditions investigated therefore this was selected as the candidate 
transaminase for further investigation into the target reaction.
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Chapter 5 - Characterisation of the synthesis of 2-amino 1,2,4- 
butanetriol from L-erythrulose by (3-Alanine: pyruvate
Transaminase
The previous chapter described an investigation into the acceptance of L-erythrulose 
as a substrate for transamination. The P-alanine: pyruvate transaminase from 
Pseudomonas aeruginosa was identified as a promising candidate to function in a 
multi- enzyme conversion with transketolase. This enzyme is little studied and the 
reaction of interest (Figure 1.4) has not been reported to date. In this chapter the 
characterisation of the L-erythrulose transamination with the p- A: P transaminase to 
produce 2-amino-1,3,4-butanetriol (ABT) is described.
5.1 Introduction
The purification of the p-A: P TAm was carried out in order to further characterise 
the enzyme for use in series with TK for the bioconversion of TK product L- 
erythrulose to ABT, a useful chiral synthon, containing two stereo centres. The 
purification of an enzyme from the host strain offers the benefit of the removal of 
any competing side reactions that may occur in lysate (or transport problems where 
whole cells are concerned). Once purification has been carried out investigation of 
the reaction of the enzyme with substrates and the effect of products on catalysis can 
be assessed. The operational stability of the enzyme is also studied. The information 
gathered from such studies may be applied to the selection of the conditions for the 
initial demonstration of the synthesis of ABT, via a bioconversion carried out with 
lysate from an E.coli strain constructed to over-express both the TK and p-A: P TAm 
(Chapter 6).
5.2 Characterisation of the transamination of L-erythrulose by P-A: P TAm
5.2.1 Purification of P-alanine: pyruvate transaminase
In order to further study the transamination of L-erythrulose by p-A: P TAm, 
purification of the enzyme was desirable to remove the complications of other 
components in the lysate. The addition of a histidine tag (His6 tag) to an enzyme can 
enable ease of purification from other cellular components by affinity
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chromatography (Porath, J. et al., 1975). The addition of a His6 tag was carried out 
by the insertion of an oligonucleotide, encoding 6 histidine residues, in between the 
Xbal and Ndel sites of the p-A: P TAm encoding plasmid pQR426 (Section 2.4.3.2). 
The new plasmid, encoding the P-A: P transaminase from Pseudomonas aeruginosa 
with an N terminal His6 tag, was named pQR428.
The addition of the histidine residues may cause a change in enzyme conformation 
which can lead to loss of activity and aggregation. Therefore testing of the activity of 
an enzyme after the addition of the histidine tag is important. Lysate from cultures 
of BL21gold(DE3) pQR426 and BL21gold(DE3) pQR428 were compared for 
activity with P-alanine and pyruvate (Section 2.4.3.4). The two strains over 
producing p-A: P TAm, with and without a histidine tag respectively, were found to 
have comparable levels of soluble enzyme and activity profiles for this reaction (data 
not shown). Therefore the addition of the His6 tag is not significantly retarding the 
activity of the P-A: P transaminase.
The p-A: P transaminase was purified to homogeneity by the capture of the His6-tag 
using immobilised nickel-ion affinity chromatography (Section 2.4.3.3). The protein 
concentration of the final preparation was 5.25 mg.mL'1 based on the Bradford assay 
(Section 2.3). The activity of the purified enzyme was verified by enzyme-linked 
assay (Section 2.7.2). This purified enzyme was subsequently used to further 
investigate the characteristics of the p-A: P TAm.
5.2.2 Verification of the transamination of L-erythrulose
The transamination of L-erythrulose was earlier demonstrated by P. aeruginosa 
P-A: P TAm using L-MBA as an amine donor (Section 4.5.1). Further confirmation 
of the transamination of L-erythrulose was obtained by the demonstration that the 
apparent rate of conversion (measured by acetophenone formation), in the absence of 
L-erythrulose, is significantly below that observed when L-erythrulose is present 
(Figure 5.1). In the absence of L-erythrulose a low level of acetophenone production 
by the p-A: P TAm strain was observed. This was -12% of the observed rate of 
acetophenone production in the presence of the L-erythrulose substrate.
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Figure 5.1: Acetophenone formation from the P-A: P TAm catalysed 
transamination between L-MBA and L-erythrulose.
Two reactions were carried out with lysate from BL21gold(DE3) pQR426. 
Reactions contained L-MBA, 10 mM, in 100 mM potassium phosphate buffer, pH 
7.0 with 2 mM pyridoxal phosphate cofactor at ambient temperature (~25°C) and 
agitation at 200 rpm (Section 2.10.2). L-erythrulose, 10 mM was added to one of the 
reactions. A control reaction containing both substrates was carried out with 
BL21gold(DE3) Wild-type host strain. The progress of each reaction was monitored 
by the decline of L-MBA substrate and the formation of acetophenone product 
(Section 2.5.5).
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The apparent turn-over of L-MBA to acetophenone in the absence of L-erythrulose 
may be due to transamination of other molecules with ketone functionality, present in 
the lysate, by the P~A: P TAm. The rate of acetophenone formation by the wild-type 
host strain was 3% of that with the strain BL231gold(DE3), pQR426, over producing 
p-A: P TAm. This implies the majority of acetophenone formation is due to the 
activity of the p-A: P TAm in the engineered strain.
End-point analysis of a similar experiment, using purified enzyme (Section 5.2.1) 
with L-MBA, in the absence of a ketone substrate, yielded no detectable ABT 
product. In the reaction with the L-erythrulose ketone substrate, 1.25 mM of ABT 
product was yielded over a 65-hour reaction period.
5.2.3 Effect of substrate concentration on native reaction
Transfer of an amine group from P-alanine to pyruvate by P-A: P TAm, under the 
conditions tested, is extremely limited with a maximum achievable conversion of 
-30% (Section 3.4.3). Transaminases belonging to the co subclass have previously 
been reported to be subject to both substrate and product inhibition (Shin, J.-S. and 
Kim, B.-G., 1999; Shin, J.-S. and Kim, B.-G., 2001). The initial rate and final 
conversion was monitored at substrate concentrations from 5 mM to 40 mM in 
reactions, with both p-alanine and pyruvate added at the same concentration, using 
the purified P-A: P TAm catalyst. Normalising the data enabled the direct 
comparison of the reaction progress at the different initial substrate concentrations 
(Figure 5.2). The initial rate of catalysis increased with increasing substrate 
concentration, and comparable reaction profiles reaching a final -30% conversion of 
substrate to product, were obtained for each of the reactions. These findings imply 
that it is the reaction equilibrium for this enzyme and not inhibition by the substrate 
or product that is limiting the reactions to 30% conversion under the conditions 
tested.
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Figure 5.2: The transamination of p-alanine and pyruvate at varied initial 
substrate concentrations
Reactions to investigate the transamination of p-alanine and pyruvate by purified P- 
A: P TAm at initial substrate concentrations between 5 mM and 40 mM (Section 
2.10.4) were carried out in 100 mM potassium phosphate buffer, pH 7.0 with 2 mM 
pyridoxal phosphate cofactor at ambient temperature (~25°C) and agitation at 200 
rpm. Catalyst was added as purified transaminase (Section 2.4.3.3) to a 
concentration of 0.61 mg.mL^.The data was normalised against initial substrate 
concentration to enable comparison of the final equilibrium at each substrate charge.
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5.2.4 Effect of substrate concentration on 2-amino-1,3,4-butanetriol formation
The effect of the substrate concentration on the transamination between L-MBA and 
L-erythrulose by purified p-A: P TAm was examined. Substrate concentrations from 
5 mM to 20 mM were investigated. Both substrates were added at the same 
concentration and the progress of each reaction was determined by monitoring the 
formation of ABT after 100 hours. The substrate concentration was found to effect 
the product yield (Figure 5.3) presented as a percentage conversion of the initial 
substrate concentration. As the initial concentration of the two substrates was 
increased from 5 mM to 20 mM the observed conversion of substrate to product 
decreased from 18% of the initial substrate concentration, at 5 mM, to 10%, at 20 
mM substrate. When the production of ABT was compared at increasing substrate 
concentrations it was found to increase whilst the percentage conversion of substrate 
to product was reduced. This implies that it is the equilibrium limiting the reaction at 
the lower substrate concentrations rather than the product reaching inhibitory levels. 
At higher substrate concentrations where higher levels of product are reached it is 
possible that the product reaches inhibitory levels and therefore product inhibition 
should be assessed (Section 5.2.5).
The (O-TAm from Vibrio fluvialis has been found to suffer substrate inhibition from 
both amine and ketone substrates (Shin, J.-S. and Kim, B.-G., 2001). In order to 
investigate the effect of the individual substrates of the erythrulose transamination 
independently, one substrate was held at 10 mM whilst the other was varied over a 5 
to 40 mM range. The effects on the initial rate of conversion and the ABT product 
formation (Figure 5.4) were examined. Increasing the concentration of either L- 
erythrulose or L-MBA from 5 mM to 10 mM showed an increase in both the initial 
rate (Figure 5.4 (A)) and the concentration of ABT produced (Figure 5.4 (B)). 
Therefore, it is likely that the reaction is being limited by subsaturating substrate 
supply when the concentration of either substrate is 5 mM or below. When either 
substrate concentration is further increased a decrease in both the initial rate (Figure
5.4 (A)) and the yield of ABT (Figure 5.4 (B)) is observed.
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Figure 5.3: Substrate inhibition of P-A: P TAm catalysed transamination of 
L-erythrulose and L-MBA
Inhibition by both substrates was assessed by reactions with varied concentration of 
substrate from 2.5 to 20 mM (Section 2.10.4). Reaction conditions were 100 mM 
potassium phosphate buffer, pH 7.0 with 2 mM pyridoxal phosphate cofactor at 
ambient temperature (~25°C) and agitation at 200 rpm. Catalyst was added as 
purified transaminase (Section 2.4.3.3) to a concentration of 0.61 mg.mL'1. Analysis 
of each reaction was by assaying ABT product formation after a 100 hour reaction 
period.
132
0.04
(A)
•_ 0.03 
.c
E
~  0.02<u
CO
CO
I  0.01
0.00
0 10 20 30 40 50
- a — varied L-MBA
varied L-erythrulose
[substrate], mM
2.0
(B)
2
E
Hm<
0.5
0.0
- a — varied L-MBA 
-■— varied L-erythrulose
10 20  30  40
[substrate], mM
50
Figure 5.4: Individual substrate inhibition of P-A: P TAm by L-erythrulose and 
L-MBA
Inhibition by each substrate was assessed by varying one substrate from 5 to 40 mM 
whilst keeping the other substrate fixed at lOmM (Section 2 .10.5). Reaction 
conditions were 100 mM potassium phosphate buffer, pH 7.0 with 2 mM pyridoxal 
phosphate cofactor at ambient temperature (~25°C) and agitation at 200 rpm. 
Catalyst was added as purified transaminase (Section 2.4.3.3) to a concentration of 
0.61 mg.mL'1. Analysis of each reaction was by assaying ABT product formation 
(Section 2.5.4) over a 100 hour reaction period. A) initial rate of ABT formation, B) 
final ABT concentration achieved.
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The decrease in initial rate, from 10 mM to 20 mM substrate, is slightly higher for L- 
MBA than for L-erythrulose. A 51 % decrease in initial rate at 20 mM L-MBA 
relative to 10 mM is observed whereas at 20 mM L-erythrulose the decrease was 
39%. This effect on initial rate implies that the substrates are inhibitory to the 
reaction. Furthermore a 70 % decrease in the final ABT yield was seen for an 
increase in either substrate concentration from 10 mM to 20 mM. Increasing the 
concentration of either substrate to 40 mM gives a further reduction in initial rate and 
ABT yield.
From the data obtained it is difficult to predict the mode of inhibition of the reaction. 
The substrates may be physically destabilising the enzyme. Inactivation has been 
observed for purified co-amino acid: pyruvate TAm from Vibrio fluvialis which 
suffered complete inactivation by 5 mM (S)- MBA over a 12 hour incubation period 
(Shin, J.S. et al., 2003). Addition of PLP with the MBA counteracts the destabilising 
effect. In the same study the addition of pyruvate enhanced the half-life of the 
enzyme. It is postulated by the authors that the inactivation of the enzyme is caused 
by the formation of E-PMP which is more un-stable than E-PLP. Alternatively the 
substrate could be binding with the enzyme in the incorrect form creating abortive 
complexes, for example the amine bound with E-PMP or the ketone bound to E-PLP. 
Experimental data for the substrate inhibition observed for an co-transaminase from 
Bacillus thuringiensis was consistent with the kinetic model of this mode of 
inhibition (Shin, J.S. and Kim, B.G., 1998).
5.2.5 Investigation into product inhibition of L-erythrulose transamination
Product inhibition can occur when the enzyme has higher affinity for the product 
than the substrate. Therefore the product can inhibit the reaction by competitively 
binding at the active site. Additionally, the product may be toxic to the enzyme, 
destabilising it and therefore reducing the activity over time. Product inhibition of 
the transamination of L-erythrulose was investigated by the addition of both products 
simultaneously at the start of the reaction.
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Figure 5.5: Investigation of the product inhibition of L-erythrulose 
transamination by p-A: P TAm
Reactions were spiked with both acetophenone and ABT at the start of the reactions. 
Reactions contained substrates, 10 mM, in 100 mM potassium phosphate buffer, pH 
7.0with 2 mM pyridoxal phosphate cofactor at ambient temperature (~28°C) and 
agitation at 200 rpm (Section 2.10.6). Catalyst was added as purified transaminase 
(Section 2.4.3.3) to a concentration of 0.61 mg.mL'1. The progress of the reactions 
was monitored by ABT formation (Section 2.5.4).
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The reactions to investigate the effect of the product on the enzyme initially 
contained 10 mM substrates and were monitored for further ABT formation. The 
profiles of reactions spiked with both acetophenone and ABT (Figure 5.5) show little 
deviation from the control reaction, containing no added product. Thus the products 
at concentrations up to 10 mM are not detrimental to the reaction progress. This 
result was confirmed by reactions with the addition of individual products over the 
same concentration range (data not shown). Therefore, at the product levels 
achieved in the previous reactions with p-A: P TAm and substrates, L-erythrulose 
and L-MBA, product inhibition is not limiting the reaction.
5.2.6 Stability of purified P-A: P TAm
The progress of the L-erythrulose transamination reactions have been found to level 
off after approximately 50 hours of incubation at 28°C (Figure 5.5). This has been 
shown not to be attributable to product inhibition (Section 5.2.5), however, there may 
be destabilisation of the catalyst over time. In order to investigate the operational 
stability of the purified enzyme it was incubated under reaction conditions (Section
2.10.2) in the absence of substrate. Aliquots were removed over a 30 hour period 
and activity tested using the native p-alanine and pyruvate reaction (Section 2.4.3.4).
The activity of the enzyme declined over the incubation period with a loss of 19% of 
the initial activity after 30 hours (Figure 5.6). Therefore, over the 75 hour reaction 
period for the L-erythrulose transamination (Figure 5.5) approximately 50% of the 
enzyme activity could be assumed to be lost. This may be exacerbated by increasing 
substrate concentrations, suggested by the inactivation of the enzyme at elevated 
substrate concentrations (Section 5.2.4), but further experiments to investigate the 
effects of substrates and products on enzyme stability are required.
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Figure 5.6: Operational Stability of p-A: P TAm
The purified enzyme at a concentration of 0.61 mg.mL'1 was incubated under the 
reaction conditions of 100 mM potassium phosphate buffer, pH 7.0 with 2 mM 
pyridoxal phosphate cofactor at ambient temperature (~28°C) and agitation at 200 
rpm (Section 2.10.2) in the absence of substrate. Activity was assessed by removal 
of an aliquot and testing for the reaction with native substrates (2.10.2). Results are 
presented as an average of 3 replicates with a 95 % confidence interval.
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5.2.7 Investigation into the L-erythrulose transamination equilibrium position
If the bioconversion is limited by enzyme inactivation before equilibrium is reached, 
then addition of further catalyst should enable a higher yield to be achieved. 
Similarly if the equilibrium position is the limiting factor, then addition of further 
substrate should promote further product accumulation back to the equilibrium 
position. This was investigated by allowing reactions to proceed to the apparent 
equilibrium at 72 hours before making an addition of either more substrate or catalyst 
(Figure 5.7).
In the reaction with the addition of more substrate (with cofactor) no further product 
formation was seen. The addition of more catalyst to the reaction resulted in the 
accumulation of a further 1.2 mM product over a further 70 hours at a slightly lower 
rate. A control reaction was also run with the addition of phosphate buffer. This 
reaction yielded no further product accumulation after 72 hours as expected. These 
results imply that the reaction is being limited by the degradation of the catalyst over 
the long reaction period. Addition of further catalyst resulted in an extra 12 % 
conversion reaching a total of 39 % conversion. Additional experiments are needed 
to further investigate the equilibrium position of the erythrulose transamination by 
the P-A: P TAm.
5.2.8 Determination of the pH optimum of the native P-A: P TAm reaction
Since the duration of the bioconversion is long (>70 hrs) the instability of the 
enzyme has a large impact on the achievable reaction yield. If the reaction rate could 
be increased, by a change in temperature or pH, it may be possible not only to reduce 
the reaction time but also increase the final product yield. This could only be 
achieved if the increase in reaction rate was significantly higher than any increase in 
enzyme instability due to the change in reaction conditions, as well as any elevated 
degradation of the reaction components.
The co-pyruvate transaminase from Pseudomonas sp.F-126 has a reported optimum 
activity at a reaction temperature of 60°C without any apparent compromise of 
enzyme stability over a 10 minute incubation (Yonaha, K. et al., 1977). The co-TAm 
from Vibrio fluvialis JS17 was found to have highest activity at 37 °C, but was
138
rapidly inactivated at temperatures exceeding this over a 30 minute incubation period 
(Shin, J.S. et al., 2003). Aside from the potential impact upon enzyme and reaction 
component stability, temperature increases at industrial scale are often unfavourable 
due to the high energy input required. The temperature optimum of the p-A: P TAm 
from P. aeruginosa was not investigated at this time although it remains a parameter 
that could potentially be manipulated to enhance the activity of the enzyme.
An investigation of pH was carried out, though it should be noted that the use of a 
whole cell biocatalyst expressing an engineered enzyme pathway is desirable. If a 
whole cell catalyst were to be employed the manipulation of pH may have different 
effects on the process to those seen with purified enzyme.
Previously reported investigations have found that several co-transaminases have pH 
optimums of pH 9.0 (Shin, J.-S., et al., 2003) or above (Kim, K.-H., 1963; Yonaha, 
K. and Toyama, S., 1978). TK has a reported pH optimum of 7.5 but retains 90% of 
the maximal activity from pH 6.5 -  8.0 (Mitra, R.K. et al., 1998). Therefore, an 
increase in pH within this range for the multiple-enzyme scheme can be predicted to 
have little detrimental effect on the activity of TK. However, an increase in pH has 
an impact on the stability of the TK reaction components, particularly the substrates 
(Mitra, R.K., 1997), although this could be circumnavigated by feeding the substrates 
at a rate similar to the rate of TK activity to reduce their residence time at the 
unfavourable pH. The pH optimum of the native transamination between P-alanine 
and pyruvate was found to be above pH 8.5 (Figure 5.8) with a near doubling of 
initial rate from pH 7.0 to pH 8.5. A conversion of 30 % was achieved for reactions 
at each pH. Values above pH 9.5 were not investigated due to the likely instability 
of reaction components at higher pH.
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A reaction at 10 mM initial substrate concentration with purified enzyme at a 
concentration of 0.61 mg.mL'1 was monitored for ABT formation (Section 2.5.4) over 
72 hours. Reaction conditions were 100 mM potassium phosphate buffer, pH 7.0 
with 2 mM pyridoxal phosphate cofactor at ambient temperature (~28°C) and 
agitation at 200 rpm (Section 2.10.2). Additions (enzyme added = enzyme + 2 mM 
cofactor, no addition = phosphate buffer only, substrate added = substrates to 
increase reaction concentration by 5 mM + 2 mM cofactor) were then made to three 
reaction samples and the further accumulation of ABT monitored (Section 2.10.7). 
Data shown accounts for volume adjustment, error bars are 95 % confidence 
calculated from triplicate analysis of the control reaction.
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Figure 5.7: Investigation into reaction equilibrium
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Figure 5.8: The effect of pH on the native reaction of p-A: P TAm
The effect of varying the pH from pH 7.0 - 9.5 was investigated by comparison of 
the initial rate of reactions investigated with 10 mM substrates p-alanine and 
pyruvate, in 0.1 M potassium phosphate buffer at the appropriate pH, 2 mM 
pyridoxal phosphate (Section 2.10.2).
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5.2.9 Determination of pH optimum of L-erythrulose transamination
A difference in pH optima has previously been reported for co-TAm from Vibrio 
fluvialis JS17 with different reaction substrates (Shin, J.-S. and Kim, B.-G., 1999). 
In this case the reaction between (S)-MBA and pyruvate had an optimum at pH 9.0. 
However the reverse transamination between L-alanine and acetophenone was found 
to have an optimum of pH 7.0 (comparison of relative activity). The authors 
postulated that the difference in optima between the reactions was due to the 
difference in pKa of the substrates. Therefore, the pH required to enable the 
formation of the internal aldimine during catalysis would be higher for MBA 
(pKa= 10.65) than for L-alanine (pKa=9.69). Additionally there may be an influence 
of pH on substrate binding. At different pH, the amino acid side chains of the active 
site may exist in different protonation states. This could affect the interactions both 
with one another and with the substrate or cofactor molecules.
The results for the effect of pH on native P-A: P TAm activity (Section 5.2.8) show 
that the enzyme activity is higher under more alkaline reaction conditions than pH 
7.0, although no information has been obtained about stability of the enzyme at 
different pH. Therefore the effect of pH between pH 6.0 and pH 8.5, upon the 
transamination of L-erythrulose by the P-A: P TAm, was investigated. Higher pH 
was not considered due to the probability of reaction components being unstable.
Upon examination of the reaction profiles (Figure 5.9 (A)), it is evident that a 
comparison of initial rates could be misleading. Whilst an increase in pH has a little 
effect on the initial rates, the conversion has a distinct pH optimum with the 
maximum accumulation of product being achieved over 70 hours at pH 7.0 (Figure
5.9 (B)). At higher pH values, whilst the initial rate is comparable to that at pH 7.0, 
the rate of reaction quickly slows reaching just 32 % of the product yield obtained at 
pH 7.0 over a 50-hour reaction period. Further experimentation is required to 
determine whether it is the instability of either substrates or products, or inactivation 
of the enzyme leading to the reduced conversion at higher pH. This experiment 
shows that increasing the pH of the bioconversion above pH 7.0 to enhance the 
product yield is not a viable option.
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Figure 5.9: The effect of pH on the transamination of L-erythrulose by P-A: P 
TAm
The effect of varying the pH from pH 7.0 - 9.5 was investigated with 10 mM L- 
erythrulose and L-MBA substrates, 2 mM pyridoxal phosphate with purified enzyme 
at a concentration of 0.61 mg.mL"1 in 0.1 M potassium phosphate buffer at the 
appropriate pH (Section 2.10.2). (A) reaction profiles (B) ABT production over 70 
hour reaction period.
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5.2.10 Demonstration of P-A: P TAm stereoselectivity
At this point in time an assay to determine the chirality of the ABT synthesised by 
the p-A: P TAm is not available. A simple way to demonstrate whether the enzyme 
is enantioselective is to investigate the acceptance of the commercially available L 
and D enantiomers of MBA. This can be used as an indicator of possible chiral 
product synthesis. However, it will not give any indication of the chirality of the 
amine product formed, as the stereoselectivity will be dependent on the ketone 
substrate. The enantioselective substrate dependence of co-transaminases has been 
previously demonstrated for the co-amino acid transaminase from Bacillus 
megaterium with a range of substrates (Stirling, D.I., 1992). Most compounds tested 
were accepted as amine donors in the (S) configuration, however for related 
hydroxylated compounds the (R) enantiomer was preferred.
Reactions using the cloned p-A: P TAm with either one of the single isomers of 
MBA or the racemic D/L-MBA mixture were set up with pyruvate as the amine 
acceptor. The formation of acetophenone was monitored to compare the 
transamination of the different enantiomers (Figure 5.10). It is apparent from the 
data obtained that the L-enantiomer of MBA is accepted as a substrate whereas the 
D-enantiomer is not a desirable substrate. The substrate in the racemic form also 
functioned as a substrate reaching 50% of the conversion reached with the L- 
stereoisomer this is as expected as the racemic mixture contains 50% of the favoured 
L-MBA substrate.
Studies on the (5)-specific co-TAm isolated from Vibrio fluvialis JS17 have shown 
that the (7?)-enantiomer of an amine substrate is not a substrate for the enzyme and 
actively inhibits the rate of reaction of the desired enantiomer (Shin, J.-S. and Kim, 
B.G., 2002a; Shin, J.-S., Kim, B.-G., 2002b). The data collected for the p-A: P TAm 
does not allow the comparison of the initial rates of catalysis of the single enantiomer 
and racemic form of MBA. In order to investigate whether this enzyme is subject to 
inhibition by the ‘wrong’ enantiomer investigation of the initial rates is required.
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Figure 5.10: Investigation into the acceptance of the MBA stereoisomers by 
P-A: P TAm
Reactions were set up with 10 mM pyruvate and 10 mM of the specified MBA amino 
donor with 100 mM potassium phosphate buffer, pH 7 and 2 mM pyridoxal 
phosphate cofactor at ambient temperature (~28°C) and agitation at 200 rpm (Section
2.10.2). Enzyme was added as lysate from BL21gold(DE3) pQR426. Reactions 
were analysed for the formation of acetophenone product (Section 2.5.4).
145
5.3 Summary
In the previous chapter the transamination of L-erythrulose was detected by the 
p-A: P TAm from Pseudomonas aeruginosa. This chapter has further investigated 
the transfer of the amine group between L-erythrulose and L-MBA, using P-A: P 
TAm. In order to simplify the study of the reaction the P-A: P TAm was purified 
(Section 5.2.1). This was carried out by the addition of a histidine tag and 
purification by affinity chromatography on a Ni2+ column.
To confirm that the ABT was the product of the enzyme catalysis, the erythrulose 
ketone substrate was not added. This retarded the formation of both the ABT and 
acetophenone products (Section 5.2.2) implying that the generation of these products 
are dependent on the addition of L-erythrulose.
A summary of the characterisation of the desired transamination of L-erythrulose 
with L-MBA is presented in Table 5.1 alongside the results for the native 
transamination, between P-alanine and pyruvate. Whilst the product accumulation in 
the native reaction proceeds to 30 % over 100 minutes, before ceasing, the desired 
reaction is significantly slower reaching a comparable point over 75 hours. The 
substrate concentration had little effect on the native transaminase reaction up to 40 
mM (Section 5.2.3) whilst increasing the substrate concentration in the 
transamination between L-erythrulose and L-MBA, with purified enzyme, from 10 
mM to 20 mM was detrimental to the reaction progress (Section 5.2.4). The reaction 
products of this reaction had no apparent negative effect on the initial rate nor the 
yield of ABT over the concentration range investigated (Section 5.2.5).
The catalytic activity of the p-A: P TAm was seen to degrade over the long reaction 
period (Section 5.2.6). Addition of fresh enzyme when the product accumulation 
ceased led to further product accumulation (Section 5.2.7). Therefore the reaction is 
being limited by enzyme degradation. It is possible that the negative effect of 
increasing substrate concentration is due to the compounds further destabilising the 
enzyme.
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In order to increase the rate of the reaction to try and improve the rate of product 
accumulation the pH optimum was investigated. Whilst the optimum for the native 
reaction was above pH 8.5 (Section 5.2.8) the L-erythrulose transamination with L- 
MBA achieved the highest product accumulation at pH 7.0 (Section 5.2.9). 
Therefore adjusting the pH to enhance the product yield was not an option.
Finally the stereo selective nature of catalysis was demonstrated by the investigation 
of the use of either the D- or L-isomer of MBA (Section 5.2.10). It was found that 
the L-isomer of this particular substrate was a desirable substrate whilst the D-isomer 
was not. Therefore the enzyme is discriminating between the substrate isomers.
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Table 5.1: Summary of the characterisation of purified P-A: P TAm
The activity of purified P-A: P TAm was characterised for the native reaction with p- 
alanine and pyruvate, and the target transamination of L-erythrulose with the L-MBA 
amine donor.
Parameter investigated Native reaction Target reaction
Yield 30% in 100 minutes 27% in 75 hrs
Substrate inhibition Not detected up to 40 mM > 10 mM
Product inhibition ND Not detected to 20 mM
pH
optimum
Initial rate pH > 8.5 pH 7.0 and above
Conversion ND pH 7.0
Operational Stability 19% decline in activity over 30 hrs
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Chapter 6 - Multi-step synthesis of 2-amino-1,3,4-butanetriol by 
coupled transketolase and p-alanine: pyruvate transaminase
The previous chapter described the characterisation of the candidate p-A : P TAm 
from P.aeruginosa for the synthesis of ABT from L-erythrulose. In this chapter the 
construction of a biocatalyst over-expressing the TK and p-A : P TAm is described. 
The synthesis of ABT using the TK and p-A : P TAm produced by the engineered 
strain is then demonstrated.
6.1 Introduction
The enzymes transketolase and transaminase, working in series have the potential to 
synthesise a product with two new chiral centres from achiral starting compounds. 
The model reaction, to demonstrate this, involves the transfer of a 2 carbon group 
from p-HPA onto glycolaldehyde by transketolase, forming an asymmetric carbon- 
carbon bond, followed by the stereospecific transfer of an amine on the carbonyl of 
the transketolase product by the transaminase, forming 2-amino-1,3,4-butanetriol 
(Figure 6.1).
In order to carry out this synthesis it is desirable to have the two enzymes over­
expressed in a single strain. Compatible plasmids encoding the enzymes have 
already been constructed (Section 3.2.1, Section 3.4.1). These can be used to 
transform the host strain to create the dual plasmid biocatalyst. The use of a dual 
plasmid strain versus a mixed culture of the two single strains has two potential 
advantages. The First is the ability to predict the enzyme concentrations in the 
fermentation. If two strains each expressing one of the enzymes were to be used they 
either could be grown up separately and then mixed to obtain the desired enzyme 
ratio, this is laborious and requires two fermentations, or a fermentation containing 
both strains could be used but maintaining the ratio of enzymes between batches may 
be difficult.
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Figure 6.1: Reaction scheme for the synthesis of ABT by the TK-p-A: P TAm 
enzyme pathway
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In the dual strain control of the expression levels of the individual enzymes can be 
achieved by the manipulation of the promoter. The second advantage may be 
concerning the transport of products. In this work lysate is examined as a catalyst 
but ultimately the evaluation of a whole cell biocatalyst would be desirable. If the 
synthetic enzymes are expressed in separate cells the membrane may impede the 
transfer of products from reactions to serve as substrates for subsequent reactions. 
The advantage of a single host strain for a synthesis involving multiple enzymes is 
exemplified by the synthesis of D-amino acids using D-hydantoinase and N- 
carbamoylase (Park, J.H. et al., 2000). The authors demonstrate the increased yield 
of product from the biocatalyst over-expressing both enzymes compared to a process 
with separately expressed enzymes, achieving yields of 98 % and 71 % respectively 
over a 15-hour reaction period. Significant accumulation of the intermediate was 
detected in the process with the separately expressed enzymes but not with the co­
expressed enzyme. This intermediate has low permeability through the cell 
membrane and, therefore, it is proposed that it is this transport that is limiting the 
reaction progress. If the intermediate is unstable the use of a dual strain may improve 
yields if the rate of the second reaction is sufficiently rapid to overcome 
accumulation of the unstable intermediate.
Once constructed, the growth and activity characteristics of the dual plasmid strain 
must be investigated in order to ensure the biocatalyst is producing an appropriate 
level of each enzyme. Lysate is used at this stage in order to remove any potential 
complications of the transport of reaction components into the cell since the 
transaminase reaction rates have been found to be very slow with isolated enzyme. 
Since there are many cellular components in the lysate it is necessary to evaluate the 
stability of the reaction components in the lysate before assessing the catalytic 
activity. Demonstration of the synthesis of the ABT product via the dual reaction 
can then be carried out and the monitoring of each component can provide a full 
profile of the bioconversion. The relative rates of reaction can then be evaluated and 
a strategy for improving the linked reaction proposed.
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6.2 Construction of the dual TK-f$-A: P TAm strain
In order to investigate the use of the multi-enzyme pathway produced in a single 
E.coli biocatalyst the plasmids pQR411 (Figure 3.1) and pQR426 (Figure 3.9), 
encoding the TK and P-A: P TAm respectively, were transformed into 
BL21gold(DE3) to form a dual plasmid strain over-expressing both enzymes 
(Section 2.11.1). This strain was cultivated in the presence of kanamycin and 
ampicillin to maintain selection for both plasmids. The over-production of both 
enzymes was verified by SDS-PAGE analysis (Figure 6.2). TK was found to make 
up ~ 24 % of the cellular protein and TAm ~ 33 %. These values are slightly lower 
than for the single plasmid strains where TK and TAm made up 33 % and 37 % 
respectively. The higher expression of the transaminase is probably due to the use of 
the T7 promoter in the pQR426 plasmid, which may be stronger than the native TK 
promoter in pQR411. The activity of both enzymes from the dual plasmid strain was 
confirmed with the model reaction for TK (Section 3.2.2) and the native reaction for 
P-A: P TAm (Section 3.4.3), as for the single strains.
The growth profile of the E.coli dual plasmid strain and the activity of both TK and 
p-A: P TAm throughout a typical fermentation are shown in Figure 6.3. The activity 
of TK was constitutive, increasing with cell density. The p-A: P TAm was induced 
with IPTG after 2 hours of growth. Retardation of growth upon induction led to the 
dual plasmid strain reaching 72% of the biomass of the wild-type strain, however the 
retardation was less than for the single plasmid strain BL21gold(DE3) pQR426 , 
which reached only 55% (Section 3.4.4). This may be due to the slightly lower 
overall production of the TAm in the dual strain as discussed above.
6.3 Stability of transamination reaction components
Stability of substrates and products becomes a particular issue over long reaction 
periods such as those observed for the transamination of L-erythrulose (Figure 5.5). 
The stability of the reaction components was therefore assessed by incubation of the 
individual reagents with lysate from the dual plasmid strain BL21gold(DE3) 
pQR41 l+pQR426 (Section 6.2), over-expressing both TK and P-A: P TAm under the 
standard reaction conditions (Section 2.10.2).
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Figure 6.2: SDS page analysis of dual plasmid strain BL21gold(DE3) 
pQR41 l+pQR426
The expression of Pseudomonas aeruginosa p-A: P TAm and TK from the 
constructed E.coli strain BL21gold(DE3) pQR411+ pQR426 was analysed on a 12% 
v/v acrylamide SDS-PAGE gel and stained with commassie blue (Section 2.3). 
Sample lanes: 1= MW marker, lanes 2+3 = replicates of BL21gold(DE3) pQR411 + 
pQR426, lanes 4+5= repeats of wild-type BL21gold(DE3). The dual plasmid strain 
over-expressing both TK and P-A: P TAm shows prominent bands at 50 KDa and 78 
kDa not present in the wild-type strain.
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Figure 6.3: Growth and activity profile of dual plasmid strain BL21gold(DE3) 
pQR41 l+pQR426
Cells were cultured, as for the single P-A: P TAm strain, from a 1/20 inoculum, in 
100 mL nutrient broth, in a baffled shake flask at 37°C, 200rpm (Section 2.4.3.5). 
Growth was monitored by OD 600 nm measurements, induction of p-A: P TAm was 
carried out by the addition of 1 mM IPTG 1 hour after inoculation. TK activity was 
measured by analysis of the initial rate of the model reaction L-erythrulose product 
formation at each time point (Section 2.4.1.3), p-A: P TAm activity was assessed by 
initial rate measurements with native substrates p-alanine and pyruvate (Section 
2.4.3.5). TAm activity is presented at lOOx actual measurement for ease of 
comparison of all data.
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Substrate L-MBA, 25 mM, showed 3.7% depletion with corresponding acetophenone 
formation over a 110-hour incubation (Figure 6.4). This is in keeping with the 
previous result obtained for incubation with the single plasmid strain over-expressing 
p-A: P TAm in the absence of L-erythrulose (Section 5.2.2). This is attributed to the 
ability of the p-A: P TAm to accept other ketones present in the lysate as substrates 
for transamination. L-erythrulose, 15 mM, also exhibited some depletion in the 
presence of lysate from the dual plasmid strain with a loss of approximately 17%, 
over a 75-hour incubation period (Figure 6.5).
A similar experiment was set up with the pathway product ABT, synthesised ‘in 
house’ (Section 2.6.1). Loss of ABT, 5 mM, when incubated with the various 
constructed strains, was detected at a rate of 0.014 mM.hr'1 in each case (Figure 6.6). 
At this rate over 75 hours a total of 1.05 mM of ABT could be lost although it is 
probable that the rate of consumption is concentration dependent. The rate of ABT 
loss was comparable between the strain over-expressing p-A: P TAm and the other 
strains. Therefore ABT product is being consumed by something other than the 
over-expressed p-A: P TAm. This was further confirmed by negligible degradation 
of the product upon incubation with purified p-A: P TAm enzyme. The appearance 
of a peak coincidental with ammonia in the chromatograms (not quantified) for the 
lysate stability experiments, suggests the activity degrading the product is possibly a 
deaminase. Deaminases are numerous in E.coli (10 are listed in the BRENDA 
database (Schomburg, I. et al, 2002)) and play important roles in metabolic 
processes. For example the tRNA adenosine deaminase has been found to play a role 
essential to cell survival, deaminating RNA to form site-specific inosine (deaminated 
adenosine) which can change the codon specificity enabling multiple protein 
products from a single mRNA (Wolf, J., Gerber, A.P. and Keller, W., 2002). 
Therefore a search to identify the pathway of ABT degradation by the cellular 
components would be tricky, and may result in the identification of an enzyme 
whose activity is essential to the cell. Thus, the enhancement of the rate of catalysis 
such that it far exceeds the rate of ABT consumption, is a more viable option than 
engineering a strain. Since ABT is the desired reaction product, this component is 
monitored to follow the transamination of L-erythrulose.
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Figure 6.4: Stability of L-MBA with the cell lysate of E.coli BL21gold(DE3) 
pQR411+pQR426.
L-MBA, 25 mM, was incubated with the lysate of BL21gold(DE3) 
pQR41 l+pQR426 under the reaction conditions, 100 mM potassium phosphate 
buffer, pH 7.0 with 2 mM pyridoxal phosphate cofactor at ambient temperature 
(~25°C) and agitation at 200 rpm (Section 2.10.2). Monitoring of L-MBA and 
acetophenone by HPLC (Section 2.5.5) was carried out over a 110-hour period.
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Figure 6.5: Stability of L-erythrulose with the cell lysate of E.coli 
BL21gold(DE3) pQR411+pQR426.
L-erythrulose, 15 mM, was incubated with the lysate of BL21gold(DE3) 
pQR41 l+pQR426 under the reaction conditions, 100 mM potassium phosphate 
buffer, pH 7.0 with 2 mM pyridoxal phosphate cofactor at ambient temperature 
(~25°C) and agitation at 200 rpm (Section 2.10.2). Monitoring of the concentration 
of L-erythrulose (Section 2.5.2) was carried out over a 75-hour period.
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Figure 6.6: Stability of ABT with the cell lysate of E.coli BL21gold(DE3) 
pQR41 l+pQR426
ABT, 5 mM, was incubated with the lysate of either BL21gold(DE3) pQR411, 
BL21gold(DE3) pQR426 or BL21gold(DE3) wild-type under the reaction 
conditions, 100 mM potassium phosphate buffer, pH 7.0 with 2 mM pyridoxal 
phosphate cofactor at ambient temperature (~25°C) and agitation at 200 rpm (Section
2.10.2). The ABT concentration was monitored over a 120-hour period (Section
2.5.4). An additional reaction contained purified enzyme in place of lysate was also 
carried out. Error bars for reactions containing lysate represent 95 % confidence 
limits from triplicate samples and from triplicate reactions in the case of purified 
enzyme.
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6.4 Demonstration of the model reaction
6.4.1 ABT formation in coupled TK and TAm reactions
The demonstration of the feasibility of the synthesis of ABT was carried out with the 
newly constructed dual strain, directly from achiral substrates glycolaldehyde and (3- 
HPA along with L-MBA amine donor (Figure 6.1). Bioconversions with the dual 
plasmid strain lysate and TK substrates, (3-HPA and glycolaldehyde, were set up in 
the presence of the transaminase amine donor substrate L-MBA and cofactors for 
both enzymes. All three substrates were charged at initial concentrations of either 10 
mM, 15 mM or 20 mM (It should be noted that the substrate for reaction with 10 mM 
substrates was incorrectly charged at 20 mM L-MBA with 10 mM TK substrates). 
Reactions were monitored for final target reaction product ABT over a 110-hr period 
(Figure 6.7). Data was reproducible on separate occasions with different cell-lysate 
preparations.
Data is presented for whole-cell experiments conducted for reactions with 10 mM 
and 20 mM substrates. The transketolase reaction (data not shown) occurred at 
approximately half the rate of the lysate reactions, reaching approximately 50 % 
conversion over the 40 minute reaction period, where the lysate reaction reached 
>98% conversion. Unfortunately the data set for this experiment is incomplete due 
to analytical problems but the ABT accumulation shows similar trends to the reaction 
with lysate. This observed activity may be whole-cell activity although lysis could 
be occurring during the reaction period. This could be tested by assaying the 
supernatant for the activity of TK or p-TAm throughout the reaction.
The reaction profiles for each substrate concentration show the ABT concentration 
increasing throughout the 95-hour reaction period. Production of ABT is, therefore, 
occurring for longer than the 72-hour time period after which accumulation was seen 
to cease with purified P-A: P TAm enzyme due to inactivation (Figure 5.7). It is 
possible that the enzyme is more stable in the environment of the lysate than in the 
purified form. Protein in lysates is often subject to attack by endogenous proteases, 
however, the chosen host BL21gold(DE3) strain is lacking both the La and OmpT 
proteases which reduces such degradation (Studier, W.F., Moffatt, B.A., 1986).
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Figure 6.7: ABT production from one-pot reaction with dual strain expressing 
both TK and p-A: P TAm
The formation of ABT was analysed for reactions set up with dual plasmid lysate. 
Substrates P-HPA, GA and L-MBA were added in equal concentration (10 mM, 15 
mM or 20 mM respectively) at the beginning of each reaction. Reactions contained 
100 mM potassium phosphate buffer, pH 7.0 with cofactors thiamine pyrophosphate,
2.4 mM, MgCb, 9 mM, and pyridoxal phosphate, 2 mM, and were incubated at 
ambient temperature (~28°C) with agitation at 200 rpm (Section .2.10.2). Whole cell 
reactions contained freshly cultivated unlysed induced cells in place of lysate.
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The structure of the closely related co-amino acid pyruvate aminotransferase from 
Pseudomonas sp. F-126 has been determined (Watanabe, N. et al., 1989) to be a 
tetramer comprised of two loosely associated dimers (Section 1.10.2). It is therefore 
possible that the increased instability of the purified p-A: P TAm enzyme may be 
due to the loss of the tetrameric conformation during purification. This could be 
investigated by examining the native form of the enzyme from both lysate and 
purified enzyme preparations.
The concentration of ABT produced increased with the increase substrate 
concentration. This result differs from those obtained for isolated enzyme (Section
5.2.4). The mechanism of substrate inhibition has not yet been determined but it may 
be that the substrates destabilise the enzyme. Therefore, the apparently increased 
stability of the enzyme in the lysate may reduce the detrimental effect of the 
substrate on the enzyme and enable conversion at higher substrate concentrations. 
Whilst the substrate concentrations investigated, selected based on the observations 
with purified enzyme (Section 5.2.4), are far below those required to utilise such a 
process on a commercial scale the results indicate the feasibility of a dual enzyme 
biocatalyst to carry out the synthesis of amino alcohols. Further investigation into 
the effect of increasing the substrate concentration using lysate and whole cell 
preparations is required.
For each concentration of substrate, the conversion of L-erythrulose to ABT reached 
-21% yield over a 95-hour time period. However, it has previously been found that 
the ABT product is degraded by the lysate (Figure 6.6). Therefore, the observed 
concentration of ABT is the cumulative effect of formation and simultaneous 
degradation. Complete analysis of all reaction components was necessary to fully 
assess the reaction. The appearance of an additional peak in the dual conversion, and 
the control using dual lysate with just transaminase substrates, overlapping with the 
product peak requires further investigation (Appendix (E)). This peak occurs only 
where crude lysate is used. The identity of this peak could be determined using an 
LC-MS method but was not examined further here.
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Figure 6.8: Complete analysis of target reaction of TK-|3-A: P TAm pathway
(A) TK reaction analysis (B) (3-TAm reaction analysis
Substrates HPA, GA and L-MBA were added each at 20 mM to reactions containing 
lysate from the dual plasmid strain over-expressing TK and (3-A: P TAm in 100 mM 
potassium phosphate buffer, pH 7.0 with cofactors thiamine pyrophosphate, 2.4 mM, 
MgCB, 9 mM, and pyridoxal phosphate, 2 mM, and were incubated at ambient 
temperature (~28°C) with agitation at 200 rpm (Section 2.11.2). Analysis was 
carried out using 3 separate assays 1) HPA, GA and erythrulose (Section 2.5.2), 
MBA and acetophenone (Section 2.5.5) and 3) ABT (Section 2.5.4).
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6.4.2 Substrate and product mass balance for the coupled ABT synthesis
In order to obtain a process mass balance of the TK P-A: P TAm reaction, analysis 
is required for all substrates and products (except CO2 ) in a one-pot process, with all 
substrates present at the start of the reaction, using the dual plasmid strain. This was 
carried out at initial substrate concentrations of 15 mM and 20 mM. Analysis of the 
TK reaction progress was carried out to completion and the TAm reaction was 
monitored over a 110-hour period. The TAm reaction was monitored for the 
depletion of both L-erythrulose and L-MBA and the formation of ABT and 
acetophenone. The analysis of the dual enzyme reaction with 20 mM substrate 
(Figure 6.8) shows the TK reaction proceeding to >95% conversion within 30 
minutes. The progression of the transaminase reaction is much slower with the 
production of ABT appearing at an initial rate of 0.043 mM.hr'1 with accumulation 
levelling off around 100 hours to give a final overall yield of 21 %. The final yield 
of ABT was 45% lower than the yield of acetophenone generated from the L-MBA.
The rates of acetophenone formation and L-MBA and L-erythrulose depletion were 
comparable at around 0.1 mM.hr'1 reaching a final conversion of ~ 60 %. Therefore 
the degradation of ABT by the lysate during catalysis is resulting in a large yield 
loss. Whilst the rate of degradation has been determined for 5 mM ABT at 0.014 
mM/hr (Section 6.3), it is difficult to predict the degradation during the reaction as 
the rate of loss will be concentration dependent. It may be possible to model the 
degradation if the rate of degradation at several concentrations was obtained. This 
was not attempted due to time constraints. Therefore, the actual rate of catalysis of 
the reaction may be more accurately followed by assessing the acetophenone 
formation.
In order to compare the reactions with different initial substrate concentrations the 
data was normalised to percentage conversion (Figure 6.9). The experiments show 
good agreement with all the components of the transamination from both 
experiments exhibiting comparable trends. The rate of erythrulose consumption for 
the reaction at 15 mM is slightly higher than the rates for L-MBA and acetophenone. 
This can be attributed to the degradation of L-erythrulose by the lysate as determined 
by earlier stability experiments (Section 6.3).
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Figure 6.9: Comparison of TAm catalysis in the dual reaction pathway at 
different substrate concentrations
The data from the dual reaction experiment (Section 2.11.2) with 15 mM and 20 mM 
substrates can be compared with the conversion of each reaction component. 
Substrates HPA, GA and L-MBA were added in equal concentrations (20 mM or 15 
mM) to reactions with 100 mM potassium phosphate buffer, pH 7.0 with cofactors 
thiamine pyrophosphate, 2.4 mM, MgCh, 9 mM, and pyridoxal phosphate, 2 mM, 
and were incubated at ambient temperature (~28°C) with agitation at 200 rpm 
(Section 2.11.2). Analysis was carried out using 3 assays 1) HPA, GA and 
erythrulose (Section 2.5.2) 2) MBA and acetophenone (Section 2.5.5) and 3) ABT 
(Section 2.5.4).
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On comparison of the rates of catalysis of the two enzymes it is apparent that the 
transketolase is far more active than the transaminase in the catalysis of the model 
reaction (Figure 6.1), under the conditions investigated. At 20 mM substrate TK 
yielded erythrulose at an initial rate of 2.1 mM.min'1. The rate of ABT accumulation 
was 0.043 mM.hr'1. This is a difference of nearly 3000 fold. However it has already 
been discussed that the actual turnover of the TAm reaction may be more accurately 
assessed by the rate of acetophenone accumulation. Acetophenone was accumulated 
at a rate of 0.1 mM.hr'1. This is still 1300 times slower than the rate of catalysis 
measured for TK in the reaction.
6.5 Confirmation of enzymatic 2-ammo-l,3>4-butanetriol product synthesis
Further analysis of the reactions from the demonstration of the model synthesis using 
dual lysate was carried out by mass spectroscopy to corroborate HPLC data 
indicating the synthesis of the ABT product. The fingerprints of both ABT 
(Appendix G) and L-MBA (Appendix H) were obtained by MSMS. This was 
necessary, over a single fragmentation to distinguish between the two compounds as 
they are isobaric, therefore, have the same molecular ion. The determination of the 
presence of the ABT product in the enzyme-catalysed reactions was then possible 
(Appendix I).
6.6 Summary
An investigation into the stability of each of the reaction components (Section 6.3) 
under the reaction conditions with dual plasmid lysate, containing both the TK and 
(3-A: P TAm catalysts, revealed the ABT product, at 5 mM, was consumed at a rate 
of 0.14 m M .hr1. Some loss of L-erythrulose was also experienced.
The model reaction was run by the addition of TK substrates p-HPA and GA, which 
are converted to L-erythrulose and the simultaneous addition of amine TAm substrate 
L-MBA, to reactions containing lysate from the constructed dual plasmid strain over­
expressing both TK and P-A: P TAm (Section 6.4). The formation of ABT product 
from the linked enzymes was detected. Interestingly the reaction containing 20 mM 
substrate yielded much greater product concentration than with 10 mM substrates. 
This was unexpected as the experiments to investigate substrate concentration with 
the purified enzyme showed substrate concentrations of above 10 mM reducing
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initial rate and product yield (Section 5.2.4). It is postulated that this result is due to 
reduced stability of the purified enzyme, which increases the susceptibility of the 
enzyme to negative effects from the substrate.
The analysis of each reaction component showed much greater accumulation of 
acetophenone than ABT. This was expected as it was previously determined that the 
ABT is degraded by the lysate (Figure 6.6). The formation of acetophenone was at a 
comparable rate to the depletion of L-MBA and L-erythrulose. It is therefore 
suggested that this rate is indicative of the actual rate of catalysis whilst the observed 
rate of ABT accumulation is a function of the production and simultaneous 
degradation. The rate of TK catalysis is 1300 fold greater than the observed rate of 
TAm activity (by acetophenone accumulation) under the conditions investigated. 
Therefore the reaction of the dual biocatalyst with the model substrate suffers from 
product degradation and does not reach completion (residual substrate present), 
within the 110-hour time period, due to the low rate of catalysis by the transaminase. 
The implications of these findings will be discussed in Chapter 7.
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Chapter 7 - Project summary and future work
7.1 Summary of project achievements
The construction of a novel bacterial biocatalyst over-expressing both transketolase, 
from E.coli and a p-alanine: pyruvate aminotransferase, from Pseudomonas 
aeruginosa, has been achieved. This involved the expression and appraisal of 
transaminase candidates to function in series with the transketolase. This required 
the cloning of the genes into plasmid vectors for expression in E.coli 
BL21gold(DE3) the development of analytical procedures to assess the activity and 
substrate acceptance of the cloned enzymes and the chemical synthesis of the 
aminobutantriol product, the ultimate product of the model reaction for the TK-TAm 
pathway. Once the (3-alanine: pyruvate aminotransferase, from Pseudomonas 
aeruginosa was identified as able to accept the TK product L-erythrulose as a 
substrate, characterisation of the enzyme activity was carried out. Finally the model 
reaction was demonstrated with the coupled TK and TAm using the lysate from the 
constructed dual plasmid E.coli strain.
7.2 Future work
Whilst the ultimate aim of the project was achieved, with the demonstration of the 
de-novo designed linked enzyme pathway (Section 6.4), the yield of the model 
reaction product, ABT, was low. This was due to the low activity of the p-A: P TAm 
with L-erythrulose (and the simultaneous degradation of the product where lysate 
was used (Figure 6.6). The low rate of catalysis led to long reaction times and the 
degradation of the purified enzyme activity (Section 5.2.6) apparently occurring 
before the reaction had run its course. Since it was found that addition of fresh 
enzyme, after product accumulation had ceased, led to the synthesis of further 
product (Figure 5.7), the reaction equilibrium had not been reached. Therefore, the 
potential to stabilise the enzyme may enable higher product yields to be achieved 
from reactions with the purified enzyme. The stability of the enzyme in the lysate 
preparation was not established, however, the longer duration of product turnover 
implied it was more stable than in the purified form (Section 6.4.1). The low 
reaction rates led to low ABT yield due to consumption of the product by other 
cellular components in the lysate. If the rate of production was higher the 
consumption of ABT may have a less significant impact on the yield.
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Mutagenesis could be employed to both enhance the transamination of TK products 
and to increase the stability of the enzyme. At this stage the lack of availability of a 
high resolution crystal structure removes the option of rational mutagenesis. 
Therefore, a random mutagenesis strategy would be required. A mutant library could 
be screened for both enhanced stability and increased activity with L-erythrulose. 
The mutagenesis strategy could be the wpepPCR, which was partially investigated 
(but shelved) during this work (Section 4.4.3). Alternatively the immobilisation of 
the enzyme may enhance stability enabling higher levels product accumulation.
An alternative approach would be to find a related transaminase to be expressed 
alongside TK that has a higher affinity for L-erythrulose. This requires the screening 
of large numbers of enzymes and may require cloning of candidate enzymes in order 
to produce enough catalyst to assess the activity. The acceptance of products from 
TK reactions with different substrates (Table 1.1), such as aromatics, could be 
investigated. Since the TK reaction is so much more efficient than the TAm reaction 
for the model reaction it may be that compromising on TK activity may enable 
synthesis of a product more favourable as a TAm substrate. This could lead to an 
enhanced yield from the transaminase and therefore increase the overall yield of an 
amino alcohol pathway product. Alternatively the TK enzyme could be modified to 
produce a product, which is a more favourable substrate for co-transaminases. This 
may be easier than modifying the activity of the p-A: P TAm since TK is a well 
studied protein, therefore enabling a more rational approach to mutagenesis.
Favourable changes to the TK product may be to replace the 1-hydroxyl with a 
methyl group by the substitution of p-hydroxypyruvate with pyruvate. This would 
require modification of the TK enzyme which has no wild-type activity with 
pyruvate (Miller, O.M., 2004). The resulting product may be a more favourable 
substrate for the transaminase as indicated by the Pseudomonas sp. F-126 co- 
transaminase having lower activity with hydroxylated substrates than their non- 
hydroxylated counterparts (Yonaha, K.a.T., M., 1978) The use of an alternative 
enzyme such as DoxP synthase (Kuzuyama, T. et al., 2000), which similarly 
synthesises carbon-carbon bonds from achiral substrates but naturally uses pyruvate
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and glyceraldehyde-3-phosphate to form xylulose-3-phosphate, creating a 
phosphorylated, less hydroxylated product than TK, could also be investigated. 
Another approach is the production of an aromatic product by transketolase. An 
aromatic compound may be a more favourable substrate to an enzyme of the co 
transaminase subclass, based on the commercial production of a variety of aromatic 
amine products from Celgene using co-transaminases from various sources (Stirling, 
D.I., 1992). The native TK has lower activity with aromatic (Humphrey, A.J. et al, 
2000; Morris, K.G. et al., 1996) substrates than for glycolaldehyde (Table 1.1). 
However the mutagenesis of TK has already been carried out to produce TK mutants 
which require further characterisation (Bacon, S., 2001).
Finally a practical limitation on this work was the availability of analytical assays for 
the efficient monitoring of enzyme activity. This led to the TAm reaction requiring 
three separate assays to fully assess the transamination of L-erythrulose. This is not a 
feasible option when high throughput is required such as mutagenesis studies. An 
alternative analytical technique could be LC-MS. This may enable both the detection 
of all the reaction components by one technique and the identification of any side 
products yielded from the reaction in a single assay. Additionally the development 
of assays, to determine the chirality of reaction products from different substrates, 
are needed.
In summary, possible extensions to this project to further optimise the linked 
pathway are:
>  Mutagenesis of P-A: P TAm to enhance the reaction rate with L-erythrulose.
> Investigation into alternative transaminase candidates.
> Exploration into the acceptance of alternative TK products by the co­
transaminases.
>  Modification of TK to produce a less hydroxylated or an aromatic product.
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